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Preface
The 1981 Progress Report of the Internationa] Joint Commission's Committee
on the Assessment of Human Heaith Effects of Great Lakes Water Quality was
prepared for both the Water Quaiity Board and for the Science Advisory Board.
Highiights from the activities of the Committee from its previous
reporting date, November 1980, to the present, are reported here.
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 Introduction
During the last few years, increasing attention has been given to the
impact of the Great Lakes Ecosystem on man's health. This interest is
reflected in the l978 Great Lakes Water Quality Agreement. The Great Lakes
Science Advisory Board and the Water Quality Board of the International Joint
Commission have established a Committee to evaluate the effects of man's
environment on his health in order to ensure that adequate attention was being
directed toward human health considerations by the Parties to the Agreement.
This report presents a sunmary of the 1980-81 activities of the Committee
on the Assessment of Human Health Effects of Great Lakes Water Quality. In
some instances, the work reported herein is the culmination of studies
initiated several years ago.
One of the major activities of the Committee since its formation has been
a health hazard evaluation of chemicals identified in the Great Lakes Basin as
reported in the l978 Water Quality Board's Report - Appendix E. The Committee
now feels it has gone as far as possible in the health hazard assessment of
these chemicals, until new toxicological or monitoring data become available.
The report on the health hazard assessment is presented in this report.
The Committee has also considered other methods of assessing the potential
effect of environmental contaminants on man's health. For example, a Workshop
on the characteristics and compatibility of cancer registries within the Great
Lakes Basin was conducted. The proceedings of this Workshop with
recommendations made by the participating experts will be published
separately. A summary of these proceedings is presented in this report.
A review of microbiological data collected within the Great Lakes Basin
has been initiated in order to determine the impact of improvements in
treatment and industrial technology and of regulatory changes incorporated by
the jurisdictions bordering the Great Lakes.
The Committee has also examined the problems of obtaining adequate
surveillance data for exposure assessment.
Finally, the Committee has begun to examine areas of future concern such
as the health impacts of energy production, methodologies for the collection
of epidemiological data pertinent to the Great Lakes Basin and the effect on
man's health of exposure to air pollutants.
  
   
1. Health Hazard Evaluation of Chemicals
Identified in the Great Lakes Ecosystem
INTRODUCTION
The most up-to—date compilation of chemicals identified in the Great Lakes
ecosystem is found in the l978 Great Lakes Water Quality Board Report -
Appendix E. Chemicals listed in that report have been identified at least
once in water, sediment or biota in one or more of the Great Lakes. Most of
the compounds were never quantified, nor was any effort made to evaluate the
quality of data and until now no attempt had been made to evaluate the
potential adverse human health effects of these chemicals.
The Committee's interim report in 1980 presented the results of a
preliminary review of the toxicological data base for the chemicals identified
in the list and indicated those of concern from an acute and chronic toxicity
perspective.
The Human Health Effects Committee re-examined the data base for all those
chemicals on the list in 1980-81 and categorized them as follows:
(l) chemicals posing a threat to man from acute exposure; (2) chemicals
causing chronic effects in mammals which are subject to regulatory monitoring;
(3) chemicals which cause chronic effects.in mammals, are not subject to
regulatory monitoring and should be considered for monitoring; (4) chemicals
of minimal health concern due to their presence in the Great Lakes; and
(5) chemicals for which insufficient data are available to conduct a health
hazard assessment. Only with additional monitoring and/or toxicity data will
a more refined estimate of human risk be made.
RESULTS OF ASSESSMENTS
 
Acute Exposures
A number of chemicals stored and transported within the Great Lakes region
have sufficient acute toxicity to be potentially hazardous to human health if
present at high concentrations in local areas. For example spills,
discharges, transportation accidents or unanticipated ground run-off could
seriously contaminate drinking water supplies in discrete areas of the Great
Lakes Basin. Table 1 lists those chemicals already identified in the Great
Lakes that are toxic in small quantities. The assessment is based on the
acute oral L050 value for the rat for which the most extensive data exist.
L050 values determined for other laboratory animals were examined and as
expected illustrated the considerable range in values obtained for individual
compounds due to species variation. To date, no single laboratory animal
species has been identified that is consistently more representative than any
other of the potential toxicity for man for the wide range of chemicals found
in our environment. ' -
Some of the chemicals listed in Table 1 also have chronic effects on
mammals, including man, hence they may also appear in one of the tables
provided in the following section on chronic exposure.
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Extremely toxic chemicals (LDso <50 m9/k9)
Aldrin
Carbofuran
Dieldrin
Dioxin (2.3.7.8-TCDD)
Endosulfan
Endrin
Ethion
Methylmercury (chloride)
Oxychlordane
Toxaphene
Trichlorotrifluoroethane
Very toxic chemicals LDso 50-500 mg oral/kg
Aniline
Bromochloroethane
Carbon disulphide
Chlordane
2-Chloraniline
4-Chloroaniline
o-Cresol
DDT
Diazinon
1,2-Dibromomethane
Dichlorobenzene (ortho-)
Dichlorobutadienes
2,4-Dichlorophenoxyacetic acid
Dichloropropane
1,3-Dichloropropene
2,3-Dichloropropene
Diphenylamine
N-Ethylaniline
Furfural
a-Hexachlorocyclohexane
Hexachlorobutadiene
Kepone
Lindane
Mirex
Pentachlorophenol
Phenol
Photomirex
Tetrachloroethane
Tetrachloropropene (1,1,2,3-)
2,4,5-Trichlorophenoxyacetic acid
Vinyl Bromide
Vinyl Chloride
Elements which form toxic compounds (L050 <500 m9 oral/k9-)
(trioxide3+)
zchloride)
Arsenic
Cadmium
Cobalt
Lead
Mercury
Nickel
Silver
Vanadium
cobaltou52*)
(a1ky14+)
(elementalo)
(acetate2+)
(nitrate3+)
(trioxide3+)
Principal data base:
NIO
SH
Reg
ist
ry
of
Tox
ic
Eff
ect
s
of
Che
mic
al
Sub
sta
nce
s,
197
9,
USH
EW.
  
Chronic Exposure
Assessment of the data obtained by the Committee on chemicals found in the
Great Lakes Basin ecosystem resulted in the identification of more than 60
chemicals that have harmful effects on mammals under conditions of long—term
exposure.
Table 2 lists those chemicals that have chronic effects on mammals and are
currently included in regulatory monitoring programs. Table 3 lists those
that have chronic effects on mammals but are not currently included in
monitoring programs. The Committee considers that the chemicals listed in
Table 3 should be considered for inclusion in various types of monitoring
programs. Sumnary evaluations (toxicity and exposure) for all chemicals
appear in the Appendix.
The Committee has also been able to identify 125 chemicals that are of
minimal concern to human health based on their lack of effects on mammals
under conditions of chronic exposure and/or based on their extremely low
levels in the Great Lakes Basin ecosystem. These chemicals are listed in
Table 4. Some chemicals do exhibit chronic effects but a review of physical
and chemical properties precludes accumulation of significant levels in the
Great Lakes. Similarly, chemicals with incomplete toxicity data bases, but
with extremely low potential for exposure are also included in Table 4.
Table 5 contains a list of chemicals found in the Great Lakes for which
there is a paucity of chronic toxicity data or exposure data. No adequate
assessment of their potential to impact on human health can be made at this
time.
PROCEDURES
Chemical toxicity and chemical exposure constitute the major elements
which provide the foundation for a health hazard evaluation of chemical
contaminants found in the environment. In order to categorize the chemicals
identified in the Great Lakes from the human health perspective it was
necessary to consider the various types and degrees of possible toxic effect
and to censider the potential for route and quantity of exposure. The
criteria used for these evaluations were presented in detail in the 1978
Committee report and are recapped as follows:
Toxicity Evaluation
Following a review of various toxicological data bases such as the
Michigan Critical Materials Register, the U.S. EPA TSCA criteria, NIOSH, and
other institutional classifications and weighting systems, it was decided to
base the toxicity evaluation on six key elements: acute toxicity;
carcinogenicity; reproductive effects; heritable mutagenicity;
neurobehavioural effects; and chronic adverse effects. These elements were
combined under the following headings:
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Che
mic
al
Mon
ito
rin
g P
rog
ram
Aldrin WQO; DQ; F
Arsenic WQO; ow; F
Cadmium WOO; DN
Chlordane NQO; ow; F
Chloroform ow
Chromium WQO; DW
DDT + Metabolites (DDD & DDE) WQO; ow; F
Diazinon ow
2,4-Dichlorophenoxyacetic acid (2,4-D) ow
Dieldrin WQO; ow; F
Endrin N00; DN; F
Heptachlor ow ‘
Heptachlorepoxide DW
Lead WQO; ow
Lindane WQO; Dw
Mer
cur
y (
met
hyl
)
NQO
; o
w;
F
Methoxychlor DH
Mirex WQO; F
Polychlorinated biphenyls (PCBs) NQO; F
Selenium ' WQO; DH
Sil
ver
WOO
-P;
ow
Sil
vex
(2,
4,5
-TP
)
ow
2,3,7,8-Tetrachlorodibenzodioxin (2,3,7,8-TCDD) WQO-P; F
Tox
aph
ene
WQO
; D
w,
F
Dw
- Un
ited
Stat
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ing
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978
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WQO-P - Water Quality Objective proposed by the Aquatic Ecosystems
Obj
ect
ive
s C
omm
itt
ee
- I
JC
Sci
enc
e A
dvi
sor
y B
oar
d
F - Guideline for acceptable levels in fish (health protection)
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Aniline
Carbon tetrachloride
Chlorinated naphthalenes**
Chlorinated terphenyls**
3-Chloro-1-propene
Diazobenzene
1,2-Dibromoethane
Dichlorobenzenes
3,3'-Dichlorobenzidene
Dichlorobutadienes
1,2—Dichloroethane
Diethylhexylphthalate
Di-isobutylphthlate
Dioxane
Ethyl Benzene
Hexachlorobenzene
Hexachlorobutadiene
a-Hexachlorocyclohexane
Hexachloroethane
Nickel
Oxychlordane
PentachlorOphenol
Photomirex
Polyaromatic hydrocarbons
(a) Benzo(a)pyrene
éb; Chrysene
c Dibenz(a,h)anthracene
Polybrominated biphenyls
Styrene
Tetrachloroethylene
Trichloroethylene
Trichlorophenols (2,4,5- and 2,4,6-)
2,4,5-Trichlorophenoxyacetic acid
Vinyl bromide
Vinyl chloride
 
*Se
e A
ppe
ndi
x f
or
inf
orm
ati
on
per
tin
ent
to
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ito
rin
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ons
ide
rat
ion
s o
n a
compound by compound basis.
**M
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nme
nta
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ist
enc
e g
ene
ral
ly
inc
rea
se
wit
h
increasing chlorination.
  
TABLE 4. CHEMICALS FOUND IN THE GREAT LAKES
0F MINIMAL CONCERN FROM A HUMAN HEALTH PERSPECTIVE*
Acenaphthene
Acetone
Anthracene
Benzanthrene
Benzene
Benzo-(k)-fluoranthrene
Benzofluorene
Benzoic acid
Benzothiazole
Benzyl alcohol
Biphenyl
Borneol
Butadiene
Butane
t-butanol
Butene
But-Z-en-l-ol
Buten-3-yne
Butyl phthalyl butylglycolate
Caffeine
Camphene
Camphor
Carbon disulphide
4-Chloro-o-toloxy acetic acid (MCPA)
Cobalt
Copper
Coronene
Cumene
Cyclohexane
Cyclopentane
Decanol
Decyl Cyclohexane
Decanoic acid
Dibenz(def,mno)chrysene
Dibutylphthalate
Dichlorodifluoromethane
Dichloromethane
3,6-Dichloro-2-methoxy benzoic acid
Diethyl benzene
Diethyl ether
Dihexyl adipate
Di-isopropyl ether
Dimethyl adipate (N,N-Dimethylaniline)
Dimethyl biphenyl
2,5-Dimethyl decane
2,6-Dimethyl undecane
Diphenyl methane
Dodecanoic acid
Emim
2-Ethyl-l-hexanol
Ethyl palmitate
Fluorene
Fluoranthrene
Fluorodichlorobromomethane
Formaldehyde
Guaiacol
Heptadecane
Heptadecanoic acid
Heptanoic acid
Hexadecane
Hexadecanoic acid
Hexane
Hexancic acid
Hexene
Isoborneol
Leptophos
Limonene
Linoleic acid
Malathion
Methyl anthracene
‘ Methyl arachidate
Methyl dihydronaphthalene
Methyl dihydroxystearate
Methyleicosane
Methyl ethyl hexanoate
Methyl ethyl ketone
Methyl isobutyl ketone
Methyl laurate
Methyl linolenate
Methyl methacrylate
Methyl myristate
Methyl octadecanoic acid
Methyl palmitate
2-Methyl pentanoic acid
Methyl phenanthrene
Methyl stearate
Myristic acid
Naphthalene
Neopentane
Nonanoic acid
Nonene
Octadecanol
Octanoic acid
Oleic acid
Palmitic acid
Palmitoleic acid
Pentadecanoic acid
Pentane
3-Pentanone
Pentene
Perylene
Phenanthrene
Pinene
Propylbenzene
Propyltoluene
Pyrene
Propanol
Safrole
Salicylic acid
Strontium
Terpene
Terpineol
n-Tetracosane
n—Tetradecane
Tetradecanoic acid
Tetradecanol
Tetradecene
Toluene
1,1,1~Trichloroethane
Trichlorofluoromethane
Trichlorotrifluoroethane
Vanillin
Xylenes
Zinc
*Based on data available on acute or chronic toxicity, neurotoxicity,
reproouctive effects, mutageniCity, carcinogenicity and teratogenicity.
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TABLE 5.
CHRONIC TOXICITY DATA ARE AVAILABLE TO CONDUCT A HEALTH HAZARD ASSESSMENT
CHEMICALS FOUND IN THE GREAT LAKES FOR WHICH INSUFFICIENT
 
6,8,11,l3—Abietate-trien-
18-oic acid
Abietic acid
Acetophenone
Acetovanillon
Alachlor
Alkyl benzene (CioHiu)
Arachidic acid
Atrazine
Behenic acid
B-Benzene Hexachloride
Benzo(b)fluoranthene
Benzo(j)fluoranthene
Benzoérst)pentaphene
Benzo ghi)perylene
Benzo(e)pyrene
p-Bromoanisole
Bromobenzene
Bromodichloromethane
Bromochloroethane
Bromoform
Butylbenzyl phthalate
t-Butyl pyrocatechol
Chloroaniline (2,3, and 4-)
Chlorobenzene
Chlorodehydroabietic acid
Chlorodibromomethane
bis-Z-Chloroethyl ether
bis-(Z-Chloro isopropyl)
ether
Chloronorbornenes
Chloroindole
Chloro-oxo-Dehydro
abietic acid
2-(4-Chlorophenoxy)-2-
methyl propionic acid
Chloropropiophenone
Chlorosyringaldehyde
Chlorotoluene
Chloroveratrole
Chloroxylenes
Chloropyrifos
Cresol
Cyprazine
Decachlorobiphenyl
Dehydroabietic acid
Dehydrodiconiferyl
alcohol
Diazinon
Dibenzo(b,def)chrysene
Dibromochloroethane
Dibromochloromethane
Dibromomethane
Dichlorobenzophenones
Dichlorobutane
Dichlorodiene resin
acids
1,2-Dichloroethylene
Dichloroguaiacol
Dichlorophenol
N-(3,4-Dichlorophenyl)
-N,N'-diethylurea
Dichloropropene
Dichloroveratrole
1,2-Diethoxyethane
N,N-Diethyl aniline
Diethyl phthalate
Dimethoxy acetophenone
3.4-Dimethoxyacetophenone
Dimethoxymethane
Dimethyl disulfide
Dimethyl naphthalene
Dimethyl phthalate
Dimethyl sulfide
Dioctyl phthalate
Diphenylacetaldehyde
- Monochloro derivative
— Dichloro derivative
— Trichloro derivative
Diphenylcumylphenyl-
phosphate
Diphenylnonylphenyl—
phosphate
Dodecanol
Endosulfan
Epibuvabione (methyl
ester)
EPTC (eptan)
2-(2-(2-Ethoxyethoxy)
ethoxy) ethanol
N-Ethylaniline
Ethyl chloride
Fenchyl alcohol
Heptachlor
Heptachlor epoxide
Heptachlorostyrenes
Heptene
Hexachlorobutene
Hexachlorostyrene
Homovanillin
Hydroxybenzothiazole
Hydroxymethoxyacetophenone
4-Hydroxy-3-methoxy-
phenyl acetic acid
4-Hydroxy-3-methoxy-
propiophenone
Indeno(1,2,3-cd)pyrene
Iodo dichloromethane
Isopimaric acid
Lauric acid
Lignoceric acid
o-Methoxyphenol
Methoxyphenol
2-Methoxy-4-propylphenol
Methyl abietate
l-Methyl anthracene
2—Methyl anthracene
9—Methyl anthracene
Methylbenzothiophene
Methyl-t-butyl-ketone
Methyl-2(4-chlorophenoxy)
butanoate
Methyl dehydroabietate
Methyl dichlorophenyl
ether
6-Methyl-1,2-dihydro
naphthalene
Methyl-9,10,-dihydroxy
stearate
4-Methyl-2-ethyl-1,3-
dioxolane
10-Methyleicosane-
Methylene chloride
Methyl-Z-ethylhexanoate
Methyl isopimarate
Methyl 7-ketodehydro—
abietate
Methyl linoelaidate
Methyl naphthalene
Methyl neoabietate
Methyl-7-oxodehydro-
abietate
Methyl pentachlorophenyl
ether
Z-Methyl phenol
Methyl pimarate
szHsan
Methyl sandaracopimarate
Methyl tetrachlorophenyl
ether
Methyl tetrahydrofuran
Methyl thiobenzothiazole
Methyl trichlorophenyl
ether
Metribuzin
Monochlorodiene resin
acid
Monochlorophenol
Naptho-(1,2,3,4,def)-
chrysene
Nonachlor, trans and-cis—
Octachloronaphthalene
7-0xodehydroabietic acid
Pentabromotoluene
Pentachloroaniline
Pentachloroanisole
Pentachlorobenzene
Pentachlorobutadienes
Pentachlorobutene
Pentachloroethane
Pentachloronorbornene
Pentachloropropane
Pentachlorotoluene
Phenylacetic acid
Phenylacetylene
1-Phenyl naphthalene
o—Phenyl phenol
Phenylpropionic acid
Pinene. a- and B-
Prometone
Sandaracopimaric acid
Simazine
B-Sitosterol
Syringaldehyde
Terphenyl
Terpinene
Tetrachloroanisole
Tetrachloroanthracene
Tetrachlorobenzene
Tetrachlorobutadienes
Tetrachlorodiene resin
acids
Tetrachloroguaiacol
Tetrachlorophenol
Tetrachloropropene
Tetrachlorotoluene
Tetrahydrofuran
Tetrahydropyran
Tetrathiohexane
Trans-stilbene oxide
Tribromoanisole
Trichloroaniline
Trichloroanisole
Trichlorobenzene
Trichlorodimethoxyphenol
Trichlorodiene resin acids
Trichloroguaiacol
Trichloropropane
3,4,5-Trichloroveratrole
Trifluralin
Trimethyl bicycle
3.1.1 heptene
Trimethylisocyanurate
Triphenyl phosphate
Trithiapentane
Vanadium
Vanilone
Zytron
b)
d)
e)
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e
scr
een
ed
in
the
pu
bl
is
he
d
li
te
ra
tu
re
and
ev
al
ua
te
d
on
th
ei
r
po
te
nt
ia
l
to
ca
us
e
beh
avi
ora
l c
han
ges
in
ani
mal
s
or
dem
ons
tra
ted
neu
rot
oxi
c e
ffe
cts
.
Sco
res
wer
e a
ssi
gne
d o
n t
he
bas
is
of
con
fir
med
hum
an
ner
vou
s s
yst
em
adve
rse
effe
cts,
conf
irme
d an
imal
neur
opat
hic
or n
euro
toxi
c ef
fect
s,
beh
avi
ora
l
cha
nge
eff
ect
s
in
ani
mal
s a
nd
tes
ted
but
not
dem
ons
tra
ted
to have any neurobehavioural effects; and
Chr
oni
c A
dve
rse
Eff
ect
s:
Lis
ted
che
mic
als
wer
e
scr
een
ed i
n t
he
pub
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hed
lit
era
tur
e a
nd
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ant
ed
for
the
ir
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ent
ial
to
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se
tox
ic
eff
ect
s u
nde
r c
ond
iti
ons
of
lon
g-t
erm
exp
osu
re.
Inf
orm
ati
on
on
tes
ts
involving the sense organs, skin, hepatobiliary, urinary,
car
dio
vas
cul
ar,
res
pir
ato
ry,
blo
od
for
min
g,
lym
pha
tic
, e
ndo
cri
ne,
reproductive and gastro-intestinal systems were evaluated. Scores
wer
e b
ase
d o
n w
het
her
adv
ers
e
eff
ect
swe
re
obs
erv
ed
in
hum
ans
and
were irreversibleor progressive, not observed in humans but in
ani
mal
s,
rev
ers
ibl
e e
ffe
cts
in
hum
ans
or
ani
mal
s a
nd
no
obs
erv
ed
effe
cts.
Weig
htin
g fa
ctor
s we
re a
ssig
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when
it w
as j
udge
d th
at
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ed
hea
lth
fro
m
oth
er
cau
ses
wou
ld
agg
rav
ate
the
eff
ect
of
exposure.
In
man
y i
nst
anc
es
no
inf
orm
ati
on
was
ava
ila
ble
con
cer
nin
g t
he
tox
ici
ty
of
a
che
mic
al
or
ins
uff
ici
ent
inf
orm
ati
on
exi
sts
at
thi
s
tim
e
to
ren
der
a
jud
gem
ent
or
ass
ign
a s
cor
e.
In
the
se
ins
tan
ces
the
che
mic
al
was
ass
ign
ed
to
the
"in
suf
fic
ien
t
inf
orm
ati
on
to
con
duc
t
a h
eal
th
haz
ard
ass
ess
men
t"
or
"mi
nim
al
con
cer
n"
(if
jud
ged
unl
ike
ly
tha
t h
uma
n e
xpo
sur
e c
oul
d o
ccu
r)
categories.
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EXPOSURE METHODOLOGY
Besides
toxicity,
exposure
potential
was
an
important
consideration
in
determining
if
a
compound
was
of
actual
or
potential
concern.
The
evaluation
included
a
review
of
concentration
data
in
Appendix
E
of
the
1978
Water
Quality
Board's
Report
for
compounds
identified
as
having
sufficient
toxicity
data
to
be
of
health
concern.
A
review
of
industrial
discharge,
manufacturing
and
use
data
available
from
several
of
the
Great
Lakes
jurisdictions
followed.
Consideration
was
then
given
to
the
physical
characteristics
of
the
compounds,
their
persistence
in
the
environment
and
their
potential
for
bioaccumulation.
These
elements
were
weighed
for
each
compound
individually.
The
results
of
the
evaluation
for
each
compound
are
given
in
the
Appendix
of
this
report.
The
rationale
for
inclusion
of
each
compound
in
the
several
tables
on
the
grounds
of
exposure
potential
is
evident
from
these
paragraphs.
The
following
sources
were
used
to
determine
exposure
potential
to
chemicals
in
the
Great
Lakes
Ecosystem:
1.
International
Joint
Commission,
Water
Quality
Board:
Appendix
E
-
Status
Report
on
Organic
and
Heavy
Metal
Contaminants
in
the
Lakes
Erie,
Michigan,
Huron,
and
Superior
Basins.
Windsor,
0nt.,
July
1978;
(contains
listing
of
concentrations
of
chemicals
found
in
water,
sediment,
fish,
wildlife
and
air
and
summarily
includes
earlier
findings
on
Lake
Ontario).
2.
State
of
New
York,
Department
of
Environmental
Conservation
Industrial
Chemical
Survey
—
Substances
of
Concern.
(A
computerized
listing
of
substances
handled
or
manufactured
in
New
York.
The
listing
used
for
this
study
included
only
companies
located
in
the
Great
Lakes
Basin
and
did
not
include
compounds
which
the
companies
reported
to
the
State
as
confidential
information).
3.
Acres
Consulting
Services
Limited:
Ontario
Inventory
for
Specified
Chlorinated
and
Aromatic
Hydrocarbons.
Prepared
for
Air
Resources
Branch,
Ontario
Ministry
of
the
Environment,
March
1980,
(contains
information
on
production,
handling
and
emissions
to
water,
air
and
as
sludge
of
17
chlorinated
and
aromatic
hydrocarbons).
4.
State
of
Michigan:
Department
of
Natural
Resources,
Bureau
of
Environmental
Protection.
Critical
Materials
Registration,
Statistical
Report
prepared
November
5,
1980.
(Amounts
used,
discharged
and
disposed
of
as
residuals
in
Michigan
for
30
compounds.)
5.
ISHON
Data
Base,
maintained
for
the
U.S.
Environmental
Protection
Agency
by
the
University
of
Minnesota
—
Duluth,
(bioaccumulation
factors
for
12
compounds
and
octanol/water
partition
coefficients
for
65 compounds).
6.
Information
on
b
i
o
d
e
g
r
a
d
a
b
i
l
i
t
y
c
o
m
p
i
l
e
d
by
staff
of
the
Environmental
Health
Institute,
New
York
State
Department
of
Health.
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7. Ontario Ministry of the Environment: St. Clair River Organics Study:
Biodegradation of Organic Compounds, November, 1980.
(Biodegradability tests on 14 compounds. Biodegradability measured
in terms of increases in bacterial densities upon exposure to 625 to
5000 ppm of the compound.)
8. New York State and U.S. Environmental Protection Agency: Inter-agency
Task Force on Hazardous Wastes, Draft Report. NYS Department of
Environmental Conservation, March 1979. (Listing of contents of
chemical waste disposal sites, some adjacent to Niagara River, in
Erie and Niagara Counties, New York, in four interviews with industry
and haulers).
The main data source (1.-1978 Water Quality Board Report, Appendix E,
above) shows several compounds in the summary listing only, without reference
to sites and concentrations in the text. Information of this type is of
little use. Several compounds have been detected only at one location so far
during intensive surveys designed to identify chemicals near outfalls from a
wastewater treatment plant which receives industrial wastes. In some
instances these compounds were not quantified. It is likely that intensive
studies in other parts of the Great Lakes Basin would reveal additional
locations for these and other compounds.
A good example is the work by Hites, gt_al;, on the Buffalo and Niagara
Rivers, New York (see: Proceedings of the Division of Environmental Chemistry,
ACS, 2nd Chemical Congress of the North American Continent, Las Vegas, 24-29
August, 1980). Several compound names in Appendix E do not refer to defined
chemical species but to mixtures (eg. chlorinated naphthalenes, chlorinated
terphenyls). Additional monitoring with species identification is required
for a meaningful evaluation of exposure potential for these groups of
compounds.
DISCUSSION
The hazard evaluation reported herein is as complete as possible, based on
present published data. It must not be construed as final; changes will occur
as new data are published. It must also be realized that the evaluation is
based on the production, use, transportation, release, etc., into the Great
Lakes Basin of the chemical named. The hazard these chemicals may pose
elsewhere is not addressed.
Surveillance programs that lead to lists of chemicals found in the Great
Lakes, such as Appendix E in the 1978 Great Lakes Water Quality Board Report,
should include information on the concentrations of the chemicals found, the
number of times they are found and looked for and more exact information on
location and ecosystem compartment. Chemicals which demonstrate limited
potential for human exposure are unworthy of additional expensive toxicology
testing; however, those with known exposures but poorly defined toxicity
require testing immediately. In turn, more information on uses, physico—
chemical properties, transport and disposal and production (inventory) data
will be needed for those chemicals having an adequate toxicological data
package. Such information will assist in prioritizing compounds for further
toxicity testing, as well as indicating future monitoring needs.
12
 
 Further efforts by the Parties on assessing the heaith significance of
chemicais found in the Great Lakes shouid await deveiopment of some of the
above information. It is a iong, resource intensive process, to carry out
detaiied hazard assessments on chemicals identified (not quantified) oniy once
in oniy one ecosystem compartment.
Adoption of the 1978 Water Quaiity Agreement represents an evoiution in
philosophy which refiects the need to understand the reiationship of
contaminants in the environment and their impact on humans. In order to
fuifiii the obiigations provided in Annex 12 to the Agreement, it is essentiai
that monitoring and surveiiiance programs provide data which can support the
needs for assessing human heaith risks. These goais can be accompiished if
the Committee's recommendations concerning toxicoiogicai and exposure data
needs are adequateiy addressed in the future.
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2. Environmental Assessments Necessary to
Support Human Health Considerations
The 1978 Great Lakes Water Quality Agreement acknowledged that Great Lakes
water quality is a function of the interactions between the air, land, water
and biota of the environment. Adoption of this ecosystem approach extends the
impact of the Great Lakes Agreement activities to human health. Recognition
of this aspect appears in the General Principles, Toxic Problem Anticipation,
Environmental Monitoring Requirements and Research Needs sections of Annex
12. Adoption of these annexes reflects an evolution in philosophy which
acknowledges a need for understanding the relationship between contaminants in
the Great Lakes and the health of man. Therefore, the rationale for
environmental monitoring must include consideration of the data requirements
necessary to evaluate human health impacts and the monitoring specifications
necessary to provide data for conducting health risk assessments. The need
for data to support human health considerations was emphasized at the 1981
Great Lakes Regional Workshop on Ocean Pollution Monitoring. There it was
determined that one rationale for changing the strategy of the Great Lakes
International Surveillance Plan (GLISP) and U.S. National programs was to
provide data adequate for determining the impact of fish contaminant levels 0
human health. ~
The fields of public health and environmental science have progressed from
the contaminant discovery and identification phase to the current emphasis on
interpretation of the toxicological meaning of these substances with respect
to man. Health problem prevention has become a public health goal. In order
to fulfill this philosophy it is necessary that anticipation and assessment
become operational objectives. With respect to the Great Lakes, this includes
surveillance to determine the presence of contaminants in drinking water,
contact water and food and assessment to define the location, quantity and
nature of potential human exposure.
Historically, surveillance and monitoring efforts have often been oriented
toward the mission of contaminant identification, enforcement monitoring and
remedial action evaluation. These objectives, while sufficient for
identifying the source of pollutants for initiation of legal or remedial
programs, have often not been adequate for fulfilling the needs of the human
health assessment goal. Too often the health profession is faced with
insufficient data upon which to make accurate estimates of exposure and
accordingly, risk. As a result, advisories must often be made on an intuitive
or subjective basis instead of on a scientifically sound assessment.
The following example illustrates this point. Routine environmental
enforcement surveillance detected the presence of dichlorobenzidine in
sediments and in 6 out of 10 carp and suckers taken near the outfall of an
industry at the eastern end of a large lake which connects to Lake Michigan.
This sampling was adequate to support enforcement action against the
offender. However publication of the findings raised concern about possible
human exposure and the advisability of issuing fish consumption warnings for
15
 
   
the lake. The data provided were not sufficient to formulate an accurate
judgement.
Unanswered were questions such as:
are other species
contaminated; are all carp and suckers contaminated or only fish at the
eastern end of the lake; is "6 out of 10" an accurate indication of the extent
of contamination in the two species or an artifact of the sampling location;
what is the range of contamination; is the whole lake affected; etc? Without
additional monitoring data a judgement on the public health aspect of the
newly identified problem could not be addressed in a reasonable and equitable
manner. These deficiencies compromised fulfillment of the public protection
goal.
In order to better address the public health aspect of Great Lakes
contamination, monitoring programs must include the following goals:
1. Identify emerging or previously unrecognized contaminantsin
indicator species;
2.
Determine trends in contaminant concentrations in selected monitoring
species; and
3.
Provide adequate data for assessing potential human exposure to
contaminants in air, water and food.
These goals can be met by using a variety of biological indicator and
monitoring species. Fish such as smelt, perch and several of the salmonids
are presently used in Great Lakes monitoring programs and have yielded useful
information for human health assessments. Other animals such as the pigeon
have been used experimentally in Britain for monitoring the effects of
airborne contaminants on lung tissue.
Monitoring domestic dogs and cats can
provide useful information on contaminants in the food chain and the urban
environment.
These have advantages over non-domestic species because owner-
maintained dietary and veterinary records provide additional information for
assessment of environmental contaminant impacts.
Monitoring requirements for adequate human risk assessment are more
stringent than those necessary for other objectives. The major elements which
need to be considered when conducting a risk assessment are outlined in Table
6. The environmental monitoring requirements shown in part IV of the outline
given in Table 6 are extensive and data for each are often not available.
Whenever data are unavailable, assumptions must be made or extrapolations used
to bridge the gaps, making assessment of human exposure and risk a subjective
discipline. The committee emphasizes, however, that environmental
surveillance and monitoring play a key role in supplying sufficient
information to reduce the subjectivity of this process and for the design of
appropriate epidemiological studies.
Prior to the initiation of expensive monitoring programs careful
consideration needs to be given to the following aspects:
1.
2.
3.
4.
5.
selection of the indicator species;
time and site of collection of specimens;
number of specimens required;
best representative specimen to analyse or examine;
laboratory analyses required;
16
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III
IV
VI
VII
TABLE 6. FACTORS CONSIDERED IN HUMAN RISK ASSESSMENT
Identification of Contaminants (surveiIIance)
Nature of the Contaminant pg:_§g
a) chemicaI properties
b) bioaccumuIation/bioconcentration/tissue storage
c) biochemicai interactions and degradation
d) environmentai fate
Toxicity
a) acute/chronic/persistent/cumuTative
b) toxic interactions with other chemicaIs
c) animaI data/human data
d) metaboIic byproducts
e) type of toxic effect (teratogenic, mutagenic, neurotoxic,
reproductive, carcinogenic)
f) site or target tissue
Sou
rce
, D
ura
tio
n a
nd
Con
cen
tra
tio
n o
f E
xpo
sur
e (
Mon
ito
rin
g)
a) matrix (fish, birds, mammais/water, air, Iand)
b) Iocation (area specific/widespread)
c) species invoIved/human consumption
d)
stat
isti
caII
y va
Tid
esti
mate
of m
ean
and
rang
e of
conc
entr
atio
n
e) reIationship between concentration and size and age
f) Iocation of contaminant within monitoring species
9) trend of concentration (increasing/decreasing)
h) route of exposure
1) persistence/transformation products
) consumption rates (estimates)/dose estimates
Identification and Characterization of Human PopuIation(s)
PotentiaIIy Exposed
Use of Risk Prediction Modeis for Estimates of Disease Outcome
EvaIuation of Existing Judgements/Guideiines/Opinions/AcceptabIe
Daiiy Intake Guides
VIII Subjective Judgement Based on Best Avaiiabie Information
 6.
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ou
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of
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t
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 3. Summary: Workshop on the Compatibility
of Great Lakes Basin Cancer Registries
INTRODUCTION
The 1978 Water Quality Agreement reaffirmed the commitment between Canada
and the United States in the protection of Human Health by the elimination of
toxic transboundary pollutants. One means of assessing the chronic and
carcinogenic effects of toxic chemicals in the Great Lakes Basin is a detailed
evaluation of cancer rates in the population residing in this region.
The Committee on the Assessment of Human Health Effects of Great Lakes
Water Quality realized the need to identify and determine the risks of cancer
development in a region inhabited by over 37 million people who might be
exposed to the toxic chemicals outlined in Chapter I. Rates of cancer
development can only be determined by the registration of newly diagnosed
cancers in a defined geographic area and using population census information
for the same area. The ability to identify new cases of cancer for research
studies, to monitor trends in cancer rates and to locate regions with
unusually high rates of cancer is contingent upon complete and accurate
registrations. A complete review of cancer incidence in the Great Lakes Basin
is also contingent upon the population coverage and the compatibility of
cancer registries with jurisdictions within the Basin.
A workshop on the compatibility of Great Lakes Basin Cancer Registries was
initiated by the Health Effects Committee and held on March 19-20, 1981.
Participants were representatives of the cancer registries within the Great
Lakes Basin and invited guest experts. The major objectives addressed at the
Workshop were: Cancer registries characteristics; data utilization for
research; and future developments. The specific details of the workshop and
recommendations are published in a separate proceedings, but highlights are
presented of the three major objectives addressed.
CANCER REGISTRIES' CHARACTERISTICS
Total coverage of the Great Lakes population is not yet complete in cancer
registration. The cancer registries in the states of Illinois (a pilot four
hospital registry), Michigan (a pilot pathology reporting system), Ohio
(reporting in Montgomery County only) and Pennsylvania (beginning a pilot
registry system) are not fully developed and require continued support to
achieve statewide implementation. A statewide cancer registry does not
currently exist in Minnesota. The remaining States and Ontario have had
cancer registries covering their total populations for a number of years.
The cancer registries were different in several aspects. The method of
registration was not uniform and some registries were based on pathology
reports, hospitalized cases of cancer or more thorough methods of case
ascertainment. Different methods of data collection and coding also affect
the compatibility of cancer information between registries. However, all
registries were collecting the essential information on cancer patients:
name; address; birth date; age at diagnosis; sex; site of cancer; histology;
and method of diagnosis.
19
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The
utility
of
cancer
registry
data
for
research
is
highly
dependent
upon
the
quality
of
data,
completeness
of
registration,
population
coverage
and
method
of
data
collection
and
coding.
The
differences
which
exist between
registries
may
create
problems
in
combining
data
from
several
registries.
However,
these
problems
would
be
minimized
when
analyses
of
cancer
rates
were
conducted
only within
specific
registry
jurisdictions.
Several
cancer
registries
have
sufficient
numbers
of
cancer
cases
and
could
begin
detailed
analysis
of
cancer
incidence
rates.
FUTURE DEVELOPMENTS
The
participants
recognized
that
insufficient
information
on
the
toxic
chemicals
in
the
Great
Lakes
Basin
(notably
concentration
levels,
specific
locations
and
lack
of presumed
health
effects)
would
hamper
the
planning
of
any
specific
studies
conducted
by the
cancer
registries.
Several
types
of
studies
identifying
high
cancer
rate
areas
could
be
conducted
using
currently
available
cancer
morbidity
and mortality
data.
The
participants
also made
specific
recommendations
as
to
the
types
of
toxic
chemical
information
desired,
the
focus
of
additional
research
of non—cancer
outcomes
and
the
utilization
of
human
tissues
or
fluids
to
assess
environmental
exposures.
CONCLUSIONS
The workshop
provided
a unique
opportunity for
cancer
registry
representatives
and
invited
experts
to
exchange
useful
information
on
registration
practices
and
cancer
research
in
Canada
and
the
United
States.
The
meeting
accomplished
the
goals
which
were
initially
set
out
and
the
forum
created
new
professional
contacts
which
will
enhance
cancer
registration
interaction
and
may
induce
further
compatibility
in
the
years
ahead.
The
cancer
registries
will
be
willing
and
able
to
undertake
specific
research
projects.
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 4. Potential Human Health Impact of
Microbiological Contamination of
the Great Lakes
TECHNOLOGY CHANGES
Public water supplies drawing water from the Great Lakes are unlikely to
contribute to the incidence of microbial infections in the population, given
the current level of wastewater treatment which is required by the
jurisdictions and the conventional full treatment applied at water treatment
plants.
However, witha view to reducing both the effects of chloride residuals on
aquatic life and the generation of chlorinated substances which may be harmful
to man, suggestions have been made that the amount of chlorine in wastewater
effluents be reduced or alternative disinfectants used. Further, the
jurisdictions have been encouraged to adopt formal policies of seasonal
chlorination for such effluents.
Additionally, the formation of products which may be harmful to human
health during the chlorination of potable water may result in modifications
being made to the conventional treatment train at water plants.
Constant vigilance is required to ensure that alterations in established
sewage and waste treatment practices do not compromise the microbial quality
of Great Lakes waters and expose the public to an unacceptable risk from the
presence of bacteria and viruses in drinking recreational water.
RECREATIONAL USES
The quality of Great Lakes Waters is sufficiently high, with few
exceptions, that continued enjoyment of recreational uses of the water by the
public in most areas can reasonably be expected to continue for an indefinite
time. It must be emphasized, however, that the few areas where the quality of
water is poor correspond to those immediately adjacent to large metropolitan
areas, where recreational use is most desired. Increased efforts to improve
microbiological quality in these areas must be continued, bacterial indicator
levels must be monitored and pathogen levels determined. Notwithstanding the
presently perceived quality of the water, measurement of bacterial indicator
levels must continue and the most modern technology should be employed to
ensure that the water quality is adequately characterized so that any adverse
trends can be discerned. New trends such as increased thermal input,
agricultural runoff and changes in precipitation quality should be evaluated
in relation to possible modifications to the viability, survival or
replication of micro-organisms of human health significance.
The Committee, whilst endorsing current methods of determining pollution
levels and consequent health impacts, would emphasize that there is no method
at the present time to accurately assess exposure and risk levels from
microbiological contamination of surface water. The development of new
technologies, perhaps using physical and/or chemical methods to address this
aspect should be actively pursued by the participating agencies.
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‘ 5. Future Considerations
TOXIC CHEMICALS
The Committee has, on the basis of available data, completed an initial
health hazard assessment of chemicals previously identified in the Great
Lakes. As additional data on exposure and/or toxicity become available to the
Committee, further assessments could be undertaken.
As research identifies new contaminants in the Great Lakes, including
those disposed of as industrial waste byproducts, health hazard assessments
will be attempted.
As a component of man's exposure to toxic chemicals, the potential health
impact of airborne toxics will be addressed by the Committee.
Intervention levels in fish and water will be reviewed with reference to
the chemicals listed in Tables 2 and 3 of this report.
The Committee will assess the present state of the art in the areas of
inmunotoxicology, neurotoxicology and neonatal toxicology to ascertain the
applicability of such methodologies for future health hazard assessments.
Other areas of concern to the Committee relate to the effect of diet, age,
disease, ethnicity and lifestyle on the potential health impact of toxic
chemicals.
EPIDEMIOLOGICAL METHODOLOGIES
 
Early in 1982, a group of resource people will be convened under the
Committee's auspices to develop guidelines for future epidemiological studies
in the Great Lakes Basin. Although general guideline documents are available,
it is considered beneficial to discuss the appropriateness of such guidelines,
given the health data bases available within the Basin jurisdictions and the
specific health questions to be answered. It is hoped to ascertain whether
meaningful epidemiological investigations associating environmental pollution
to specific health effects can be carried out. Concurrently, a small group of
experts will be asked to provide recommendations on appropriate surveillance
methodologies in support of these epidemiological studies.
HEALTH IMPACTS OF ENERGY PRODUCTION
In order to properly address the health impact of alternative energy
sources the following information is necessary: -
' 0o
i) Comprehensive inventories of emissions and residuals from each energy
source; and
ii) Adequate toxicological data on such material. Toxicological data
could include animal experiments as well as epidemiology of
populations exposed and workers in energy related industries.
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 6 Recommendations
HEALTH HAZARD EVALUATION OF CHEMICALS IDENTIFIED IN THE GREAT LAKES ECOSYSTEM
1. Inventory and use data shoqu be deveToped for chemicaTs Tisted in
TabTe 3. ATso information on concentrations now in the environment
shoqu be deveToped through carefuTTy considered monitoring programs.
2. For the chemicals found in high concentrations in the environment and
wideTy used, routine monitoring shoqu be carried out to deTineate
man's exposure.
3. The Parties shoqu be urged to deveTop toxicity information for the
chemicaTs in TabTe 5, which have an inadequate data base, are wideTy
used in the Great Lakes Basin and are identified as contaminants
therein.
4. The Parties shoqu update Tists of chemicaTs in the Great Lakes
providing quantification, Tocation of sampTing, frequency of
identification and ecosystem compartment.
5. More intensive efforts shoqu be expended to identify industriai
byproducts which have been discharged or are now stored within the
Great Lakes Basin.
ENVIRONMENTAL ASSESSMENTS NECESSARY TO SUPPORT HUMAN HEALTH CONSIDERATIONS
1. Great Lakes monitoring and surveiTTance programs shoqu address
themseTves more cToseTy to the requirements cited as necessary to
support human heaTth risk assessments.
WORKSHOP ON THE COMPATIBILITY OF GREAT LAKES BASIN CANCER REGISTRIES
1. The jurisdictions shoqu be urged to take into account the
recommendations deveToped by the Cancer Registries Workshop when
deveToping programs in the Great Lakes Basin.
POTENTIAL HUMAN HEALTH IMPACT OF MICROBIOLOGICAL CONTAMINATION
OF THE GREAT LAKES
1. MicrobioTogicaT monitoring of Great Lakes waters shoqu be continued
to reveaT trends in the water quaTity which may deveTop as a resuTt
of the introduction of new treatment and industriaT technoTogies into
the Basin. ‘
2. Research efforts shoqu be directed towards the deveIopment of a
suppTementary test which more cToseTy correTates with a risk of
infection from pathogenic micro-organisms.
25
 3. The development and/or application of an improved strategy for
reporting waterborne diseases occurring as a result of water use
within the Great Lakes Basin shouid be encouraged.
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 APPENDIX
TOXICITY PROFILES
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APPENDIX
EXPOSURE
AND
TOXICITY
PROFILES
OF
91
CHEMICALS
FOUND
IN THE GREAT LAKES
Note:
These
exposure
and
toxicity
profiTes
are
brief
summaries
of
data
usefuT
for
preIiminary
hazard
and
risk
assessments
of
chemicais
found
in
the
Great
Lakes.
They
do
not
summarize
all
research
pubTished;
however,
they
do
attempt
to
present
up—to-date
information
(and
references)
on
the
chemicaT
characteristics
of
each
compound.
A
more
comprehensive
Titerature
search
wouId
provide
additionaT
information.
New
research
resuTts,
as
they
become
avaiTabTe,
shoqu
be
carefuTIy
considered
as
they
could
affect
the
hazard
and
risk
assessments
for
these
compounds.
THESE
ASSESSMENTS
ADDRESS
THE
IMPACT
ON
THE
HEALTH
OF
PERSONS
IN
THE
GREAT
LAKES
BASIN.
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A. PROCEDURE AND CRITIQUE OF SOURCES OF EXPOSURE PROFILES
 
The following sources were used to determine exposure potential to
chemicals in the Great Lakes Ecosystem:
1.
 
International Joint Commission, Water Quality Board: Appendix E -
Status Report on Organic and Heavy Metal Contaminants in the Lakes
Erie, Michigan, Huron, and Superior Basins). Windsor, Ontario, July
1978 (contains listing of concentrations of chemicals found in water,
sediment, fish, wildlife, and air).
State of New York, Department of Environmental Conservation
Industrial Chemical Survey - Substances of Concern. (A computerized
listing of substances handled or manufactured in New York. The
listing used for this study included only companies located in the
Great Lakes Basin and did not include compounds which the companies
reported to the State as confidential information).
Acres Consulting Services Limited: Ontario Inventory for Specified
Chlorinated and Aromatic Hydrocarbons. Prepared for Air Resources
Branch, Ontario Ministry of the Environment, March 1980, (contains
information on production, handling and emissions to water, air and
as sludge of 17 chlorinated and aromatic hydrocarbons).
State of Michigan: Department of Natural Resources, Bureau of
Environmental Protection. Critical Materials Registration,
Statistical Report prepared November 5, 1980. (Amounts used,
discharged, and disposed of as residuals in Michigan for 30
compounds). ,
ISHOW Data Base, maintained for the U.S. Environmental Protection
Agency by the University of Minnesota - Duluth (bioaccumulation
factors for 12 compounds, and octanol/water partition coefficients
for 65 compounds).
Information on biodegradability compiled by staff of Environmental
Health Institute, NewYork State Department of Health.
Ontario Ministry of the Environment: St. Clair River Organics
Study: Biodegradation of Organic Compounds, November, 1980.
(Biodegradability tests on 14 compounds. Biodegradability measured
in terms of increases on bacterial densities upon exposure to 625 to
5000 ppm of the compound.)
New York State and U.S. Environmental Protection Agency:
Inter-agency Task Force on Hazardous Wastes, Draft Report. NYS
Department of Environmental Conservation, March, 1979. (Listing of
Contents, based on interviews with industry and haulers, of chemical
waste disposal sites, some adjacent to Niagara River, in Erie and
Niagara Counties, New York.)
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The main data source (Appendix E of the IJC Water QuaTity Board) shows
severaT compounds in the summary Tisting onTy, without reference to sites and
concentrations in the text. Information of this type is of Tittie use.
SeveraT compounds have been detected only at one Tocation so far during
intensive surveys designed to identify chemicaIs near outfaIIs from wastewater
treatment piants which receive industria] wastes. In some instances these
compounds were not quantified. It is TikeTy that intensive studies in other
parts of the Great Lakes Basin that are simiIarTy affected woqu reveaI the
presence of these and other compounds. A good exampTe is the work by Hites,
et aI., on the Buffan and Niagara Rivers, NewYork (see: Proceedings of the
DTstion of Environmentai Chemistry, ACS, 2nd ChemicaI Congress of the North
American Continent, Las Vegas, 24-29 August, 1980). The Committee feeTs that
additionai intensive surveys of this kind shoqu be undertaken. Severai
compound names in Appendix E do not refer to defined chemicaI species but to
mixtures. This information cannot be used because the component species
differ in soTubiIity, biodegradabiIity and toxicity (e.g., chIorinated
naphthaTenes, chTorinated terphenyis).
8. DEFINITIONS AND INFORMATION ON SUBSECTIONS OF TOXICITY PROFILES
1. The PermissibIe Exposure Limit is a work-shift (8 hr/day, 5 days/wk)
time-weighted average vaTue as defined in 29 CFR 1910.1000.
2. The Immediateiy Dangerous to Life or HeaTth Limit is the vapor-phase
concentration of a given chemicaI from which one couId escape within
30 minutes without any escape—impairing symptoms or any irreversibie
heaIth effects.
3. L050 is the dose that kiITs 50% of the test popuIation.
4. LC50 is the concentration that kiTIs 50% of the test popuIation.
5. LDLO is the Towest Ietha] dose or concentration administered to the
test popuiation.
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 Aniline (CAS Reg No: 62533) (Tables: 1 & 3)
Exposure profile: This synthetic chemical is quite soluble, non bioaccu—
mulating and quite readily mineralized, e.g. in biological wastewater
treatment plants. Although very large amounts are used by the chemical
industry, significant local exposure is expected only in case of a serious
accidental release. Appendix E cites occurrence in a waste effluent. No
quantification is given.
Toxicity profile:
Oral L050: Found to be 440 mg/kg (rat, mouse) and 195 mg/kg (dog) (1).
Carcinogenicity: Based on current information aniline is not believed to be a
human or animal carcinogen (30). Subcutaneous injections of 1 mg/kg in
mice over 2 years produced no tumors (67).
Chronic Adverse Effects: Repeated exposure in man (inhalation, dermal) may
cause headache, irritability, insomnia, dizziness, decreased appetite,
pale
ness
and
anem
ia (
44).
Dogs
, ra
ts,
mice
and
guin
ea p
igs
expo
sed
to 5
ppm in air daily for 5 months showed no ill effects other than slight
methemoglobinemia in rats. Heinz body formation in erythrocytes has also
been detected in man (67).
CNS Effects: In humans, confusion, ataxia, vertigo, tinnitus, weakness,
disorientation, lethargy, drowsiness, convulsions and coma can occur (67).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in standard Salmonella assay, but becomes mutagenic
with co-mutagen harman.
Permissible Exposure Limit: (OSHA) 19 mg/m3 (42).
Inmediately Dangerous to Life or Health: (OSHA) 100 ppm (42). Lowest lethal
dose for humans: 50 mg/kg (67).
Existing Environmental Regulations: None known.
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y st
ages
of p
oiso
ning
caus
e at
axia
, a
nore
xia
and
nau
sea
.
Inf
lam
mat
ion
of
muc
ous
epi
the
liu
m i
n t
he
res
pir
ato
ry
sys
tem
is
comn
on a
s ar
e si
gns
of d
erma
l ke
rato
sis
and
mela
nosi
s.
Neur
olog
ical
sign
s
and malignant transformations also occur (40).
CNS
Eff
ect
s:
Sen
sor
y p
eri
phe
ral
neu
rit
is
aff
ect
ing
han
ds
and
fee
t c
an
lea
d t
o
motor paralysis (40).
Reproductive Effects: No data found.
Ter
ato
gen
ici
ty:
Ars
ena
tes
and
ars
eni
tes
(Na
sal
ts)
hav
e b
een
sho
wn
to
be
ter
ato
gen
ic
for
rat
s,
ham
ste
rs
and
mic
e
in
the
10-
45
mg/
kg
ran
ges
whe
n f
ed
during mid-gestation (55).
Mut
age
nic
ity
:
Mam
nal
ian
in
vit
ro
stu
die
s h
ave
sho
wn
dos
e-d
epe
nda
nt
mut
age
nic
eff
ect
s
fol
low
ing
exp
osu
re
to
sod
ium
ars
ena
te.
Chr
omo
som
e
bre
aka
ge
and
stru
ctur
al
anom
alie
s ma
y be
asso
ciat
ed w
ith
occu
pati
onal
expo
sure
(40)
.
Perm
issi
ble
Expo
sure
Limi
t:
The
Drin
king
Wate
r Gu
idel
ine
in C
anad
a is
0.05
mg/L (40). ACGIH gives a value of 0.5 mg/m3 (43).
Imnediately Dangerous to Life or Health: 10-25 mg/kg (orally) of arsenic
trioxide.
ExistingﬁEnvironmental Regulations: None known.
Rec
omm
end
ati
on:
Ars
eni
c c
omp
oun
ds
hav
e v
ary
ing
acu
te
tox
ici
tie
s
but
som
e
cou
ld
be
of
con
cer
n i
n t
he
eve
nt
of
hig
h l
ocal
con
tam
ina
tio
n.
In
add
iti
on
it
has
chr
oni
c t
oxi
cit
y e
ffe
cts
of
con
cer
n t
o h
uma
n h
eal
th.
The
ele
men
t
appe
ars
to b
e ad
equa
tely
moni
tore
d fo
r th
e pu
rpos
e of
publ
ic h
ealt
h
protection.
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Be
nz
en
e
(C
AS
Re
g
No
:
71
43
2)
(T
ab
ie
:
4)
Ex
po
su
re
pr
of
ii
e:
Th
is
pe
tr
oc
he
mi
ca
I—
de
ri
ve
d
an
d
sy
nt
he
ti
c
co
mp
ou
nd
is
ex
tr
em
ei
y
co
mm
on
as
a
so
Iv
en
t,
as
an
in
du
st
ri
ai
ra
w
pr
od
uc
t
an
d
in
mo
to
r
fu
eI
s.
Fr
om
av
ai
Ia
bI
e
da
ta
,
an
nu
aI
us
ag
e
in
th
e
Gr
ea
t
La
ke
s
Ba
si
n
ma
y
be
in
th
e
or
de
r
of
I
mi
II
io
n
to
ns
,
wi
th
we
II
ov
er
1,
00
0
to
ns
re
ie
as
ed
as
I
wa
st
e
an
d
a
gr
ea
te
r
am
ou
nt
em
it
te
d
as
ve
hi
cI
e
ex
ha
us
t.
Th
e
co
mp
ou
nd
is
vo
ia
ti
ie
,
si
ig
ht
iy
so
iu
bi
e
in
wa
te
r,
mo
de
ra
te
iy
ac
cu
mu
ia
ti
ve
bu
t
ai
so
bi
od
eg
ra
da
bi
e,
pa
rt
ic
ui
ar
iy
un
de
r
ae
ro
bi
c
co
nd
it
io
ns
.
Wh
il
e
hi
gh
er
co
nc
en
tr
at
io
ns
un
do
ub
te
dI
y
wi
IT
no
t
pe
rs
is
t
in
th
e
en
vi
ro
nm
en
t,
To
w-
Ie
ve
i
ba
ck
gr
ou
nd
co
nc
en
tr
at
io
ns
in
th
e
or
de
r
of
1
to
5
ug
/L
ca
n
be
ex
pe
ct
ed
to
ex
is
t
in
ma
ny
ar
ea
s
an
d
ar
e
co
nf
ir
me
d
by
th
e
fe
w
st
ud
ie
s
th
at
ha
ve
be
en
co
nd
uc
te
d.
Th
ey
mo
st
Ii
ke
r
in
di
ca
te
a
st
ea
dy
st
at
e
co
nd
it
io
n
of
co
nt
in
uo
us
in
pu
ts
an
d
bi
od
eg
ra
da
ti
on
.
Toxicity profiie:
Or
a)
L0
50
:
Ra
ng
es
be
tw
ee
n
3,
80
0—
4,
70
0
mg
/k
g
in
va
ri
ou
s
ro
de
nt
sp
ec
ie
s
(1
).
Ca
rc
in
og
en
ic
it
y:
St
ud
ie
s
wi
th
mi
ce
di
d
no
t
un
eq
ui
vo
ca
IT
y
in
di
ca
te
th
at
be
nz
en
e
wa
s
ca
rc
in
og
en
ic
(7
5)
.
Th
er
e
ar
e
so
me
in
di
ca
ti
on
s
th
at
be
nz
en
e
ac
ts
as
a
co
ca
rc
in
og
en
in
hu
ma
ns
;
it
ma
y
be
a
Ie
uk
em
og
en
.
Be
nz
en
e
Te
uk
em
ia
is
ac
ut
e
st
em
ce
II
or
my
eI
ob
Ia
st
ic
Te
uk
em
ia
,
so
me
ti
me
s
aT
eu
ke
mi
a
(6
7)
.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
Ra
ts
ex
po
se
d
5
hr
/d
ay
,
5
da
ys
/w
k
fo
r
5-
8
wk
s
to
44
x
an
d
47
pp
m
de
ve
io
pe
d
a
mo
de
ra
te
de
gr
ee
of
Ie
uk
op
en
ia
.
Th
is
wa
s
no
t
ob
se
rv
ed
at
co
nc
en
tr
at
io
ns
of
15
-3
1
pp
m.
In
an
ot
he
r
st
ud
y
50
%
of
ra
ts
ex
po
se
d
to
50
pp
m
fo
r
60
0
hr
ex
hi
bi
te
d
bi
ia
te
ra
i
ca
ta
ra
ct
s.
It
ha
s
be
en
ob
se
rv
ed
th
at
in
ad
eq
ua
te
di
et
ar
y
pr
ot
ei
n
in
ta
ke
ha
s
a
be
ar
in
g
on
th
e
’
de
ve
Io
pm
en
t
of
be
nz
en
e
to
xi
ci
ty
.
30
0
pp
m
be
nz
en
e
fo
r
6
hr
/d
ay
,
5
da
ys
/w
k
fo
r
Ti
fe
pr
od
uc
ed
Iy
mp
ho
cy
to
pe
ni
a,
mi
id
an
em
ia
an
d
si
ig
ht
Iy
re
du
ce
d
Ii
fe
sp
an
in
ra
ts
.
Th
er
e
wa
s
no
ev
id
en
ce
of
Ie
uk
em
ia
.
Co
nt
in
ue
d
or
re
pe
at
ed
sk
in
co
nt
ac
t
ma
y
ca
us
e
er
yt
he
ma
,
bi
is
te
ri
ng
an
d
de
rm
at
it
is
.
In
ma
n,
ch
ro
ni
c
ex
po
su
re
ha
s
be
en
re
po
rt
ed
to
ca
us
e
th
ro
mb
oc
yt
op
en
ia
,
/
Ie
uk
op
en
ia
,
my
ei
oc
yt
ic
an
em
ia
an
d
Ie
uk
em
ia
.
Ot
he
r
sy
mp
to
ms
in
cI
ud
e
\
he
ad
ac
he
,
To
ss
of
ap
pe
ti
te
,
dr
ow
si
ne
ss
,
ne
rv
ou
sn
es
s,
pa
il
or
,
pe
te
ch
ia
e
an
d
W
ab
no
rm
ai
bI
ee
di
ng
.
An
em
ia
ma
y
pr
og
re
ss
to
co
mp
le
te
ap
Ia
si
a
of
bo
ne
ma
rr
ow
‘
6 .
CN
S
Ef
fe
ct
s:
Do
gs
in
ha
ii
ng
be
nz
en
e
de
mo
ns
tr
at
ed
pa
ra
iy
si
s
of
th
e
va
so
mo
to
r
sy
st
em
(6
0)
.
In
ma
n,
di
zz
in
es
s,
To
ss
of
eq
ui
ii
br
iu
m,
hy
pe
rk
in
es
is
,
tr
em
or
s,
pa
ra
iy
si
s,
un
co
ns
ci
ou
sn
es
s,
co
nv
uI
si
on
s,
co
ma
an
d
en
ce
ph
an
pa
th
y
have been observed (67).
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
Re
du
ct
io
ns
in
Ii
tt
er
si
ze
ha
ve
be
enr
ep
or
te
d
(5
5)
.
\
Te
ra
to
ge
ni
ci
ty
:
Pr
eg
na
nt
ra
ts
ex
po
se
d
to
1
to
67
0
mg
/m
3
(v
ap
or
)
di
d
no
t
\
pr
od
uc
e
si
gn
if
ic
an
t
nu
mb
er
s
of
ma
if
or
me
d
fe
tu
se
s,
ho
we
ve
r,
th
e
nu
mb
er
of
fe
tu
se
s
pe
r
Ii
tt
er
in
th
e
hi
gh
er
do
se
gr
ou
ps
wa
s
re
du
ce
d.
Pr
eg
na
nt
ra
ts
ex
po
se
d
to
2,
20
0
pp
m
(v
ap
or
)
pr
od
uc
ed
no
ma
lf
or
me
d
fe
tu
se
s,
al
th
ou
gh
in
so
me
ca
se
s
sk
el
et
al
gr
ow
th
wa
s
re
ta
rd
ed
.
Mi
ce
in
je
ct
ed
wi
th
3
mg
/k
g
pr
od
uc
ed
of
fs
pr
in
g
wi
th
an
in
cr
ea
se
d
in
ci
de
nc
e
of
cl
ef
t
pa
la
te
an
d
m
a
n
d
i
b
l
e
r
e
d
u
c
t
i
o
n
(5
5)
.
Mu
ta
ge
ni
ci
ty
:
Ne
ga
ti
ve
in
Sa
lm
on
el
la
bu
t
in
du
ce
s
ch
ro
mo
so
me
ab
er
ra
ti
on
s
in
cu
lt
ur
ed
ma
mm
al
ia
n
ce
ll
s
(6
5)
.
Th
er
e
ha
ve
be
en
re
po
rt
s
of
va
ri
ou
s
ki
nd
s
of
ch
ro
mo
so
ma
l
br
ea
ks
or
ab
er
ra
ti
on
s
in
wo
rk
er
s
oc
cu
pa
ti
on
al
ly
ex
po
se
d
to
be
nz
en
e;
ho
we
ve
r
th
es
e
ob
se
rv
at
io
ns
ar
e
co
mp
li
ca
te
d
by
si
mu
lt
an
eo
us
ex
po
su
re
to
ot
he
r
co
mp
ou
nd
s
(2
).
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
1
pp
m
(O
SH
A)
(4
2)
an
d
10
pp
m
or
30
mg
/m
3
(ACGIH) (43).
In
me
di
at
el
y
Da
ng
er
ou
s
to
Li
fe
or
He
al
th
:
2,
00
0
pp
m
(O
SH
A)
(4
2)
.
Pr
ob
ab
le
or
al
le
th
al
do
se
in
ma
n
is
50
-5
,0
00
mg
/k
g
(b
et
we
en
1
te
as
po
on
fu
l
an
d
1
oz
fo
r
a
70
kg
pe
rs
on
)
(6
7)
.
Lo
we
st
le
th
al
do
se
in
ma
n
is
50
mg
/k
g
(o
ra
l)
.
Lo
we
st
do
se
(i
nh
al
at
io
n)
ca
us
in
g
to
xi
c
ef
fe
ct
s
in
ma
n
is
21
0
pp
m
(6
7)
.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
l
Re
gu
la
ti
on
s:
g§
A:
(N
YS
)
—
5
pg
/L
re
co
mm
en
de
d
li
mi
t
in
dr
in
ki
ng
wa
te
r.
Re
co
mm
en
da
ti
on
:
Be
nz
en
e
ha
s
a
lo
w
ac
ut
e
to
xi
ci
ty
an
d
at
ex
is
ti
ng
le
ve
ls
in
th
e
Gr
ea
t
La
ke
s
is
un
li
ke
ly
to
po
se
a
si
gn
if
ic
an
t
ch
ro
ni
c
he
al
th
th
re
at
.
39
 
   
 
  
Benzyl Alcohol (CAS Reg No: 100516) (Table: 4)
Exposure profile: This compound occurs naturally in plants and is of interest
here as a synthetic solvent and industrial solvent. Annual usage is
probably in the range of 10 to 100 tons; the compound has been detected in
an effluent but has not been quantified. Benzyl alcohol is quite soluble
in water and not persistent in the aquatic environment. The compound does
not bioaccumulate.
Toxicity profile:
Oral L050: l,040-1,580 mg/kg in various rodent species (1).
Carcinogenicity: No data found.
Chronic Adverse Effects: Prolonged administration of benzyl alcohol to
fasting animals increases their blood sugar (60).
CNS Effects: Benzyl alcohol causes degeneration of nerve fibers in the area
of injection. In mice subcutaneous injection gave rise to respiratory and
muscular paralysis, convulsions and narcosis (60). There is CNS
depression in humans (74); high doses cause convulsions, followed by
paralysis of the respiratory center (67).
Reproductive Effects: No data found.
Teratogenicity: When 0.01 or 0.02‘mL were injected into a chick yolk sac,
meningoceles and skeletal defects occurred (55). No mammalian data were
found.
Mutagenicity: Negative in Salmonella (65).
Permissible Exposure Limit:
Inmediately Dangerous to Life or Health: Probable oral lethal dose in man is
SOD-5,000 mg (between 1 oz and 1 pint for a 70 kg person) (60).
Existing Environmental Regulations: None known.
 
Recommendation: Benzyl alcohol is unlikely to be a cause for concern for
human health due to its presence in the Great Lakes.
   
 bi
s—
(2
-C
h1
0r
oe
th
y1
)e
th
er
‘
(C
AS
Re
g
No
:
11
14
44
)
(T
ab
Te
:
5)
Ex
po
su
re
pr
of
il
e:
Th
is
co
mp
ou
nd
wa
s
de
te
ct
ed
in
on
e
ef
fi
ue
nt
bu
t
wa
s
no
t
qu
an
ti
fi
ed
.
It
is
di
sc
ha
rg
ed
in
Mi
ch
ig
an
in
am
ou
nt
s
no
t
ex
ce
ed
in
g
10
Tb
s
pe
r
ye
ar
.
No
ot
he
r
in
fo
rm
at
io
n
is
av
ai
Ta
bT
e.
Th
e
co
mp
ou
nd
is
in
so
Tu
bT
e
in
wa
te
r
an
d
vo
Ta
ti
Te
.
Toxicity profiie:
Or
aT
LD
50
:
Ra
ng
es
fr
om
75
mg
/k
g
to
13
6
mg
/k
g
in
ro
de
nt
s
(I
AR
C
V0
1.
9,
19
75
).
Ca
rc
in
og
en
ic
it
y:
Bi
s
2(
ch
io
ro
et
hy
1)
et
he
r
pr
od
uc
ed
an
in
cr
ea
se
d
in
ci
de
nc
e
of
Ti
ve
r—
ce
TT
tu
mo
rs
in
tw
o
st
ra
in
s
of
ma
Te
mi
ce
fo
TT
ow
in
g
or
aT
ad
mi
ni
st
ra
ti
on
.
Su
bc
ut
an
eo
us
in
je
ct
io
n
in
to
mi
ce
pr
od
uc
ed
on
Ty
a
To
w
in
ci
de
nc
e
of
sa
rc
om
as
at
th
e
si
te
of
in
je
ct
io
n
(I
AR
C
V0
1.
9,
19
75
).
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
Ra
ts
an
d
gu
in
ea
pi
gs
ex
po
se
d
vi
a
in
ha
ia
ti
on
to
69
pp
m
fo
r
5
da
ys
pe
r
we
ek
fo
r
13
0
da
ys
ex
hi
bi
te
d
de
pr
es
se
d
gr
ow
th
(8
8)
.
CN
S
Ef
fe
ct
s:
Th
e
fo
iT
ow
in
g
sy
mp
to
ms
ha
ve
be
en
ex
hi
bi
te
d
in
hu
ma
ns
:
ve
rt
ig
o,
si
ow
re
sp
ir
at
io
n
at
fi
rs
t
be
co
mi
ng
sh
aT
To
w
an
d
ra
pi
d,
si
ig
ht
vo
mi
ti
ng
,
un
co
ns
ci
ou
sn
es
s
Te
ad
in
g
to
de
at
h.
Ex
po
su
re
to
10
0
pp
m
ca
us
ed
un
co
ns
—
ci
ou
sn
es
s
on
iy
af
te
r
13
ho
ur
s.
Ma
y
be
na
rc
ot
ic
in
hi
gh
co
nc
en
tr
at
io
ns
bu
t
ex
tr
em
e
ir
ri
ta
ti
on
fr
om
no
n-
na
rc
ot
ic
co
nc
en
tr
at
io
ns
ma
ke
s
th
e
oc
cu
rr
en
ce
of
na
rc
os
is
un
Ti
ke
Ty
(8
8)
.
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
No
da
ta
fo
un
d.
Te
ra
to
ge
ni
ci
ty
:
No
da
ta
fo
un
d.
Mutagenicity: None found.
Pe
rm
is
si
bi
e
Ex
po
su
re
Li
mi
t:
No
da
ta
fo
un
d.
In
me
di
at
ei
y
Da
ng
er
ou
s
to
Li
fe
or
He
ai
th
:
Pr
ob
ab
ie
or
a1
Te
th
aT
do
se
in
hu
ma
ns
is
50
-5
00
mg
/k
g
(b
et
we
en
1
te
as
po
on
fu
i
an
d
1
oz
fo
r
a
70
kg
pe
rs
on
)
(7
4)
.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
i
Re
gu
Ta
ti
on
s:
No
ne
kn
ow
n.
 
Re
co
mm
en
da
ti
on
:
Li
mi
te
d
to
xi
co
io
gi
ca
i
da
ta
in
di
ca
te
th
at
mo
ni
to
ri
ng
to
de
te
rm
in
e
am
bi
en
t
Te
ve
Ts
wo
ui
d
be
wo
rt
hw
hi
ie
.
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 Borneol
(CAS Reg No: 507700)
(Table: 4)
Exposure profile:
This camphor-related chemical occurs naturally in plant
material but it is also used in the synthesis of pharmaceuticals and
antiseptics.
It has been discovered as a minor constituent in pulp and
paper mill effluent.
It is readily biodegradable and not expected to lead
to measurable human exposure from water
in the Great Lakes.
Toxicity profile:
Oral L050:
No L050 values found but the LDLO in rabbits is 2,000 mg/kg (1).
Carcinogenicity: No data found.
Chronic Adverse Effects: No data found.
CNS Effects:
May cause dizziness and convulsions (71), hallucinations
delirium, tremor, general CNS depression and coma (74).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in Salmonella (65).
Permissible Exposure Limit: No data found.
Imnediately Dangerous to Life or Health: Probable oral lethal dose in man is
50-500 mg/kg (between 1 teaspoon and 1 oz for a 70 kg person) (67).
Existing Environmental Regulations: None known.
 
Recommendation: Based on its biodegradability and low levels in water,
Borneol is not of particular concern for human health due to its presence
in the Great Lakes. Monitoring is not recommended.
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 1-Bromo-1-Chloroethane
Exp
osu
re
pro
fil
e:
Thi
s c
omp
oun
d i
s v
ola
til
e a
nd
pro
bab
ly
non
~bi
ode
gra
dab
le.
It
is
a r
aw
pro
duc
t f
or
the
syn
the
sis
of
flu
oro
car
bon
s.
It
has
bee
n
det
ect
ed
in
was
tew
ate
r d
isc
har
ges
to
the
Gre
at
Lak
es
and
in
the
wat
er
col
umn
of
Lak
e M
ich
iga
n
in
tra
ce
con
cen
tra
tio
ns
(1
to
2 u
g/L
).
Sig
nif
ica
nt
exp
osu
re
is
unl
ike
ly,
exc
ept
in
cas
e o
f a
cci
den
tal
rel
eas
e.
Toxicity profile:
Ora
l
L05
0:
Est
ima
ted
ora
l
L05
0
in
rat
is
64
mg/
kg.
Carcinogenicity: No data found.
Chronic Adverse Effects: No data found.
CNS Effects: No data f0und.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: No data found.
Permissible Exposure Limit: No data found.
Immediately Dangerous to Life or Health: No data found.
Existing Environmental Regulations: None known.
 
Rec
omm
end
ati
on:
Alt
hou
gh
exp
osu
re
is
lik
ely
to
be
low
, f
ew
dat
a o
n i
ts
long
-ter
m ef
fect
s on
man
or a
nima
ls w
ere
foun
d,
henc
e no
adeq
uate
ass
ess
men
t o
f h
aza
rd
or
ris
k c
an
be
mad
e.
Mon
ito
rin
g i
s n
ot
rec
omm
end
ed
except possibly in industrial effluents.
(CAS Reg No: 25620546) (Tables: 1 & 5)
1,
3-
Bu
ta
di
en
e
(C
AS
Re
g
No
:
10
69
90
)
(T
ab
ie
:
4)
Ex
po
su
re
pr
of
il
e:
Th
is
im
po
rt
an
t
ra
w
pr
od
uc
t
fo
r
th
e
ma
nu
fa
ct
ur
e
of
sy
nt
he
ti
c
ru
bb
er
is
pr
ob
ab
iy
us
ed
in
th
e
Gr
ea
t
La
ke
s
Ba
si
n
in
si
gn
if
ic
an
t
qu
an
ti
ti
es
.
It
has
be
en
de
te
ct
ed
(bu
t
not
qu
an
ti
fi
ed
)
in
a
di
sc
ha
rg
e
to
th
e
De
tr
oi
t
Ri
ve
r.
As
a
wa
te
r-
in
so
iu
bi
e
gas
,
ho
we
ve
r,
it
is
not
of
concern as an aquatic poiiutant.
Toxicity profiie:
Ora
i
L0
50
:
5,
48
0
mg
/k
g
(ra
t)
and
3,
21
0
mg
/k
g
(m
ous
e)
(1)
.
Carcinogenicity: No data found.
Chr
oni
c A
dve
rse
Eff
ect
s:
Dai
iy
exp
osu
re
of
var
iou
s
sma
ii
ani
mai
spe
cie
s
to
6,
70
0
pp
m
ov
er
8 m
on
th
s
re
su
it
ed
in
no
si
gn
if
ic
an
t
ch
ro
ni
c
ef
fe
ct
s
(44
).
Rab
bit
s
exp
ose
d
to
200
,00
0
to
250
,00
0
ppm
onc
e
dai
iy
for
15
to
21
day
s
sh
ow
ed
no
de
ie
te
ri
ou
s
ef
fe
ct
s
(67
).
Wo
rk
er
s
ex
po
se
d
to
bu
ta
di
en
e
va
po
rs
(pu
rit
y u
nsp
eci
fie
d)
com
pla
ine
d
of
irr
ita
tio
n
to
eye
s,
nas
ai
pas
sag
es,
throat and iungs (44).
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mu
ta
ge
ni
ci
ty
:
Po
si
ti
ve
in
Sa
im
on
ei
ia
(65
).
Pe
rm
is
si
bi
e
Ex
po
su
re
Li
mi
t:
2,
20
0
mg
/m
3
(O
SH
A)
(4
2)
.
Im
me
di
at
ei
y
Da
ng
er
ou
s
to
Li
fe
or
He
al
th
:
20
,0
00
pp
m
(OS
HA)
(42
).
Exi
sti
ng
Env
iro
nme
nta
i
Reg
uia
tio
ns:
Non
e
kno
wn.
Rec
omm
end
ati
on:
But
adi
ene
has
an
app
are
nti
y
iow
ord
er
of
tox
ici
ty
and
wat
er
so
iu
bi
ii
ty
.
Da
ng
er
ou
s
ex
po
su
re
s
in
th
e
Gr
ea
t
La
ke
s
Ba
si
n
are
un
ii
ke
iy
.
Monitoring is not recommended.
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 Cad
miu
m
(Ta
ble
s:
1 &
2)
Exp
osu
re
pro
fil
e:
Cad
miu
m i
s w
ide
ly
dis
tri
but
ed
in
the
ind
ust
ria
l
env
iro
nme
nt.
Dis
cha
rge
s f
rom
sme
lte
rs,
oil
and
coa
l-f
ire
d p
owe
r p
lan
ts,
the
pla
tin
g i
ndu
str
y,
pig
men
t,
tex
til
e a
nd
che
mic
al
pla
nts
con
tri
but
e t
o
the
Gre
at
Lak
es
whi
le
dif
fus
e s
our
ces
(wea
r o
f p
ain
t c
oat
ing
s,
met
al
corr
osio
n)
cont
ribu
te c
admi
um t
o ur
ban
runo
ff a
nd t
heir
asso
ciat
ed
slu
dge
s.
The
con
cen
tra
tio
ns
in
Gre
at
Lak
es
wat
ers
are
bel
ow
U.S.
dri
nki
ng
wate
r st
anda
rds,
but
maxi
mum
obse
rved
conc
entr
atio
ns a
re w
ithi
n on
e or
der
of
mag
nit
ude
of
the
sta
nda
rd
and
tri
but
ary
con
cen
tra
tio
ns
may
exc
eed
the
standard several fold. Concentrations in Great Lakes fish are below 1 ppm.
Toxicity profile:
Oral
L050
:
225
mg/k
g m
rats
(1).
Cadm
ium
fume
s ar
e mo
re t
oxic
than
cadm
ium
dust (44).
Carc
inog
enic
ity:
Cadm
ium
is a
n an
imal
carc
inog
en u
nder
cond
itio
ns
of
repe
ated
subc
utan
eous
or i
ntra
musc
ular
inje
ctio
n.
No c
arci
noge
nici
ty h
as
bee
n o
bse
rve
d a
fte
r t
wo
yea
rs
of
oral
exp
osu
re.
Pro
lon
ged
inh
ala
tio
n o
f
cadm
ium
by m
an m
ay i
ncre
ase
the
risk
of p
rost
ate
and
resp
irat
ory
canc
er (
40).
Chro
nic
Adve
rse
Effe
cts:
Emph
ysem
a an
d re
nal
dist
urba
nces
acco
mpan
y ch
roni
c
expo
sure
to a
irbo
rne
cadm
ium
at 3
-15
mg/m
3.
Kidn
ey t
ubul
e da
mage
is
observed at 0.2 mg/g. Liver dysfunction and hypertension have been
rep
ort
ed.
Ita
i—I
tai
dis
eas
e i
nvo
lvi
ng
ost
eop
oro
sis
has
bee
n a
sso
cia
ted
with chronic cadmium exposure (40).
CNS Effects: No data found.
Reproductive Effects: Cadmium sulphate injected into the lingual vein of
female hamsters on day 8 of pregnancy caused a high incidence of
resorption and malformed offspring; acute necrosis of rat testes followed
large oral or parenteral doses (44). Testicular effects have been
reported in humans (54).
Teratogenicity: Fetal anomalies have been reported in some rodent studies but
were not found in others (54) (55).
Mutagenicity: Negative in bacteria. Both negative and positive results
reported for insects and in cultured mammalian cells (65).
Permissible Exposure Limit: PEL is 60 pg oral per day; drinking water
guideline in Canada is 0.005 mg/L (40). ACGIH gives a value of 0.05
mg/m for dusts and salts of cadmium (43).
Inmediatgly Dangerous to Life or Health: Greater than 0.5 mg oral/kg and 10
mg/mJ for 2—5 hours (40).
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 Existing Environmentai Reguiations:
y§A: Drinking Water Standard.
Canada: Drinking Water Guideiine.
IJC Objectives: Yes.
Rec
omm
end
ati
on:
Cad
miu
m h
as
con
sid
era
bie
acu
te
and
chr
oni
c t
oxi
cit
y a
nd
rem
ain
s o
n t
he
iist
of
tox
ic
met
ais
tha
t r
equ
ire
mon
ito
rin
g f
or
sou
rce
s,
fate and time trends.
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 Ca
mp
ho
r
(C
AS
Re
g
No
:
76
22
2)
(T
ab
le
:
4)
Ex
po
su
re
pr
of
il
e:
Ca
mp
ho
r
is
a
na
tu
ra
l
te
rp
en
e
an
d
is
al
so
pr
od
uc
ed
sy
n-
th
et
ic
al
ly
.
It
ha
s
be
en
di
sc
ov
er
ed
in
tr
ac
e
am
ou
nt
s
in
La
ke
Mi
ch
ig
an
.
Th
e
so
ur
ce
is
un
kn
ow
n.
Ca
mp
ho
r
is
ra
pi
dl
y
mi
ne
ra
li
ze
d
by
an
ac
cl
im
at
ed
ba
ct
er
ia
l
co
mm
un
it
y
an
d
si
gn
if
ic
an
t
hu
ma
n
ex
po
su
re
is
no
t
li
ke
ly
ex
ce
pt
wh
en
la
rg
e
am
ou
nt
s
of
th
e
co
mp
ou
nd
is
ha
nd
le
d.
Toxicity profile:
Or
al
L0
50
:
1,
31
0
mg
/k
g
in
mi
ce
(6
7)
.
C
a
r
c
i
n
o
g
e
n
i
c
i
t
y
:
No
d
a
t
a
f
o
un
d
.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
No
da
ta
fo
un
d.
CN
S
Ef
fe
ct
s:
Ne
ur
on
al
ne
cr
os
is
ha
s
be
en
pr
od
uc
ed
in
mi
ce
gi
ve
n
mu
lt
ip
le
do
se
s;
sy
mp
to
ms
in
cl
ud
e
he
ad
ac
he
,
co
nf
us
io
n,
ve
rt
ig
o,
ex
ci
te
me
nt
,
re
st
le
ss
ne
ss
,
de
li
ri
um
,
ha
ll
uc
in
at
io
ns
,
in
cr
ea
se
d
mu
sc
ul
ar
ex
ci
ta
bi
li
ty
,
tr
em
or
s,
je
rk
y
mo
ve
me
nt
s,
ep
il
ep
ti
fo
rm
co
nv
ul
si
on
s,
fo
ll
ow
ed
by
de
pr
es
si
on
an
d
co
ma
.
VC
NS
de
pr
es
si
on
ma
y
be
th
e
pr
im
ar
y
cl
in
ic
al
re
sp
on
se
(7
4)
.
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
No
da
ta
fo
un
d.
Te
ra
to
ge
ni
ci
ty
:
No
da
ta
fo
un
d.
Mu
ta
ge
ni
ci
ty
:
Ne
ga
ti
ve
in
Sa
lm
on
el
la
(6
5)
.
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
12
mg
/m
3
(O
SH
A)
(4
2)
.
I
m
m
e
d
i
a
t
e
l
y
Da
ng
er
ou
s
to
Li
fe
or
He
al
th
:
20
0
mg
/m
3
(O
SH
A)
(4
2)
.
On
e
gr
am
ha
s
ca
us
ed
a
f
a
t
a
l
i
t
y
in
ma
n.
Pr
ob
ab
le
le
th
al
do
se
fo
r
ma
n
of
c
a
m
p
h
o
r
a
t
e
d
oi
l
is
20
mL
an
d
fo
r
ca
mp
ho
r
li
ni
me
nt
,
5
mL
(6
7)
.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
l
Re
gu
la
ti
on
s:
No
ne
kn
ow
n.
Re
co
mm
en
da
ti
on
:
Ca
mp
ho
r
is
of
li
tt
le
co
nc
er
n
pr
es
en
tl
y
be
ca
us
e
of
it
s
lo
w
to
xi
ci
ty
an
d
th
e
un
li
ke
li
ho
od
of
ex
po
su
re
.
Mo
ni
to
ri
ng
is
no
t
co
ns
id
er
ed
necessary.
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Carbofuran (CAS Reg No: 1563662) (Table: 1)
Exposure profile: This pesticide is produced and handled in large amounts in
the basin. In agricultural use it is metabolized rapidly but the complete
mineralization of its metabolites is a slower process. It does not
bioaccumulate. Agricultural watersheds tributary to Lake Erie have shown
concentrations of the compound of less than 1 ug/L.
Toxicity profile:
Oral L050: 2-5.3 mg/kg in various rodent species. The L050 for man is 11
mg/kg (oral) (1).
Carcinogenicity: Carbonates are generally not carcinogenic.
Chronic Adverse Effects: No effects were observed in rats fed 25 ppm for 2
years and 10 ppm for 3 generations or in dogs fed 20 ppm for 2 years and
50 ppm for one generation (67).
CNS Effects: Carbofuran is a cholinesterase inhibitor. Loss of muscle
coordination, slurring of speech, fasciculations and twitching of muscles
have been observed, as have random jerky movements, incontinence,
convulsions and coma (74).
Reproductive Effects: No data found.
Teratogenicity: No defects occurred in the offspring of rats, rabbits and
dogs fed 100 ppm carbofuran; however, there was a reduction in survival
rate (55).
Mutagenicity: No data found.
Permissible Exposure Limit: (ACGIH) 0.1 mg/m3 (43).
Inmediately Dangerous to Life or Health: Acute exposure is the major concern
(L050 (orally) for man, 11 mg/kg) (1).
Existing Environmental Regulations: None known.
Recommendation: Carbofuran is only of concern in the event of high local
exposure. Routine monitoring is not required.
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 Ca
rb
on
Di
su
lp
hi
de
(C
AS
Re
g
No
:
75
15
0)
(T
ab
le
:
1)
Ex
po
su
re
pr
of
il
e:
Th
is
co
mp
ou
nd
ha
s
be
en
de
te
ct
ed
in
a
di
sc
ha
rg
e
to
th
e
St
.
Cl
ai
r
Ri
ve
r
bu
t
no
qu
an
ti
ta
ti
ve
da
ta
ar
e
gi
ve
n.
Ca
rb
on
di
su
lp
hi
de
ap
pa
re
nt
ly
st
il
l
is
us
ed
in
ch
em
ic
al
sy
nt
he
se
s,
bu
t
in
mo
st
or
al
l
of
it
s
fo
rm
er
en
d
us
es
it
ha
s
be
en
re
pl
ac
ed
by
ot
he
r
co
mp
ou
nd
s.
Th
is
co
mp
ou
nd
is
sp
ar
in
gl
y
so
lu
bl
e
in
wa
te
r
an
d
qu
it
e
vo
la
ti
le
.
It
is
no
t
bi
od
eg
ra
da
bl
e
bu
t
of
l
i
m
i
t
e
d
c
h
e
m
i
c
a
l
s
t
a
b
i
l
i
t
y
.
T
o
x
i
c
i
t
y
p
r
o
f
i
l
e
:
Or
al
L0
50
:
No
L0
50
va
lu
es
fo
un
d.
Ca
rc
in
og
en
ic
it
y:
No
da
ta
fo
un
d.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
In
hu
ma
ns
—
al
on
g
wi
th
CN
S
ef
fe
ct
s
th
er
e
ma
y
be
ey
e
da
ma
ge
wi
th
su
ch
sy
mp
to
ms
as
bl
in
d
sp
ot
s,
na
rr
ow
in
g
of
vi
si
on
an
d
de
cr
ea
se
d
ab
il
it
y
to
se
e
in
th
e
da
rk
.
In
cr
ea
se
d
ar
te
ri
os
cl
er
os
is
ma
y
oc
cu
r
wh
ic
h
ma
y
ca
us
e
or
in
cr
ea
se
da
ma
ge
to
th
e
he
ar
t
an
d
ot
he
r
or
ga
ns
.
Hi
gh
bl
oo
d
pr
es
su
re
,
ki
dn
ey
da
ma
ge
,
li
ve
r
da
ma
ge
an
d
st
om
ac
h
pr
ob
le
ms
ma
y
oc
cu
r
(4
4)
.
Ga
st
ro
in
te
st
in
al
di
st
ur
ba
nc
es
su
ch
as
ch
ro
ni
c
ga
st
ri
ti
s
an
d
ac
hl
or
hy
dr
ia
ha
ve
be
en
ob
se
rv
ed
as
we
ll
as
re
na
l
da
ma
ge
(a
lb
um
in
ur
ia
,
mi
cr
oh
em
at
ur
ia
,
el
ev
at
ed
bl
oo
d
ur
ea
ni
tr
og
en
,
di
as
to
li
c
hy
pe
rt
en
si
on
)
(4
4)
.
Ma
le
wo
rk
er
s
sh
ow
a
si
gn
if
ic
an
t
de
cr
ea
se
in
17
ke
to
—
an
d
hy
dr
ox
y-
co
rt
ic
os
te
ro
id
ex
cr
et
io
n.
Lo
ss
of
li
bi
do
is
a
co
mm
on
co
mp
la
in
t
(6
7)
.
CN
S
Ef
fe
ct
s:
In
cl
ud
e
da
ma
ge
to
cr
an
ia
l
ne
rv
es
an
d
de
ve
lo
pm
en
t
of
pg
ly
ne
ur
it
is
an
d
pa
re
st
he
si
as
(4
4)
.
Ex
po
su
re
of
hu
ma
ns
at
le
ss
th
an
65
mg
/m
fo
r
se
ve
ra
l
ye
ar
s
ha
s
be
en
re
po
rt
ed
to
ca
us
e
po
ly
ne
ur
op
at
hy
(6
7)
.
Wo
me
n
ap
pe
ar
to
be
mo
re
se
ns
it
iv
e
th
an
me
n
to
th
e
ne
ur
ot
ox
ic
ef
fe
ct
s
(6
7)
.
Ar
ea
s
of
de
ge
ne
ra
ti
on
we
re
fo
un
d
th
ro
ug
ho
ut
th
e
ce
nt
ra
l
ne
rv
ou
s
sy
st
em
,
th
e
gr
ey
ma
tt
er
be
in
g
mo
re
af
fe
ct
ed
th
an
th
e
wh
it
e
an
d
th
e
ce
re
be
ll
um
mo
re
th
an
th
e
re
st
of
th
e
br
ai
n
(6
7)
.
Ot
he
r
sy
mp
to
ms
in
cl
ud
e:
mu
sc
le
we
ak
ne
ss
;
nu
mb
ne
ss
;
fe
el
in
g
of
pi
ns
an
d
ne
ed
le
s;
un
st
ea
dy
wa
lk
in
g;
an
d
di
ff
ic
ul
ty
in
sw
al
lo
wi
ng
.
Pa
ls
y,
sp
ee
ch
di
ff
ic
ul
ty
an
d
mu
sc
le
sp
as
ti
ci
ty
ma
y
al
so
oc
cu
r
as
we
ll
as
:
me
mo
ry
lo
ss
;
he
ad
ac
he
;
di
ff
ic
ul
ty
in
sl
ee
pi
ng
;
ne
rv
ou
sn
es
s;
fa
ti
gu
e;
ir
ri
ta
bi
li
ty
;
de
pr
es
si
on
;
su
ic
id
al
te
nd
en
ci
es
;
an
d
psychosis in humans (44).
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
Me
ns
tr
ua
l
ir
re
gu
la
ri
ti
es
an
d
sp
on
ta
ne
ou
s
ab
or
ti
on
ha
ve
be
en
re
po
rt
ed
in
wo
me
n
an
d
as
pe
rm
ia
in
me
n
(4
4)
.
Teratogenicity: No data found.
Mut
age
nic
ity
:
Neg
ati
ve
in
Sal
mon
ell
a
str
ain
TA1
00.
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
q
1
pp
m
(N
IO
SH
)
(4
2)
.
20
pp
m
(O
SH
A)
(4
4)
.
AC
GI
H
gives 20 ppm or 60 mg/m~ (43).
 Im
me
di
at
el
y
Da
ng
er
ou
s
to
Li
fe
or
He
al
th
:
500
pp
m
(OS
HA)
(42
).
In
ma
n
th
e
LDL
O
is
14
mg/
kg
and
the
LCL
O
is
4,0
00
ppm
/30
min
ute
s
(67
).
Exi
sti
ng
Env
iro
nme
nta
l
Reg
ula
tio
ns:
Non
e k
now
n.
Re
co
mm
en
da
ti
on
:
Ca
rb
on
di
su
lp
hi
de
is
ve
ry
ac
ut
el
y
to
xi
c
and
re
qu
ir
es
st
ri
ct
con
tro
l
of
use
and
con
tai
nme
nt
in
ind
ust
rie
s
and
in
tra
nsi
t.
Mon
ito
rin
g
in
ef
fl
ue
nt
s
ma
y
be
us
ef
ul
ho
we
ve
r.
Mo
ni
to
ri
ng
in
th
e
aq
ua
ti
c
ec
os
ys
te
m
is unproductive.
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 Ca
rb
on
Te
tr
ac
hl
or
id
e
(C
AS
Re
g
No
:
56
23
5)
(T
ab
le
:
3)
Ex
po
su
re
pr
of
il
e:
Ca
rb
on
te
tr
ac
hl
or
id
e
is
us
ed
in
ve
ry
la
rg
e
am
ou
nt
s
in
th
e
ch
em
ic
al
in
du
st
ry
fo
r
sy
nt
he
se
s,
bu
t
in
mo
st
of
it
s
di
ss
ip
at
iv
e
en
d
us
es
it
ha
s
be
en
re
pl
ac
ed
by
ot
he
r
co
mp
ou
nd
s.
St
il
l,
se
ve
ra
l
hu
nd
re
d
to
ns
ar
e
di
sc
ha
rg
ed
an
nu
al
ly
in
wa
st
e
st
re
am
s
an
d
tr
ac
e
co
nc
en
tr
at
io
ns
in
th
e
ra
ng
e
of
0.
09
to
0.
04
7
pg
/L
ha
ve
be
en
de
te
ct
ed
.
Th
e
co
mp
ou
nd
is
pe
rs
is
te
nt
an
d
ma
y
ac
cu
mu
la
te
sl
ig
ht
ly
in
li
vi
ng
ti
ss
ue
s.
Toxicity profile:
Or
al
L0
50
:
Ra
ng
es
fr
om
2,
80
0
mg
/k
g
to
12
,8
00
mg
/k
g
in
va
ri
ou
s
ro
de
nt
speCies (1).
Ca
rc
in
og
en
ic
it
y:
Or
al
ad
mi
ni
st
ra
ti
on
of
ca
rb
on
te
tr
ac
hl
or
id
e
ha
s
be
en
as
so
ci
at
ed
wi
th
th
e
de
ve
lo
pm
en
t
of
he
pa
to
ma
s
in
ro
de
nt
s
(3
).
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
In
do
gs
,
90
da
ys
of
co
nt
in
uo
us
in
ha
la
ti
on
ex
po
su
re
to
10
pp
m
of
ca
rb
on
te
tr
ac
hl
or
id
e
ca
us
ed
li
ve
r
en
la
rg
em
en
t
an
d
hi
st
ol
og
ic
al
ch
an
ge
s
(3
).
CN
S
Ef
fe
ct
s:
In
ha
la
ti
on
ex
po
su
re
to
le
ve
ls
of
10
0-
30
0
pp
m
ca
us
ed
ap
at
hy
an
d
mental confusion (3).
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
A
si
gn
if
ic
an
t
de
cr
ea
se
in
bo
dy
we
ig
ht
an
d
in
cr
ow
n-
ru
mp
le
ng
th
wa
s
ob
se
rv
ed
in
of
fs
pr
in
g
of
pr
eg
na
nt
ra
ts
ex
po
se
d
to
30
0
pp
m
or
1,
00
0
pp
m
of
ca
rb
on
te
tr
ac
hl
or
id
e
du
ri
ng
ge
st
at
io
n
(5
).
Te
ra
to
ge
ni
ci
ty
:
Th
e
in
ci
de
nc
e
of
mi
cr
os
co
pi
c
st
er
ne
br
al
an
om
al
ie
s
wa
s
si
gn
if
ic
an
tl
y
in
cr
ea
se
d
in
th
e
of
fs
pr
in
g
of
pr
e
na
nt
ra
ts
ex
po
se
d
to
1,
00
0
pp
m
of
ca
rb
on
te
tr
ac
hl
or
id
e
du
ri
ng
ge
st
at
io
n
(5
).
Mu
ta
ge
ni
ci
ty
:
No
po
si
ti
ve
mu
ta
ge
ni
c
ef
fe
ct
wa
s
de
mo
ns
tr
at
ed
wi
th
an
13
vi
tr
o
Sa
lm
on
el
la
/m
ic
ro
so
me
as
sa
y
or
in
a
ho
st
-m
ed
ia
te
d
as
sa
y
(3
).
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
50
pp
m
or
55
mg
/m
3
(O
SH
A)
(2
).
Im
me
di
at
el
y
Da
ng
er
ou
s
to
Li
fe
or
He
al
th
:
1,
50
0
pp
m
(O
SH
A)
(2
).
Ex
is
ti
ng
En
vi
ro
nm
en
ta
l
Re
gu
la
ti
on
s:
No
ne
kn
ow
n.
Re
co
mm
en
da
ti
on
:
Ch
ro
ni
c
ef
fe
ct
s,
qu
an
ti
ti
es
in
us
e
an
d
pr
es
en
ce
in
th
e
Gr
ea
t
La
ke
s
of
ca
rb
on
te
tr
ac
hl
or
id
e
su
gg
es
t
th
at
th
is
co
mp
ou
nd
sh
ou
ld
be
mo
ni
to
re
d
in
Gr
ea
t
La
ke
s
wa
te
rs
an
d
es
pe
ci
al
ly
in
wa
st
e
wa
te
r
ef
fl
ue
nt
s.
  
 
   
 
Chl
ord
ane
,
cis
-,
tra
ns-
(Ta
ble
s:
1 &
2)
Ex
osu
re
rof
ile
:
Thi
s
pes
tic
ide
has
bee
n
dis
cov
ere
d
in
fis
h
fro
m
Lak
e
Sup
eri
or
(0.
06
to
0.5
9
ug/
g)
and
Lak
e
Eri
e
(0.
13
ug/
L
or
les
s),
in
eff
lue
nts
to
Lak
e M
ich
iga
n
(0.
05
to
0.1
2 u
g/L
)
and
in
the
wat
er
col
umn
(0.
000
02
to
0.3
2 u
g/L
).
N.Y
. S
tat
e r
epo
rts
an
ann
ual
usa
ge
of
ove
r
11,
000
lbs
.
The
com
pou
nd
is
per
sis
ten
t
and
sho
ws
acc
umu
lat
ion
in
liv
ing
tissue.
Toxicity profile:
Ora
l
LD5
0:
Fou
nd
in
rat
s
to
be
335
-43
0 m
g/k
g
(3)
.
Car
cin
oge
nic
ity
:
Chl
ord
ane
fed
at
56
ppm
to
mal
e m
ice
pro
duc
ed
an
88.
9%
inc
ide
nce
of
hep
ato
cel
lul
ar
car
cin
oma
(3)
.
Ins
uff
ici
ent
dat
a e
xis
t f
or
an
eva
lua
tio
n o
f t
he
car
cin
oge
nic
ity
for
man
(IA
RC
Vol
. 2
0).
Chr
oni
c A
dve
rse
Eff
ect
s:
Die
tar
y a
dmi
nis
tra
tio
n
of
chl
ord
ane
to
exp
eri
men
tal
ani
mal
s c
aus
ed
liv
er
enl
arg
eme
nt
and
his
tol
ogi
c c
han
ges
(6)
.
CNS
Eff
ect
s:
Ano
rex
ia,
ner
vou
s d
iso
rde
rs
and
vis
ual
dis
tur
ban
ces
hav
e
bee
n
obs
erv
ed
in
exp
eri
men
tal
ani
mal
s e
xpo
sed
to
chl
ord
ane
at
acu
te
lev
els
(4).
Rep
rod
uct
ive
Eff
ect
s:
A d
ecr
eas
e i
n r
epr
odu
cti
ve
suc
ces
s o
ccu
rre
d
in
fem
ale
rats
trea
ted
with
a 25
mg/k
g d
ose
of c
hlor
dane
for
thre
e we
eks
(8).
Ter
ato
gen
ici
ty:
No
ter
ato
gen
ic
eff
ect
s w
ere
obs
erv
ed
in
a 3
gen
era
tio
n s
tud
y
on
ra
ts
ad
mi
ni
st
er
ed
30
mg
/k
g
in
th
e
di
et
.
At
60
mg
/k
g
th
er
e
wa
s
an
inc
rea
se
in
fet
al
mor
tal
ity
in
the
F3
gen
era
tio
n
(10
1).
Mu
ta
ge
ni
ci
ty
:
Ch
lo
rd
an
e
ex
hi
bi
te
d
no
po
si
ti
ve
mu
ta
ge
ni
c
ef
fe
ct
s
in
a
do
mi
na
nt
lethal assay conducted in mice (6).
Per
mis
sib
le
exp
osu
re
lim
it:
0.5
mg/
m3
(2)
.
Can
adi
an
Dri
nki
ng
Wat
er
Guideline is 0.007 mg/L.
Imm
edi
ate
ly
Dan
ger
ous
to
Lif
e o
r H
eal
th:
500
mg/
m3
(2)
.
Existing Environmental Regulations:
Caﬂ
aga
:
Dri
nki
ng
Wat
er
Gui
del
ine
and
act
ion
lev
el
for
fis
h.
IJC
Obj
ect
ive
s:
A g
rea
t L
ake
s W
ate
r Q
ual
ity
Obj
ect
ive
has
bee
n e
sta
bli
she
d.
Rec
omm
end
ati
on:
Mon
ito
rin
g p
rog
ram
s a
lre
ady
exi
st
for
chl
ord
ane
in
Gre
at
Lakes waters.
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 ChTorinated NaphthaTenes (CAS Reg No: 2198756) (Tabie: 3)
(CAS Reg No: 90131)
(CAS Reg No: 91587)
(CAS Reg No: 2050693)
Exposure profiTe: Appendix E gives no substantiation for their detection in
the Great Lakes Ecosystem. New York State reports an annuaT usage of
1,900 Tbs with 1,730 Tbs at hand. These compounds are Tipophiiic and
biodegradabTe to varying extents depending on the number and positions of
the chTorine atoms. Existing information is cieariy insufficient to
assess exposure potentia].
Toxicity profiTe:
Ora] L050: There is a variety of chTOrinated naphthaienes. The oraT
L050 of monochToronaphthaTene in rodents was between 886-2,078 mg/kg.
1-2 mm3 of penta— and hexa- were acuteTy toxic to man. Toxicity
increases with chTorination (44).
Carcinogenicity: No data found.
Chronic Adverse Effects: Liver necrosis and jaundice were observed in rats
exposed repeatedTy to 8.9 mg hexachToronaphthaTene/m3; this amount was
fataT. Triu and tetrach10ronaphtha1ene caused minor 1iver ce11 damage at
11 mg/m3 over a 2% month period. Chiorinated naphthaienes are acnegenic (44).
CNS Effects: Dizziness and vertigo have been reported after acute exposure (44).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: No data found.
Permissible Exposure Limit: 5 mg/m3 (trichToro-), 2 mg/m3 (tetrachioro-),
0.2 mg/m (hexachioro-) (42).
ImmediateTy Dangerous to Lgfe or HeaTth: 50 mg/m3 (trichToro—), 20 mg/m3
(tetrachToro-), 2 mg/m (hexachToro—) (42).
Existing Environmenta] ReguTations: None known.
 
Recommendation: ChTorinated naphthaTenes have potentiaTTy hazardous chronic
effects. Monitoring data to adequateTy assess exposure is necessary to
determine the risks this compound may pose for human heaTth.
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Chlorinated Terphenyls (CAS Reg No: 61788338) (Table: 3)
(CAS Reg No: 31372357)
(CAS Reg No: 27043045)
Exposure profile: Chlorinated Terphenyls have been identified in a discharge
to the St. Clair River but not quantified or characterized in greater
detail. No usage data are available. Biodegradability will vary withthe
number and positions of chlorine atoms. Available information is
insufficient to assess exposure potential.
Toxicity profile:
Oral L050: No data found but probably less toxic than chlorinated biphenyls.
Carcinogenicity: No data found.
Chronic Adverse Effects: After 6 weeks of a 5,000 ppm chlorinated terphenyl
diet monkeys lost hair, developed subcutaneous edema and acne and showed
discharges from the eyes. Hypertrophy of liver and gastric mucosa were
also reported. After 6 months hyperplasia and dysplasia of the gastric
mucosa was observed (46).
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: No data found.
Permissible Exposure Limit: Unknown.
Imnediately Dangerous to Life or Health: Unknown.
Existing Environmental Regulations: None found.
Recommendation: Chlorinated terphenyls have known chronic effects and need to
be
mon
ito
red
in
the
Gre
at
Lak
es
in
ord
er
to
ass
ess
exp
osu
re
to
man
.
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 2-Chloroaniline
(CAS Reg No: 95512)
(Tables: 1 & 5)
Exposure profile: This compound was detected in Muskegon wastewater effluent
but not quantified. In New York approximately 100,000 lbs are handled
annually.
The compound is only slightly soluble in water but is not
expected to be accumulated into living tissues. All isomers of
chloroaniline are mineralized at moderate rates, e.g. in a secondary
wastewater treatment.
Toxicity profile:
Oral L050: 256 mg/kg in mice (1).
Carcinogenicity: No data found.
Chronic Adverse Effects: No data found.
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in Salmonella (65).
Permissible Exposure Limit: No data found.
Immediately Dangerous to Life or Health: No data found.
Existing Environmental Regulations: None known.
Recommendation:
Little toxicological data on chloroaniline were found hence
no assessment of hazard can be made.
Monitoring of effluents that have
not been subjected to secondary wastewater treatment should be considered
if chloroaniline is found to be toxic.
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Chloroform (CAS Reg No: 67663) (Table: 2)
Exposure profile: This compound is used in quantities of several million kg
per year and discharged in quantities of several thousand kg per year.
Trace concentrations of 1 to 10 ug/L have been found in the lakes and
the Niagara River; chloroform is undoubtedly widespread. The compound is
not degraded biologically but volatilizes easily from aqueous solution.
Toxicity profile:
Oral LD50: Ranges from 118 mg/kg to 1,257 mg/kg in rodents. Acute
exposures led to hepatic and renal necrosis (1).
Carcinogenicity: Male rats fed 90 or 180 mg/kg for 111 weeks developed renal
epithelial tumors, females fed doses that were 35% greater did not develop
tumors. Hepatocellular carcinomas were observed in both sexes of
B5C3F1 mice administered chloroform by gavage. Epidemiological data
indicate an association between chlorinated water, containing halomethanes
and an increased incidence of cancer in some areas however. The incidence
of cancer correlated with other contaminants as well (40).
Chronic Adverse Effects: 23-37 mg/kg for 10 years leads to reversible
hepatotoxicity (centrolobular necrosis). No effects were observed after
1-5 years exposure to 0.34-0.96 mg/kg (40).
 
CNS Effects: Chloroform is a CNS depressant. Anesthesia, hypotension and
respiratory arrest can result from acute or prolonged inhalation of a 2%
chloroform-air mixture (40).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in Salmonella and positive in yeast (65).
Permissible Exposure Limit: Drinking Natgr Guideline in Canada 0.35 mg/L
(40). OSHA gives a value of 240 mg/m (42).
Inmediately Dangerous to Life or Health: 210 mg oral/kg (40). 1,000 ppm
(OSHA) (42).
Existing Environmental Regulations:
Q§A: FMonitored under U.S. Safe Drinking Water Regulations.
Caaaaa: Drinking Water Guidelines for trihalomethanes.
Recommendation: Monitoring for chloroform presently exists. Ambient
concentrations are much lower than those produced in the chlorination of
drinking water. Additional monitoring is recommended for industrial
discharges only.
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3—Ch10ro-1-propene (CAS Reg No: 590216) (Tabie: 3)
Exposure profiie: This compound is used in chemicai syntheses and was
detected in a discharge to the St. Ciair River. It was not quantified.
It is a voiatiie, iipophiiic compound which may be biodegradabie. No
other data are avaiiabie.
Toxicity profile:
Orai L050: No data found.
Carcinogenicity: No data found
Chronic Adverse Effects: Subacute exposure (50 ppm) causes eye and nose
irritation, drowsiness, weakness and labored breathing. Liver, kidney and
iung damage have been reported (94).
CNS Effects: CNS system may be affected by chioropropene.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Positive in the Saimoneiia/mammaiian-microsome assay (65).
Permissibie Exposure Limit: No data found.
Inmediateiy Dangerous to Life or Health: No data found.
Existing Environmentai Reguiations: None known.
  
Recommendation: Chioropropene can adverseiy affect major organs, however
quantitative exposure data for the Great Lakes are unavaiiable. This
compound shouid be monitored in discharges, but is not 1ike1y to be of
consequence or concern in the waters of the Great Lakes.
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 Chromium (Table: 2)
Exposure profile: Coal is an important source of chromium, but of
significance here is its occurrence in hexavalent form in industrial
discharges. In the Great Lakes, it can be expected to occur mostly in
insoluble or inert forms containing the trivalent form. There are
reports, however, that some reoxidation of the trivalent form to the
hexavalent form can occur under natural conditions in water. Maximum
concentrations of total chromium in Great Lakes water are below 50 ug/L,
but much higher concentrations occur in industrial wastewater effluents.
Great Lakes fish contain less than 0.7 ppm total chromium, with an
isolated finding of 1.8 ppm (bloater chub off Goderich, Ontario).
Toxicity profile:
Oral L050: Soluble hexavalent chromium (Cr6+) salts have an L050 of
approximately 1,500 mg/kg in rodents. Trivalent chromium is considerably
less toxic (54).
Carcinogenicity: Continuous exposure to high levels of Cr6+ has been
implicated as a cause of digestive tract cancers. There is an increased
risk of bronchial and pulmonary carcinoma among workers exposed to
chromium dust (40).
Chronic Adverse Effects: Consumption of Cr6+ in drinking water by man (1-25
mg/L for 3 years), dogs (11.2 mg/L for 4 years) and rats (25 mg/L for 6
months) caused no ill effects.
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Cr6+ compounds of high 3nd medium solubilities induce
significant levels of mutation; Cr + compounds do not. Base pair
substitution is suspected (40). Induces micronuclei in whole animal
studies.
Permissible Exposure Limit: Drinking Water Guideling in Canada is 0.05 mg/L
(
(40). Chromium metal and insoluble salts 1 mg/m OSHA) (42); for
chronic and chromous salts 0.5 mg/m3 (OSHA) (42).
Immediately Dangerous to Lgfe or Health: 1-10 mg (oral) of Cr6+/kg body
weight (40). 500 mg/m (OSHA) (42).
Existing Environmental Regulations:
 
Reconmendation:
Canada: Drinking Water Guideline.
IJC Objectives: Yes.
General monitoring for chromium exists but monitoring should
concentrate on industr?al effluents.
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Cob
alt
(Tab
les:
1 &
4)
Exposure profile: The sources and chemical forms of cobalt in Great Lakes
wat
ers
are
not
well
kno
wn.
Nat
ura
l s
our
ces
may
be
imp
ort
ant
and
org
ani
c
complexes may be the predominant form in the environment. Cobalt occurs
toge
ther
with
nick
el
and
sour
ces
of t
he l
atte
r ma
y co
ntri
bute
to c
obal
t as
well. Industrial uses in alloys, catalysts, pigments do not supply the
ele
men
t i
n a
for
m w
hic
h i
s r
ead
ily
sol
ubi
liz
ed.
Cob
alt
is
an
ess
ent
ial
micr
onut
rien
t an
d as
with
othe
r he
avy
meta
ls
it f
orms
an i
nsol
uble
sulf
ide
in a
naer
obic
sedi
ment
s.
Wate
r co
lumn
conc
entr
atio
ns i
n th
e Gr
eat
Lake
s
are
bel
ow
10
ug/
L,
iso
lat
ed
mea
sur
eme
nts
of
fis
h t
iss
ues
sho
w
concentrations of 1 ppm or less.
Toxicity profile:
Oral
L050
:
As a
meta
l p
owde
r in
rats
1,50
0 mg
/kg.
Coba
lt o
xide
(60)
has
an
L050 of between 135 and 1,700 mg/kg in rodents (54).
Carcinogenicity: No data found.
Chro
nic
Adve
rse
Effe
cts:
Pneu
moco
nios
is
has
been
repo
rted
in h
amst
ers
expo
sed
to C
00 f
or t
wo y
ears
at 1
0 mg
/m3
and
75 m
g/m3
.
Inha
lat§
on b
y an
imal
s
of
an
ind
ust
ria
l m
ix
of
cob
alt
and
met
als
at
20
mg
Co/
m
for
3 y
ear
s l
ed
to granulomas, epithelial hyperplasia and focal fibrosis in the
bro
nch
opu
lmo
nar
y s
yst
em.
Cob
alt
(as
Co
804)
was
lin
ked
to
car
dia
c
myop
athi
es
and
thyr
oida
l l
esio
ns i
n he
avy
beer
drin
kers
in t
he 1
960'
s (5
4).
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Originally reported as non-mutagenic in a bacterial (E,
sub
til
is)
rec
ass
ay,
but
CoCl
is
pos
iti
ve
in
a m
odi
fie
d r
ec
ass
ay
and
weak
ly p
osit
ive
in a
poin
t mu
tati
on
assa
y us
ing
Chin
ese
hams
ter
ovar
y
cell
s in
vitr
o.
It i
s an
timu
tage
nic
in c
ombi
nati
on w
ith
cert
ain
muta
gens
in E, coli.
Permissible Exposure Limit: 0.1 mg/m3 (OSHA) (42).
Immediately Dangerous to Life or Health: 20 mg/m3 (OSHA) (42).
Existing Environmental Regulations: None known.
Reco
mmen
dati
on:
Toxi
city
and
quan
tity
and
use
data
indi
cate
litt
le n
eed
for
monitoring in the Great Lakes.
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DDT
and
met
abo
lit
es
(Ta
ble
s:
1 &
2)
Exp
osu
re
pro
fil
e:
App
end
ix
E c
ite
s w
ate
r c
olu
mn
con
cen
tra
tio
ns
of
0.0
001
3 t
o
0.6
8 u
g/L
and
con
cen
tra
tio
ns
in
fis
h o
f 0
.01
to
3.3
ug/
g.
Stu
die
s
con
duc
ted
in
Ont
ari
o
and
New
Yor
k
ind
ica
te
a c
ont
inu
ing
dec
lin
e
of
con
cen
tra
tio
ns
in
Gre
at
Lak
es
fis
h a
nd
fis
h e
ati
ng
bir
ds
sin
ce
the
use
of
DDT was discontinued.
Toxicity profile:
Ora
l
L05
0:
In
rod
ent
s,
the
L05
0
for
DDT
ran
ges
fro
m
100
-25
0 m
g/k
g;
for
DDE
it
is
1,0
00
mg/
kg
in
rat
s (
1).
No
dat
a w
ere
fou
nd
for
DDD
.
Car
cin
oge
nic
ity
:
An
NCI
-sp
ons
ore
d
bio
ass
ay
of
the
car
cin
oge
nic
ity
of
DDT
pro
ved
neg
ati
ve,
but
bio
ass
ays
con
duc
ted
els
ewh
ere
hav
e r
epo
rte
d
a
pos
iti
ve
car
cin
oge
nic
eff
ect
.
Mic
e f
ed
DDE
at
250
ppm
dev
elo
ped
a h
igh
inc
ide
nce
of
liv
er
tum
ors
.
Mic
e
fed
250
ppm
DDD
dev
elo
ped
an
inc
rea
sed
incidence of lung and liver tumors (7).
Chr
oni
c
Adv
ers
e
Eff
ect
s:
Enl
arg
eme
nt
and
his
top
ath
olo
gic
cha
nge
s
occ
urr
ed
in
the
liv
ers
of
rat
s
fed
DDT
at
lev
els
of
250
ppm
for
8 w
eek
s.
Mal
e m
ice
fed
250
ppm
DDE
suf
fer
ed
a r
edu
ced
lif
esp
an
and
a h
igh
inc
ide
nce
of
myo
car
dia
l
nec
ros
is.
Mic
e
fed
250
ppm
DDD
suf
fer
ed
a r
edu
ced
lif
esp
an
(7)
.
CNS
Eff
ect
s:
Mar
ked
cha
nge
s
occ
urr
ed
in
the
EEG
pat
ter
n
of
rat
s
fed
20
mg
DDT
/kg
/da
y
for
4 w
eek
s
(7)
.
No
dat
a
was
fou
nd
for
DDE
or
DDD
.
'
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
Se
ve
ra
l
ad
ve
rs
e
ef
fe
ct
s
on
re
pr
od
uc
ti
on
of
mi
ce
we
re
no
te
d
wh
en
br
ee
de
rs
we
re
fe
d
25
0
pp
m
DD
T
(7
).
No
da
ta
we
re
fo
un
d
fo
r
DD
E
or DDD.
Te
ra
to
ge
ni
ci
ty
:
Av
ai
la
bl
e
da
ta
do
no
t
es
ta
bl
is
h
th
e
te
ra
to
ge
ni
ci
ty
of
DD
T,
»
DDE or DDD (7).
Mut
age
nic
ity
:
DDT
has
bee
n
sho
wn
to
be
mut
age
nic
in
sev
era
l
dif
fer
ent
ass
ay
sy
st
em
s
and
bo
th
DD
D
and
DD
E
ha
ve
be
en
re
po
rt
ed
to
ca
us
e
ch
ro
mo
so
ma
l
dam
age
in
a n
umb
er
of
in
vit
ro
and
in
viv
o
stu
die
s
(7)
.
Per
mis
sib
le
Exp
osu
re
Lim
it:
1 m
g/m
3
for
DDT
(2)
.
Not
kno
wn
for
DDE
or
DDD
.
Can
adi
an
Dri
nki
ng
Wat
er
Gui
del
ine
for
DDT
and
its
iso
mer
s
is
0.0
3
mg/
L.
Imm
edi
ate
ly
Dan
ger
ous
to
Lif
e
or
Hea
lth
:
Not
kno
wn
for
DDT
or
its
met
abo
lit
es.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
l
Re
gu
la
ti
on
s:
1
D§Az Drinking water and fish action levels.
gan
aga
:
Dri
nki
ng
wat
er
Gui
del
ine
and
act
ion
lev
el
in
fis
h.
I
J
C
O
b
j
e
c
t
i
v
e
s
:
Y
e
s
.
i
60
Re
co
mm
en
da
ti
on
:
Mo
ni
to
ri
ng
fo
r
DD
T
and
its
me
ta
bo
li
te
s
ex
is
ts
.
Pe
ri
od
ic
stu
die
s
of
con
cen
tra
tio
ns
in
fis
h
in
are
as
whe
re
con
cen
tra
tio
ns
are
sti
ii
high and are stiii useful.
61
 Di
az
in
on
(T
ab
le
s:
1 &
2)
Exp
osu
re
pro
fil
e:
Thi
s
bio
deg
rad
abl
e
pes
tic
ide
has
bee
n
det
ect
ed
in
agr
icu
ltu
ral
wat
ers
hed
s
tri
but
ary
to
Lak
e
Eri
e
in
con
cen
tra
tio
ns
of
les
s
tha
n
1 u
g/L
.
The
com
pou
nd
is
kno
wn
to
be
dis
cha
rge
d
in
Mic
hig
an
in
am
ou
nt
s
be
tw
ee
n
10
-1
0,
00
0
lbs
pe
r
ye
ar
.
It
do
es
not
ac
cu
mu
la
te
in
li
vi
ng
tissues.
Toxicity profile:
Or
al
LD5
0:
30
-2
50
mg
/k
g
in
va
ri
ou
s
ro
de
nt
sp
ec
ie
s
(1)
.
Carcinogenicity: No data found.
Chr
oni
c
Adv
ers
e
Eff
ect
s:
Rat
s
- f
ed
1,0
00
mg/
kg
die
t
sho
wed
som
e
gro
wth
in
hi
bi
ti
on
(70
).
Mo
nk
ey
s
-
in
hi
bi
ti
on
of
er
yt
hr
oc
yt
e
and
pl
as
ma
cho
lin
est
era
se
was
see
n
at
the
0.5
and
5.0
mg/
kg
dos
e
(2
yea
rs
dur
ati
on)
(70
).
Sl
ig
ht
re
du
ct
io
n
in
ch
ol
in
es
te
ra
se
ac
ti
vi
ty
was
fo
un
d
in
sp
ra
ym
en
due
to
ext
ens
ive
occ
upa
tio
nal
exp
osu
re
(70
).
CNS Effects: No data found.
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
No
da
ta
fo
un
d.
Te
ra
to
ge
ni
ci
ty
:
No
te
ra
to
ge
ni
c
ef
fe
ct
s
we
re
ob
se
rv
ed
wh
en
0.
12
mg
/k
g
wa
s
ad
mi
ni
st
er
ed
on
da
y
6,
7,
and
8
of
ge
st
at
io
n
or
wh
en
2.
25
mg
/k
g
was
ad
mi
ni
st
er
ed
on
da
y
7
or
8
to
ha
ms
te
rs
.
No
te
ra
to
ge
ni
c
ef
fe
ct
wa
s
se
en
in
rab
bit
s
whe
n
7
or
30
mg/
kg
per
day
was
adm
ini
ste
red
on
day
s
5-1
5
of
gestation (70).
Mu
ta
ge
ni
ci
ty
:
Ne
ga
ti
ve
in
ba
ct
er
ia
and
ye
as
t.
Po
si
ti
ve
in
ma
mm
al
ia
n
ce
ll
s
in
culture (65).
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
AC
GI
H
gi
ve
s
a
va
lu
e
of
0.1
mg
/m
3
fo
r
ex
po
su
re
to
ski
n
(43
).
Can
adi
an
Dri
nki
ng
Wat
er
Gui
del
ine
is
0.0
14
mg/
L.
Imm
edi
ate
ly
Dan
ger
ous
to
Lif
e
or
Hea
lth
:
Unk
now
n.
Existing Environmental Regulations:
Canada: Drinking Water Guideline.
Re
co
mm
en
da
ti
on
:
Di
az
in
on
is
ac
ut
el
y
to
xi
c
bu
t
is
at
low
co
nc
en
tr
at
io
ns
in
th
e
Gr
ea
t
La
ke
s
an
d
de
gr
ad
es
ra
pi
dl
y.
Mo
ni
to
ri
ng
is
un
de
rw
ay
.
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Diazobenzene (CAS Reg No: 103333) (Table: 3)
Exposure profile: This compound is used in chemical syntheses and has been
detected, but not quantified, in one industrial effluent. The compound is
sufficiently biodegradable to be largely removed by biological wastewater
treatment.
Toxicity profile:
Oral LDSO: 1,000 mg/kg in rats (1).
Carcinogenicity: An excess of hepatomas occurred in male mice given orally
21.5 mg/kg diazobenzene at 7 days of age and then daily until 28 days of
age at which time they were given 56 mg/kg of diet for up to 80 weeks.
However, theresults require additional evaluation (67).
Chronic Adverse Effects: Dogs fed 600 ppm for 63 days suffered high mortality
and liver damage. Rats treated with diazobenzene for 3—30 days showed a
reduced rate of drug metabolism and decreased cytochrome p450 activity in
liver microsomes (67).
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Positive in Salmonella (65).
Permissible Exposure Limit: Unknown.
Immetiately Dangerous to Life or Health: Probable oral LD 0 in man is
50—500 mg/kg (between 1 teaspoonful and 1 oz for a 70 9 person) (74).
Existing Environmental Regulations: None known.
 
Recommendation: Because of the chronic toxicity of this compound some
monitoring in industrial effluents should be considered.
a
1,2-Dibromoethane (CAS Reg No: 106934) (Tabie: 3)
Exposure profiie: This compound with 1,2-Dichioroethane, is used as a 1ead
scavenger in 1eaded gaso1ine. Concentrations of 6 ug/L were found in
Lake Michigan. It is probab1y biodegradabie in the environment but no
information is avaiiabie to predict rates of decomposition at very 10w
concentrations. It is probabiy wideiy distributed in trace amounts
because of spiiis and evaporation of gasoiine; it is destroyed during
combustion.
Toxicity profiie:
Ora] L050: In rodents, ranges from 110 to 420 mg/kg.
Carcinogenicity: Administration of dibromoethane (5 times/wk, 60 mg/kg by
gavage in corn oi1) has been reported to produce squamous ce11 carcinoma
of the forestomach in mice (19).
Chronic Adverse Effects: Abnormai spermatozoa were observed in buiis fed 4
mg/kg of dibromoethane on aiternate days (19).
CNS Effects: Exposure of experimentai animais to acute 1eve1s of
dibromoethane causes depression of the CNS (4).
Reproductive Effects: When administered in doses of 2 mg/kg/day, dibromo-
ethane had no effect on the reproductive capacity of cows and ewes (19).
Teratogenicity: Fetai abnormaiities were observed when pregnant rats_and mice
were exposed to 31.6 ppm dibromoethane during days 6-15 of gestation (18).
Mutagenicity: 2,4-D has been shown to be mutagenic in severai assay systems (1).
Permissibie Exposure Limit: 20 ppm (2).
Immediateiy Dangerous to Life or Heaith: 400 ppm (2).
Existing Environmentai Reguiations: No information. Not 1isted among EPA
priority po11utants (Method 601).
 
Recomnendation: Dibromoethane (and dichioroethane) can have considerab1e acute
and chronic effects on man; hence monitoring shouid be considered to determine
ambient 1eve1s in air and water.
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 Dichlorobenzenes (CAS Reg No: 541731) (Tables: 1 & 3)
and others)
Exposure profile: Ortho— and para- dichlorobenzenes are used in millions of
kilograms per year in New York alone. The meta- form is used in lesser
amounts. Several thousand tons of dichlorobenzenes are present in Niagara
Falls chemical landfills. They have been detected in concentrations of 1
to 18 ug/L in the waters of Lake Michigan and in unquantified amounts in
the Saginaw River. Dichlorobenzenes are biodegradable in principle and
mineralized at moderate rates by acclimated microbial communities, but
removal from water in trace quantities is less certain. They are
moderately lipophilic but only sparingly water soluble. Presently
available data are not sufficient to assess the abundance and exposure
risk for these compounds.
Toxicity profile:
Oral LD : For g—dichlorobenzene 2000 mg/kg in the rat (48) and for —
dicﬁ90robenzene BOO-5,000 mg/kg in rats and 2950 mg/kg in mice (3?.
Carcinogenicity: Neither of nor 2- dichlorobenzene are known to be
carcinogenic (53).
Chronic Adverse Effects: Ogdichlorobenzene is more toxic acutely and
chronically than p-dichlorobenzene. Skin, ocular and respiratory
irritation have been reported for both (44). Q—dichlorobenzene causes
liver and kidney damage where as p—dichlorobenzene only appears to cause
liver damage. The maximum tolerated dose (MTD), i.e. the no effect level,
for o-dichlorobenzene in rats exposed orally 5 d/wk for 28 weeks was
19-190 mg/kg/day. Exposure to g—dichlorobenzene vapor for 30 h/wk for 6-7
months of several animal species at 93 ppn caused no effects; for
p—dichlorobenzene, 158 ppm was tolerated (60).
CNS Effects: Rabbits fed 500 mg/kg p-dichlorobenzene experienced tremors
(3). A variety of species exposed to 798 ppm pedichlorobenzene have shown
tremors, weakness and some individuals lost consciousness (60).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in Salmonella and positive in Aspergillus (65).
Permissible Exposure Limit: For g—dichlorobenzene, OSHA gives a value of 300
mg/m3 and for p—dichlorobenzene, 450 mg/m3 (42).
Inmediately Dangerous to Life or Health: For gfdichlorobenzene, OSHA gives a
value of 1,700 ppm and for p—dichlorobenzene, a value of 1,000 ppm (42).
Existing Environmental Regulations: None known.
Recommendation: Dichlorobenzenes are toxic after long-term exposure and some
have an acute toxicity, however, exposures in the Great Lakes are not well
established. Monitoring should be considered.
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 Dichlorobenzidine 2,2- or 3,3- (DCB) (CAS Reg No: 84684) (Table: 3)
Exposure profile: This compound has been detected in influent.waste streams
of the Muskegon, Michigan treatment system, but not in the effluent,
supporting the notion that the compound is biodegradable at moderate rates
as are related compounds, e.g. aniline and the dichlorobenzenes. The
compound is used in the manufacture of azo dyes and more information on
usage and diSposal is required to determine exposure potential.
Toxicity profile:
Oral LD : No LD value found, however rat LDLO for 3,3-DCB (oral) is
4,728 mg/kg (?9.
Carcinogenicity: 3,3—dichlorobenzidine is carcinogenic in the hamster after
oral administration and in the rat, following both oral and subcutaneous
administration. No cases of 008 inducing cancer in humans have been
reported (78).
Chronic Adverse Effects: No data found.
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Positive in the Salmonella/mannalian-microsome assay. Both
2,2'— and 3,3'- compounds induce unscheduled DNA synthesis in mammalian
cells in culture (65).
Permissible Exposure Limit: Not known.
Immediately Dangerous to Life or Health: Not known.
Existing Environmental Regulations: None known.
Recunnendation: Because of the chronic toxicity of DCB monitoring of
effluents is recommended to develop data on exposure.
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 Dichlorobutadienes (CAS Reg No: 1653196
(CAS Reg No: 6061069
(CAS Reg No: 3574401
(CAS Reg No: 2984421
(Tables: 1 & 3)
Exposure profile:
Dichlorobutadienes have been detected in a discharge to the
St. Clair River.
No identification or quantitation has been attempted.
No other data on occurrence or use are available. The compounds are
slightly lipophilic and possibly biodegradable.
More information is
needed to determine exposure potential.
Toxicity profile:
Oral L050: Reported to be 146-280 mg/kg for rodents (91).
Carcinogenicity: No data found.
Chronic Adverse Effects: Male rats exposed to 140 mg/m3 of dichloro-
butadiene suffered adverse effects on spermatogenesis (92).
CNS Effects:
Poisoning with dichlorobutadiene was characterized by unrest and
excitement, followed by apathy and reduced mobility (93).
Reproductive Effects: No data found.
Teratogenicity: When pregnant rats were exposed to 5/mg/m3 of dichloro-
butadiene, the process of embryo development was impaired (91).
Mutagenicity: No data found.
Permissible Exposure Limit: 0.3 mg/m3 (93).
Immediately Dangerous to Life or Health:
No data found.
Existing
Environmental
Regulations:
None
known.
Recommendation:
Dichlorobutadienes have significant acute and chronic
toxicity.
More information on usage and disposal is needed to determine
specific monitoring needs, however monitoring is necessary to determine
exposure potential.
67
Dichloroethane
 
(CAS Reg No: 107062) (Table: 3)
Exposure profile: This compound is added to leaded motor fuels as a lead
scav
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methods used to identify other chlorinated solvents. See dibromethane
(ethylene dibromide) also.
Toxicity profile:
Oral L050: Is 680 mg/kg in rats and 860 mg/kg in rabbits (1).
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Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Dichloroethane has been shown to be mutagenic in several
different assay systems (1).
Permissible Exposure Limit: 200 ppm (2).
Immediately Dangerous to Life or Health: 4,000 ppm (2).
Existing Environmental Regulations: None known.
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and
like
dibromoethane is in widespread use. Monitoring should be considered.
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 2,4-Dich10rophenoxyacetic acid (2,4-0) (CAS Reg No: 94757) (TabTes: 1 & 2)
Exposure profiTe: This compound has been detected in concentrations of 0 to
3.9 ug/L in a detaiied survey of agricuTturaT watersheds draining into
Lake Erie and it occurs in Lake Erie sediments (<8 ug/L dwt). U.S.
watershed concentrations are apparentiy decreasing. Usage is in the order
of 30,000 Tbs per year in New York; in Ontario there is currentiy a ban on
use. 2,4—0 is sTowTy mineraTized by an acciimated microbiaT community.
Toxicity profiTe:
OraT L050: Is 360-500 mg/kg in rodents (1).
Carcinogenicity: IARC considers 2,4-D to be a suspected carcinogen in animaTs (1).
Chronic Adverse Effects: No adverse effects were observed in rats fed up to
1,250 ppm 2,4-D for 2 years (3). Dibenzo—p-dioxins have been found as
contaminants in 2,4,-D.
CNS Effects: CNS depression has been reported (confusion, dizziness, stupor,
Toss of consciousness) as we11 as paraTysis, paraesthesia, poTyneuritis
and damage to sensory nerves (89).
Reproductive Effects: The offspring of rats fed 1,500 ppm 2,4-0 suffered
reduced survivaT and reduced weight (3).
Teratogenicity: When administered to pregnant mice by avage (1 mmoTe/kg) on
days 12-15 of gestation, a 6% incidence of cieft pa ates was noted (20).
Mutagenicity: 2,4-D has been shown to be mutagenic in severaT assay systems (1).
Permissibie Exposure Limit: 10 mg/m3 (OSHA) (2). Canadian Drinking Water
Guideiine is 0.1 mg/L (40).
Imnediateiy Dangerous to Life or HeaTth: 500 mg/m3 (2 . The LDLO in man
(dermai absorption) may be as Tow as 100 mg/kg (89 .
Existing Environmentai ReguTations:
usg; The compound is monitored in drinking water under the U.S. Safe
Drinking Water ReguTations.
Canada: Drinking Water Guideiine.
Recommendation: 2,4-D is reguTated and at present appears to be adequateTy monitored.
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l
1
J Dieidrin (CAS Reg No: 60571) (Tabies: 1 & 2)
1
Exposure profiie: Dieidrin is an organochiorine pesticide and readiiy
bioaccumuiated in 1iving tissues. It occurs in Great Lakes fish in
concentrations of up to 0.76 and occasionaiiy in the water coiumn in
concentrations of up to 0.12 ug/L. New York industriai usage is given
as 8,957 1bs per year, but end use is restricted as of 1971 and
appiications are rare and speciaiized (beiow—surface use, nursery soiis,
termite controi). According to NYS-DEC (U.S.), Dieidrin apparentiy is no
longer used as a wood preservative. For biodegradabiiity, see A1drin.
Toxicity profi1e: ’
Ora) L050: In rodents, ranges from 38 to 60 mg/kg (1).
Carcinogenicity: Dieidrin causes 1iver tumors in mice fed as 1itt1e as 0.1
pan in the diet (3).
Chronic Adverse Effects: In rats fed dieidrin at 0.5 mg/kg/day, histoiogic ‘/
changes occurred in the 1iver, as weii as an increase in 1iver weight (8).
CNS Effects: Sheep fed dieidrin at 1eveis as 10w as 2.5 mg/kg/day had ’
abnormal encephaiographic and behaviorai responses (3).
Reproductive Effects: Marked effects on fertiiity, gestation, viabiiity,
1actation and survivai indices were noted in the offspring of mice fed
dieidrin at 25 mg/kg/day (8).
Teratogenicity: Dieidrin caused a significant incidence of terata in the
offspring of pregnant mice given 1/2 the L050 on day 9 of gestation (3).
Mutagenicity: Dieidrin has been reported to be mutagenic (1).
Permissibie Exposure Limit: 0.25 mg/m3 (OSHA) (2). Canadian Drinking Water
Guideiine is 0.0007 mg/L.
Immediateiy Dangerous to Life or Heaith: 450 mg/m3 (OSHA) (2). /
Existing Environmentai Reguiations:
 
Q§Az Action 1eveis for drinking water.
Canada: Drinking Water Guideiine and fish action 1eveis.
IJC Objectives: Great Lakes Water Quaiity Objective has been estabiished.
Recommendation: Monitoring programs for dieidrin aiready exist and appear to
e a equa e.
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 Di(2—ethy1hexy1)phtha1ate (DEHP) (CAS Reg No: 117817) (Tabie: 3)
Exposure profiie: Phthaiate esters are ubiquitous in the human environment in
10w concentrations. Their wide distribution is consistent with the notion
that they are reieased from many sources as a resuit of their incorpora-
tion into many industriai products. DEHP is detectab1e in most Great
Lakes waters in concentrations from 1 to 6 ug/iiter, iower concentra—
tions were found oniy in Lake Superior, the highest occurred in the
Detroit River. Up to 5,000 mg/kg dwt were found in Detroit municipai
wastewater siudges. DEHP is accumu1ated into fish; concentrations up to
1.3 ppm were found. As DEHP and the other phthaiates are siowiy but
compieteiy biodegradabie in naturai waters, the observed 1eve1s in Great
Lakes waters probabiy refiect a steady-state condition of amounts entering
the 1akes and those disappearing by microbia] action.
Toxicity profiie:
Ora1 LD50: 30,000—34,000 mg/kg in various rodent species (1).
Carcinogenicity: Recent studies have shown that DEHP may cause cancer in mice
and rats (81).
Chronic Adverse Effects: Rats fed up to 0.4% DEHP for 2 years suffered 1iver
eniargement and histoiogic changes (86).
CNS Effects: DEHP administered i.v. gave indications of CNS stimuiation in
mice, as evidenced by decreased duration of hexobarbitai - induced
sieeping (82).
Reproductive Effects: Rat studies indicate that DEHP administered i.p. caused
fatai resorption and when administered i.v. caused adverse effects upon
impiantation and parturition (86).
Teratogenicity: Decreased feta] weight has been reported when dams were fed
1.7 gram DEHP/kg/day (86).
Mutagenicity: Negative in the Saimoneiia/mammaiian-microsome assay but
positive in a dominant-1ethal assay system (65).
Permissibie Exposure Limit: Not known.
Imnediateiy Dangerous to Life or Heaith: Not known.
Existing Environmentai Reguiations: None known.
 
Recomnendation: DEHP has significant chronic toxicity and is ubiquitousiy
distributed in the environment. A1though 1eveis presentiy in the
environment are uniikeiy to pose a hazard to heaith, monitoring programs
shouid be initiated to determine trends in DEHP ieveis.
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 Diisobutylphthalate (DIBP)
(CAS Reg No: 84695) (Table: 3)
Exposure profile:
This product is widely used in industry,
apparently mostly
as a plasticizer.
Recorded discharges are insignificant.
The compound is
quite
lipophilic
and
therefore may
accumulate
in
biological
tissues.
It
is slowly mineralized by acclimated microbial communities but its
degradation at very low concentrations
is uncertain.
The compound
has
been detected at 1 pg/L
in Lake Michigan and may be widely distributed
in trace concentrations.
Toxicity profile:
Oral
L050:
13 gm/kg
in mice
(1), 20—25 g/kg in rats
(80).
Carcinogenicity:
No evidence was found to indicate whether diisobutyl-
phthalate was or was not a carcinogen.
However,
diethylhexylphthalate may
be a carcinogen.
Chronic Adverse
Effects:
Dietary
administration of DIBP to male rats induced
severe atrophy of the testes (83).
CNS Effects:
DIBP, when administered i.v. at 100 mg/kg, stimulates
respiration in anesthetized rabbits (82).
Reproductive Effects: No data found.
Teratogenicity:
DIBP caused dose-related gross and skeletal abnormalities in
rat fetuses when administered to dams on days 5, 10 and 15 of gestation at
doses representing up to 1/3 of L050 (84).
Mutagenicity:
Negative
in
Salmonella
(65).
Permissible Exposure Limit: Not known.
Immediately Dangerous
to Life
or
Health:
Not
known.
Existing Environmental
Regulations:
None known.
Recommendation:
Although no information on carcinogenicity exists,
DIBP has
significant chronic toxicity and monitoring for this phthalate is
recommended.
72
b
 
 N,N—
Dime
thy1
ani1
ine
(CAS
Reg
NO:
1216
98)
(Tah
ie:
4)
Exposure profiie: This compound is used in quantities of severai miiiion kg
per year in New York aione. It occurs in stiii bottoms. Discharge data
are not avaiiabie. It was discovered in the infiuent, but not in the
eff1uent, of the Muskegon, Michigan Wastewater Treatment System,
confirming that the compound is biodegradabie at a moderate or siow rate.
Without additionai data on usage and disposai, exposure cannot be assessed.
Toxicity profiie:
Orai L050: 1,410 mg/kg in rats (1).
Carcinogenicity: No data found.
Chronic Adverse Effects: Rats inhaiing dimethyi aniiine for 24 hours (0.3
mg/m3) showed an aitered hematoiogicai profiie (87). In dogs, repeated
1.5 9 injections caused vomiting, weakness, cyanosis, methemogiobinemia
and hypergiobuiinemia (44).
CNS Effects: Rats inhaling dimethyi aniiine (0.3 mg/m3) for 24 hours showed
significant CNS effects (87).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in Saimoneiia (65).
Permissibie Exposure Limit: 25 mg/m3 (OSHA) (42).
Inmediateiy Dangerous to Life or Heaith: 100 ppm (OSHA) (42). Probable orai
iethai dose in humans is 50-500 mg/kg (between 1 teaspoonfui and 1 oz for
a 70 kg person) (74).
Existing Environmentai Reguiations: None known.
Recommendation: It is uniikeiy that this compound poses a heaith risk to man
in the Great Lakes Basin, however, effiuent monitoring for this compound
couid be considered.
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 Dioxane (CAS Reg No: 123911) (Tabie: 3)
Exposure profile: This synthetic soivent has been detected oniy once and in
trace concentrations (1 pg/L) in Lake Michigan. Dioxane is miscibie
with water and not biodegradabie. No further information is avaiiabie to
assess its abundance in the Great Lakes..
Toxicity profiie:
Orai L050: 2,000-5,700 mg/kg in various rodent species (1).
Carcinogenicity: Tumors of the nose, iiver and iungs have been found in
animais foiiowing ingestion of high concentrations of dioxane. Rats given
drinking water with 1% dioxane for 716 days deveioped hepatoceiiuiar
carcinanas, choiangiomas and squamous ceii carcinomas of the nasal
cavity. No human carcinogenicity case reports or epidemioiogicai studies
were found (44).
Chronic Adverse Effects: Repeated exposure of severai animai species to 1,000
ppm produced damage to kidneys and iiver. Inhaiation of 800 ppm for 30
days byrabbits occasionaiiy caused fatai kidney damage. Fatai
intoxication due to iiver necrosis and severe kidney damage was reported
in workers after 2 months of heavy exposure to dioxane vapor (one case
showed significant brain damage) (44). Rats exposed to 1.0 or 0.1%
1,4-dioxane in drinking water for 4-24 months showed renai tubuiar and
hepatoceiiuiar degeneration, necrosis and regeneration (67).
CNS Effects: Rats exposed to 4—20 mg/m3 for 90 days showed pro1onged
duration of narcotic sieep and motor chronaxia. CNS depression has been
repo
rted
in m
an
and
brai
n d
amag
e wa
s de
tect
ed i
n wo
rker
s wh
o di
ed a
fter
being exposed for 1 week to an average dioxane concentration of 470 ppm
(67).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in Saimoneiia. Reported to have positive effects in
bariey, but the test materiai contained peroxide (65). Immersion of chick
embryos in dioxane has been reported to cause possibie mutagenic effects
(44).
Permissibie Exposure Limit: 360 mg/m3 (OSHA) (42). ACGIH gives a vaiue of
180 mg/m but specifies for exposure to skin (43).
Imnediateiy Dangerous to Life or Hea1th: 100 ppm (OSHA) (42). Probabie
iethai dose in humans 0.5-5.0 g/kg (between 1 oz and 1 pint for a 70 kg
person). In man the LCLO is 470 ppm for 3 days (74).
Existing Environmentai Reguiations: None known.
Recomnendation: Dioxane has significant chronic toxicity. More information
on usage and disposai is needed to assess exposure potentiai prior to any
risk assessment. Monitoring is recommended.
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PermissibTe Exposure Limit: 0.1 mg/m3 for skin (43).
ImmediateTy Dangerous to Life or HeaTth: No data found.
Existing EnvironmentaT Reguiations: None known.
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chr
oni
c t
oxi
cit
y f
or
man, however environmentai TeveTs are reTativeTy Tow.
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 End
rin
(Ta
ble
s:
1 &
2)
Exp
osu
re
pro
fil
e:
End
rin
has
bee
n l
ook
ed
for
ext
ens
ive
ly
in
the
Gre
at
Lak
es
and
its
dis
tri
but
ion
is
rel
ati
vel
y w
ell
-kn
own
.
Up
to
0.5
2 p
g
hav
e
bee
n
det
ect
ed
in
riv
er
and
Geo
rgi
an
Bay
fis
h,
but
lev
els
are
-de
cre
asi
ng.
End
rin
acc
umu
lat
es
in
liv
ing
tis
sue
s.
It
is
met
abo
liz
ed
by
mic
roo
rga
nis
ms
’
to
chl
ori
nat
ed
ket
one
s
and
ald
ehy
des
but
is
not
min
era
liz
ed.
Thi
sv
pes
tic
ide
is
reg
ula
ted
and
per
mit
s a
re
giv
en
on
a c
ase
-by
—ca
se
bas
is
I
(U.
S.)
.-
New
Yor
k D
EC
rep
ort
s t
hat
no
per
mit
s h
ave
bee
n
iss
ued
in
rec
ent
'
;
yea
rs
in
the
New
Yor
k p
ort
ion
of
the
Gre
at
Lak
es
Bas
in.
’
Toxicity profile:
Ora
l
L05
0:
Ran
ges
fro
m 1
.4
to
16
mg/
kg
in
rod
ent
s;
in
mon
key
s 3
mg/
kg
(1)
.
Car
cin
oge
nic
ity
:
End
rin
has
not
bee
n
sho
wn
to
be
an
ani
mal
car
cin
oge
n
(1,
100
).
Chr
oni
c A
dve
rse
Eff
ect
s:
End
rin
fed
to
rat
s
at
25
pun
in
the
die
t
cau
sed
red
uce
d
lif
esp
an,
liv
er
enl
arg
eme
nt
and
his
tol
ogi
c c
han
ges
in
the
bra
in,
liv
er,
kid
ney
and
adr
ena
ls
(3)
.
In
a 2
yea
r
fee
din
g
stu
dy
in
ani
mal
s
the
no-
eff
ect
lev
el
was
1 p
pm
(0.
05
mg/
kg/
day
)
(10
0).
CNS
Eff
ect
s:
Dog
s
tre
ate
d
wit
h
end
rin
(10
mg/
kg)
dev
elo
ped
con
vul
sio
ns,
hyp
ert
ens
ion
, h
ype
rex
cit
abi
lit
y a
nd
oth
er
CNS
-re
lat
ed
sym
pto
ms
(3)
.
His
tol
ogi
cal
cha
nge
s
in
the
bra
in
of
rat
s
fed
25
mg/
kg
in
the
die
t
hav
e
been reported (3).
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
En
dr
in
fe
d
pr
eg
na
nt
mi
ce
(5
pp
m
fo
r
30
da
ys)
had
si
gn
if
ic
an
tl
y
sm
al
le
r
li
tt
er
s
th
an
co
nt
ro
l
an
im
al
s
(3)
.
Te
ra
to
ge
ni
ci
ty
:
En
dr
in
ca
us
ed
a
si
gn
if
ic
an
t
in
ci
de
nc
e
of
te
ra
ta
in
fe
tu
se
s
fr
om
pr
eg
na
nt
mi
ce
gi
ve
n
1/
2
th
e
L0
50
on
da
y
9
of
ge
st
at
io
n
(3
);
ho
we
ve
r
no
te
ra
ta
we
re
re
po
rt
ed
wh
en
ra
ts
we
re
fe
d
0.1
mg
/k
g
ov
er
3
ge
ne
ra
ti
on
s
(10
0).
Mu
ta
ge
ni
ci
ty
:
Ne
ga
ti
ve
in
Sa
lm
on
el
la
,
ye
as
t
an
d
do
mi
na
nt
le
th
al
te
st
s
in
mi
ce
.
Ch
ro
mo
so
ma
l
ab
be
ra
ti
on
s
ha
ve
be
en
re
po
rt
ed
in
ge
rm
in
al
ti
ss
ue
of
rats (56).
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
0.
1
mg
/m
3
(2)
.
Ca
na
di
an
Dr
in
ki
ng
Wa
te
r
Guideline is 0.0002 mg/L.
Im
me
di
at
el
y
Da
ng
er
ou
s
to
Li
fe
or
He
al
th
:
20
0
mg
/m
3
(2)
.
In
ma
n
1 m
g/
kg
ma
y
produce repeated convulsions (100).
Existing Environmental Regulations:
Canada: Drinking Water Guideline.
Re
co
mn
en
da
ti
on
:
Re
gu
la
ti
on
and
mo
ni
to
ri
ng
of
en
dr
in
sh
ou
ld
co
nt
in
ue
.
3
,
.
.
.
,
7
.
7
-
V
_
.
.
V
(
.
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Et
hi
on
(Ta
ble
:
1)
Ex
po
su
re
pr
of
il
e:
Th
is
co
mp
ou
nd
is
re
la
te
d
to
ma
la
th
io
n.
0.
00
00
2
to
0.
00
00
4
ug
/L
wer
e f
oun
d
in
the
wat
er
col
umn
in
one
stu
dy,
no
oth
er
dat
a
are
ava
ila
ble
.
The
com
pou
nd
app
ear
s
to
be
suf
fic
ien
tly
bio
deg
rad
abl
e
to
app
ear
rar
ely
,
if
eve
r,
in
wa
te
r
sa
mp
le
s.
It
is
not
ac
cu
mu
la
te
d
bi
ol
og
ic
al
ly
.
Pr
od
uc
ti
on
in
New
Yor
k's
por
tio
n
of
the
Gre
at
Lak
es
Bas
in
is
giv
en
as
11,
830
lbs
per
ye
ar
.
Us
e
as
a
pe
st
ic
id
e
is
re
st
ri
ct
ed
.
Toxicity profile:
Ora
l
L05
0:
13
-4
0
mg
/k
g
in
va
ri
ou
s
ro
de
nt
sp
ec
ie
s
(1)
.
Ca
rc
in
og
en
ic
it
y:
No
t
li
ke
ly
to
be
a
ca
rc
in
og
en
but
not
te
st
ed
.
Chr
oni
c A
dve
rse
Eff
ect
s:
No
adv
ers
e
eff
ect
s
wer
e
not
ed
in
dog
s
or
cat
s
fed
et
hi
on
fo
r
2
ye
ar
s
at
di
et
ar
y
le
ve
ls
up
to
20
pp
m
(61
).
CNS
Eff
ect
s:
Eth
ion
is
a r
eve
rsi
ble
cho
lin
est
era
se
inh
ibi
tor
and
pro
duc
es
acu
te
neu
rol
ogi
cal
sig
ns
(sp
asm
s,
con
vul
sio
ns
and
com
a).
It
is
rap
idl
y
metabolized and excreted.
Reproductive Effects: No data found.
Ter
ato
gen
ici
ty:
No
ter
ata
obs
erv
ed
in
rat
fet
use
s a
fte
r t
he
mot
her
s w
ere
fed
3 m
g/
kg
/d
ay
on
day
s
6
th
ro
ug
h
15
of
ge
st
at
io
n
(62
).
Mutagenicity: Positive in Salmonella (65).
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
0.
4
mg
/m
3
(AC
GIH
)
fo
r
ex
po
su
re
to
sk
in
(43
).
Imn
edi
ate
ly
Dan
ger
ous
to
Lif
e o
r H
eal
th:
No
dat
a
fou
nd.
Exi
sti
ng
Env
iro
nme
nta
l
Reg
ula
tio
ns:
Non
e
kno
wn.
Re
co
mm
en
da
ti
on
:
Et
hi
on
is
ex
tr
em
el
y
to
xi
c
on
an
ac
ut
e
ba
si
s
but
de
gr
ad
es
ra
pi
dl
y.
It
is
of
mi
ni
ma
l
co
nc
er
n
to
he
al
th
on
a
lo
ng
-t
er
m
ba
si
s
an
d
monitoring is not required.
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Ethyl benzene (CAS Reg No: 100404) (Table: 3)
Exposure profile: This compound is very widely used in the Great Lakes Basin.
Annual production or usage in New York is 120,000 lbs and in Ontario,
nearly 200 million kg. Ontario discharges 175,000 kg annually to the
Great Lakes. Ethyl benzene is biodegradable to phenylacetic acid, by
acclimated bacteria, but may persist in trace concentrations and in
anaerobic sludges. One study has shown 1 to 2 ug of ethyl benzene in
the water column.
Toxicity profile:
Oral L050: 3,500 mg/kg in rats (1).
Carcinogenicity: No data found.
Chronic Adverse Effects: Irritation of skin, eyes and the upper respiratory
tract have been reported in man; edema and hemorrhage occur in lungs after
aspiration. Ethyl benzene is rapidly metabolized and excreted (44). No
significant effects were reported in rats, rabbits, guinea pigs or monkeys
exposed to 400-2,200 ppm for 40 h/wk for 6 months (60).
CNS Effects: High concentrations cause depression of the CNS and narcosis (44).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in the Salmonella/mannalian—microsome assay (65).
Permissible Exposure Limit: 435 mg/m3 (OSHA) (42).
Immediately Dangerous to Life or Health: 2,000 ppm (OSHA) (42).
Existing Environmental Regulations: None known.
Recommendation: High volume use of ethyl benzene coupledwith chronic
toxicity (inhalation) suggests air (and water) monitoring are adVisable.
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 Fo
rm
al
de
hy
de
(C
AS
Re
g
No
:
50
00
0)
(T
ab
le
:
4)
Ex
pO
Su
re
pr
of
il
e:
Th
is
co
mp
ou
nd
ha
s
ma
ny
us
es
an
d
it
s
an
nu
al
us
e
in
th
e
ba
si
n
is
in
mi
ll
io
ns
of
ki
lo
gr
am
s.
It
ha
s
be
en
de
te
ct
ed
in
a
di
sc
ha
rg
e
to
th
e
St
.
Cl
ai
r
Ri
ve
r.
Fo
rm
al
de
hy
de
is
a
wa
te
r—
so
lu
bl
e
ga
s
an
d
re
ad
il
y
an
d
ra
pi
dl
y
mi
ne
ra
li
ze
d
in
aq
ue
ou
s
so
lu
ti
on
s
of
ar
ou
nd
0.
1%
or
lo
we
r.
It
wi
ll
no
t
no
rm
al
ly
be
de
te
ct
ed
in
th
e
Wa
te
r
co
lu
mn
an
d
as
a
re
su
lt
of
it
s
so
lu
bi
li
ty
an
d
ra
pi
d
de
gr
ad
at
io
n
wi
ll
no
t
be
ac
cu
mu
la
te
d
in
to
li
vi
ng
tissues.
Toxicity profile:
Or
al
LD
SO
:
26
0-
80
0
mg
/k
g
in
va
ri
ou
s
ro
de
nt
sp
ec
ie
s
(1
).
Ca
rc
in
Og
en
ic
it
y:
Fo
rm
al
de
hy
de
(g
as
)
ha
s
ca
us
ed
an
in
cr
ea
se
d
in
ci
de
nc
e
of
na
sa
l
ca
nc
er
s
in
ra
ts
at
6
an
d
15
pp
m
an
d
in
mi
ce
at
15
pp
m.
Ep
id
em
io
lo
gi
ca
l
in
ve
st
ig
at
io
ns
of
pa
th
ol
og
is
ts
an
d
mo
rt
ic
ia
ns
ha
s
no
t
re
ve
al
ed
an
in
cr
ea
se
d
in
ci
de
nc
e
of
na
sa
l
ca
nc
er
s
(4
7)
.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
Ey
e,
no
se
an
d
th
ro
at
ir
ri
ta
ti
on
in
it
ia
ll
y;
fo
ll
ow
ed
by
br
on
ch
op
ne
um
on
ia
,
pu
lm
on
ar
y
ed
em
a
an
d
oc
ca
si
on
al
ly
as
th
ma
(4
7)
.
Fo
rm
al
de
hy
de
is
a
se
ns
it
iz
in
g
ag
en
t.
CNS Effects: No data found.
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
No
da
ta
fo
un
d.
Te
ra
to
ge
ni
ci
ty
:
No
ey
id
en
ce
ex
is
ts
to
su
gg
es
t
te
ra
to
ge
ni
ci
ty
.
Pr
eg
na
nt
ra
ts
ex
po
se
d
to
1
mg
/m
(v
ap
or
)
di
d
no
t
pr
od
uc
e
fe
tu
se
s
wi
th
ma
lf
or
ma
ti
on
s
(5
5)
.
Mu
ta
ge
ni
ci
ty
:
Po
si
ti
ve
in
ba
ct
er
ia
,
ye
as
t
an
d
Dr
os
op
hi
la
.
It
in
du
ce
s
un
sc
he
du
le
d
DN
A
sy
nt
he
si
s
bu
t
no
t
mu
ta
ti
on
s
in
ma
mm
al
ia
n
ce
ll
s
in
cu
lt
ur
e
(6
5)
.
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
(O
SH
A)
3
pp
m
(4
2)
.
(A
CG
IH
)
3
mg
/m
3
(4
3)
.
Im
me
di
at
el
y
Da
ng
er
ou
s
to
Li
fe
or
He
al
th
:
(O
SH
A)
10
0
pp
m)
(4
2)
.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
l
Re
gu
la
ti
on
s:
No
ne
kn
own
.
Re
co
mn
en
da
ti
on
:
Mo
ni
to
ri
ng
in
wa
te
r
is
no
t
re
qu
ir
ed
be
ca
us
e
fo
rm
al
de
hy
de
de
gr
ad
es
ra
pi
dl
y.
Fo
rm
al
de
hy
de
sh
ou
ld
be
pr
op
er
ly
co
nt
ai
ne
d
an
d
sp
il
ls
and other major discharges prevented.
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 Guaiacoi (methoxyphenoi) (CAS Reg No: 90051) (Tab1e: 4)
Exposure profile: This compound is a major component in effiuents of the pulp
and paper industry and has been identified in such discharges to Lake
Superior. It is, however, readiiy and rapidiy mineralized by
microorganisms. It is quite soiub1e in water and is not accumuiated into
iiving tissues.
Toxicity profi1e:
Ora] LD50: 725 mg/kg in rats (1).
Carcinogenicity: No data found.
Chronic Adverse Effects: No data found.
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in Saimoneiia and yeast.
Permissibie Exposure Limit: No data found.
Imnediateiy Dangerous to Life or Heaith: No data found.
Existing Environmental Reguiations: None known.
Recommendation: Aithough littie information on toxicity was found the rapid
degradation of guaiaco] suggests monitoring is not necessary.
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 Hep
tac
hlo
r
(CA
S
Reg
No:
764
48)
(Ta
ble
:
2)
Exp
osu
re
pro
fil
e:
Hep
tac
hlo
r
is
les
s f
req
uen
tly
det
ect
ed
in
the
env
iro
nme
nt
tha
n
its
oxi
dat
ion
pro
duc
t,
hep
tac
hlo
r e
pox
ide
.
It
occ
urs
in
Gre
at
Lak
es
wat
er
in
con
cen
tra
tio
ns
bel
ow
0.0
05
ug/
L
(ex
cep
t f
or
the
Det
roi
t R
ive
r
wat
er
whe
re
it
rea
che
d
0.0
2 u
g/L
).
Rai
nwa
ter
ove
r
Lak
e E
rie
agr
icu
ltu
ral
wat
ers
hed
s
con
tai
ned
7 p
g/L
,
mun
ici
pal
eff
lue
nts
ent
eri
ng
Lak
e E
rie
con
tai
ned
up
to
0.0
35
ug/
L.
The
com
pou
nd
was
det
ect
ed
in
Lak
e
Sup
eri
or
fis
h b
ut
not
qua
nti
fie
d.
Hep
tac
hlo
r
and
its
oxi
dat
ion
pro
duc
ts
acc
umu
lat
e
in
liv
ing
tis
sue
s
and
are
per
sis
ten
t.
Toxicity profile:
Ora
l L
050
:
40—
116
mg/
kg
in
var
iou
s r
ode
nt
spe
cie
s
(1)
.
Car
cin
Oge
nic
ity
:
Hep
tac
hlo
r
(co
nta
ini
ng
chl
ord
ane
)
is
con
sid
ere
d
car
cin
oge
nic
to
mic
e
(12
)
how
eve
r,
it
has
not
bee
n
fou
nd
to
be
car
cin
Oge
nic
in
rat
s
fed
5 o
r 1
0 p
pm
(0.
25
or
0.5
mg/
kg/
day
) f
or
8 m
ont
hs
(41
).
Chr
oni
c A
dve
rse
Eff
ect
s:
Sub
chr
oni
c
exp
osu
re
(14
0
day
s)
of
rat
s
to
hep
tac
hlo
r
at
45
ppm
(2.
3 m
g/k
g/d
ay)
in
the
die
t
led
to
liv
er
pat
hol
ogy
and
bio
che
mic
al
cha
nge
s.
Eff
ect
s
on
kid
ney
and
spl
een
hav
e
als
o b
een
rep
ort
ed
in rats fed 5 mg/kg for 200 days (41).
CNS
Eff
ect
s:
Sti
mul
ati
on
of
the
CNS
sys
tem
has
bee
n o
bse
rve
d a
fte
r 5
0 d
ays
'
exposure of rats to 5 mg/kg heptachlor (41).
Rep
rod
uct
ive
Eff
ect
s:
10
ppm
of
hep
tac
hlo
r (
0.5
mg/
kg/
day
) f
ed
to
rats
ove
r 3
gen
era
tio
ns
pro
duc
ed
no
adv
ers
e e
ffe
cts
on
rep
rod
uct
ive
cap
aci
ty,
gro
wth
or survival (41).
Teratogenicity: No data found.
Mut
age
nic
ity
:
NOn
—mu
tag
eni
c i
n D
. s
ubt
ili
s r
ec
ass
ay,
Sal
mon
ell
a,
Dr0
50p
hil
a
and
dom
ina
nt
leth
al
ass
ays
, b
ut
pos
iti
ve
for
DNA
dam
age
in S
V40
-tr
ans
—
for
med
hum
an
cel
ls.
Ind
uce
s c
hro
mos
ome
abe
rra
tio
ns
in
viv
o i
n m
ous
e b
one
marrow assay (65).
 
Per
mis
sib
le
Exp
osu
re
Lim
it:
ACG
IH-
TVL
is 0
.5
mg/
m3
(42)
.
Can
adi
an
Dri
nki
ng
Water Guideline is 0.003 mg/L.
Imme
diat
ely
Dang
erou
s to
Life
or H
ealt
h:
46 9
sing
le d
erma
l e
xpos
ure
or
1.2
g re
peat
ed d
erma
l e
xpos
ure
in m
an
(4])
.
100
mg/m
3 (
OSHA
) (
42).
Existing Environmental Regulations:
Canada: Drinking Water Guideline.
Recannendation: Heptachlor is presently monitored.
 Hep
tac
hio
r e
pox
ide
(CAS
Reg
No:
133
866
80)
(Tab
Te:
2)
Exp
osu
re
pro
fii
e:
Hep
tac
hTo
r e
pox
ide
is
the
pre
dom
ina
nt
per
sis
ten
t o
xid
ati
on
pro
duc
t o
f t
he
pes
tic
ide
hep
tac
hTo
r a
nd
it
is
its
elf
bio
Tog
ica
TTy
act
ive
.
Hep
tac
hTo
r u
se
is
now
sev
ere
iy
con
tro
TTe
d.
The
fat
e o
f i
ts
res
idu
es
ove
r
tim
e i
s n
ot
cie
ar.
Con
cen
tra
tio
ns
of
the
epo
xid
e i
n G
rea
t L
ake
s
tri
but
ari
es
hav
e b
een
fro
m n
ot
det
ect
abT
e t
o a
bou
t 1
0 u
g/T
ite
r;
the
hig
hes
t c
onc
ent
rat
ion
s w
ere
fou
nd
in
agr
icu
itu
rai
wat
ers
hed
s.
The
com
pou
nd
is
wid
eTy
dis
tri
but
ed
in
Gre
at
Lak
es
fis
h
in
con
cen
tra
tio
ns
of
0.1
—8
(in
one
cas
e 2
8)
ug/
kg.
Her
rin
g g
uTT
egg
s i
n t
he
Lak
es
Eri
e a
nd
Mic
hig
an
wat
ers
hed
s c
ont
ain
ed
abo
ut
0.2
(fr
om
0.1
-0.
6)u
/gr
am
fre
sh
weight.
Toxicity profiTe:
0ra1 L050: 62 mg/kg in rats (1).
Car
cin
Oge
nic
ity
:
The
re
is
Tim
ite
d e
vid
enc
e t
hat
hep
tac
hTo
r e
pox
ide
is
car
cin
oge
nic
in
mic
e
(12
)
how
eve
r,
the
inc
ide
nce
of
tum
ors
of
a1]
kin
ds
in
rat
s f
ed
hep
tac
hTo
r e
pox
ide
at
var
iou
s d
ose
Tev
eTs
was
sim
iTa
r t
o t
he
incidence in controT animaTs (41).
Chr
oni
c A
dve
rse
Eff
ect
s:
Rat
s f
ed
die
tar
y T
eve
Ts
of
hep
tac
hTo
r e
pox
ide
gre
ate
r t
han
80
ppm
(4
mg/
kg/
day
)
die
d w
ith
in
2 t
o 2
0 w
eek
s
of
the
fir
st
exp
osu
res
.
No
sig
ns
of
dis
eas
e o
the
r t
han
hep
ato
meg
aiy
wer
e o
bse
rve
d
aft
er
two
yea
rs
of
exp
osu
re
at
20
ppm
(1
mg/
kg/
day
)
or
Tes
s (
41)
.
CNS Effects: No data found.
Rep
rod
uct
ive
Eff
ect
s:
Hep
tac
hio
r
epo
xid
e
did
not
aff
ect
rat
s
whe
n
fed
at
10
pp
m
(0.
5
mg
/k
g/
da
y)
ov
er
th
re
e
ge
ne
ra
ti
on
s
(41
).
Ter
ato
gen
ici
ty:
No
ter
ato
gen
ic
eff
ect
s a
ttr
ibu
tab
Te
to
hep
tac
hTo
r
epo
xid
e
wer
e f
oun
d
whe
n
pre
gna
nt
fem
aTe
rab
bit
s
wer
e
fed
5 m
g/k
g
on
day
s
6
to
11
of gestation (41).
Mut
age
nic
ity
:
Non
-mu
tag
eni
c i
n S
aTm
one
TTa
,
Dro
sop
hiT
a a
nd
dom
ina
nt
Tet
haT
ass
ays
and
pos
iti
ve
in
a D
NA
dam
age
ass
ay
usi
ng
SV4
0-t
ran
sfo
rme
d
hum
an
ceTTs in cuTture.
 
Per
mis
sib
ie
Exp
osu
re
Lim
it:
Can
adi
an
Dri
nki
ng
Wat
er
Gui
deT
ine
is
0.0
03
mg/
L.
Imn
edi
ate
iy
Dan
ger
ous
to
Lif
e
or
Hea
Tth
:
Unk
now
n,
see
hep
tac
hTo
r.
Existing EnvironmentaT ReguTations:
Canada: Drinking Water GuideTine.
Rec
omm
end
ati
on:
Mon
ito
rin
g
for
hep
tac
hTo
r
epo
xid
e
air
ead
y
exi
sts
.
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 Hexachlorobenzene (HCB) (CAS Reg No: 118741) (Table: 3)
Exposure profile: Hexachlorobenzene has been found in fish from the lower
lakes and the Niagara River (up to 0.025 ug/g) and Lake Superior (up to
0.04 ug/g) and in air over Lake Superior (2.8 ppt). Levels in fish
eati
ng b
irds
have
been
decl
inin
g si
nce
1975
., F
igur
es o
n us
e an
d di
scha
rge
(1,000 kg used in New York per year, 12 kg discharged in Michigan) are
unimpressive, but the persistent nature of this compound and its strong
tendency to accumulate in biological tissues make this compound a
candidate for closer surveillance.
Toxicity profile:
Oral L050: 1,000-4,000 mg/kg in rats (1) (56).
Car
cin
oge
nic
ity
:
Die
tar
y l
eve
ls
of
200
ppm
HCB
cau
sed
a s
ign
ifi
can
t i
ncr
eas
e
in incidence of hepatonas, hemangioendotheliomas and thyroid adenanas in
hamsters (49). It is also carcinogenic (hepatomas) in mice (12).
Chr
oni
c A
dve
rse
Eff
ect
s:
Ham
ste
rs
mai
nta
ine
d o
n a
die
t c
ont
ain
ing
200
ppm
HCB
suffered reduced lifespan and a marked reduction in weight gain (49).
Accidental chronic exposure in man results in porphyria cutanea tarda
(weakness, anorexia, porphyrinuria, hyperpigmentation) hepatomegaly and
cir
rho
sis
and
"pi
nk
sore
" i
n c
hil
dre
n;
a c
ond
iti
on
tha
t i
s 9
5%
fat
al
(56)
.
CNS
Effe
cts:
Rats
give
n 50
mg/k
g of
HCB
by s
toma
ch t
ube
on a
lter
nate
days
developed tremors and suffered an average of 2 degrees drop in body
temperature (50).
Rep
rod
uct
ive
Eff
ect
s:
The
off
spr
ing
of
rat
s f
ed
320
ppm
of
hex
ach
lor
obe
nze
ne
in
the
die
t s
uff
ere
d r
edu
ced
via
bil
ity
and
fer
til
ity
(52)
.
Ter
ato
gen
ici
ty:
Alt
hou
gh
mos
t s
tud
ies
hav
e f
oun
d H
CB
not
to
be
ter
ato
gen
ic
(56
),
pre
gna
nt
mic
e a
dmi
nis
ter
ed
HCB
by
gav
age
(10
0 m
g/k
g)
on
day
s 7
thr
oug
h 1
6 o
f g
est
ati
on
pro
duc
ed
fet
use
s w
ith
a s
ign
ifi
can
tly
inc
rea
sed
inc
ide
nce
of
clu
b f
oot
, c
lef
t p
ala
te
and
inc
rea
sed
mor
tal
ity
(48)
.
Mut
age
nic
ity
:
HCB
exh
ibi
ted
no
mut
age
nic
eff
ect
in
a d
omi
nan
t l
etha
l t
est
con
duc
ted
in
rat
s (
51)
and
was
neg
ati
ve
in
a S
alm
one
lla
/ma
mna
lia
n
microsome assay (56) (65).
Per
mis
sib
le
Exp
osu
re
Lim
it:
WHO
con
dit
ion
al
acc
ept
abl
e d
ail
y i
nta
ke
val
ue
is
0.6 ug/kg (56).
Imnediately Dangerous to Life or Health: No data found.
Existing Environmental Regulations: None known.
 
Reca
nnen
dati
on:
Alth
ough
leve
ls o
f HC
B ap
pear
to b
e de
clin
ing,
moni
tori
ng
sho
uld
be
con
sid
ere
d t
o c
onf
irm
tha
t l
eve
ls
are
con
tin
uin
g t
o d
rop.
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He
xa
ch
io
ro
bu
ta
di
en
e
(H
CB
D)
(C
AS
Re
g
No
:
87
68
3)
,(
Ta
bT
es
:
1
&
3)
Ex
po
su
re
pr
of
il
e:
Th
is
co
mp
ou
nd
ha
s
be
en
de
te
ct
ed
bu
t
no
t
qu
an
ti
fi
ed
in
fi
sh
fr
om
La
ke
Hu
ro
n
an
d
th
e
As
ht
ab
uT
a
Ri
ve
r.
Ne
w
Yo
rk
pr
od
uc
es
ne
ar
iy
10
0,
00
0
Tb
s
pe
r
ye
ar
,
Mi
ch
ig
an
di
sc
ha
rg
es
ar
e
es
ti
ma
te
d
at
1
to
11
Tb
s
pe
r
ye
ar
.
Th
e
co
mp
ou
nd
is
st
ab
ie
an
d
is
ac
cu
mu
ia
te
d
in
to
Ti
vi
ng
ti
SS
ue
s.
Av
ai
Ta
bT
e
in
fo
rm
at
io
n
is
to
o
sc
an
ty
to
pe
rm
it
es
ti
ma
te
s
of
ex
po
su
re
.
Toxicity profiie:
Or
aT
L0
50
:
In
ra
ts
,
mi
ce
an
d
gu
in
ea
pi
gs
,
or
aT
L0
50
ra
ng
es
fr
om
90
-1
00
mg/kg (1).
Ca
rc
in
og
en
ic
it
y:
A
si
gn
if
ic
an
t
in
ci
de
nc
e
of
ki
dn
ey
ne
0p
1a
sm
s
oc
cu
rr
ed
in
ra
ts
fe
d
20
mg
/k
g/
da
y
of
he
xa
ch
To
ro
bu
ta
di
en
e
fo
r
24
mo
nt
hs
(1
2)
.
IA
RC
co
ns
id
er
s
th
at
th
er
e
is
Ti
mi
te
d
ev
id
en
ce
th
at
HC
BD
is
ca
rc
in
og
en
ic
in
ra
ts
(1
2)
.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
Wh
en
ra
ts
we
re
fe
d
di
et
s
co
nt
ai
ni
ng
up
to
20
mg
/k
g/
da
y
of
he
xa
ch
io
ro
bu
ta
di
en
e
fo
r
24
mo
nt
hs
,
th
ey
su
ff
er
ed
in
cr
ea
se
d
mo
rt
aT
it
y,
re
du
ce
d
we
ig
ht
ga
in
an
d
pa
th
oi
og
ic
ch
an
ge
s
in
th
e
ki
dn
ey
(1
2)
.
CN
S
Ef
fe
ct
s:
In
ac
ut
e
do
sa
ge
,
he
xa
ch
io
ro
bu
ta
di
en
e
ap
pe
ar
ed
to
af
fe
ct
th
e
CN
S
of mice (13).
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
Wh
en
br
ee
de
r
ra
ts
we
re
fe
d
up
to
20
mg
/k
g/
da
y
of
he
xa
ch
io
ro
bu
ta
di
en
e,
th
ei
r
of
fs
pr
in
g
we
re
co
mp
ar
ab
Te
to
co
nt
ro
is
ac
co
rd
in
g
to
va
ri
ou
s
su
rv
iv
ai
in
di
ce
s,
bo
dy
we
ig
ht
an
d
pa
th
oi
og
y
(1
2)
.
Te
ra
to
ge
ni
ci
ty
:
He
xa
ch
io
ro
bu
ta
di
en
e
ha
s
be
en
re
po
rt
ed
to
ca
us
e
te
ra
ta
in
th
e
fe
tu
se
s
of
pr
eg
na
nt
mi
ce
iv
en
16
0
mg
/k
g
by
in
tr
ap
er
it
on
ea
i
in
je
ct
io
n
on
days 1-15 of gestation (I).
Mu
ta
ge
ni
ci
ty
:
He
xa
ch
To
ro
bu
ta
di
en
e
is
re
po
rt
ed
to
be
mu
ta
ge
ni
c
in
Sa
im
on
ei
ia
typhimurium (14).
Pe
rm
is
si
bi
e
Ex
po
su
re
Li
mi
t:
No
da
ta
fo
un
d.
Im
me
di
at
eT
y
Da
ng
er
ou
s
to
Li
fe
or
He
aT
th
:
No
da
ta
fo
un
d.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
i
Re
gu
ia
ti
on
s:
No
ne
kn
ow
n.
Re
co
mm
en
da
ti
on
:
Ac
ut
e
an
d
ch
ro
ni
c
to
xi
ci
ty
da
ta
su
gg
es
t
th
at
mo
ni
to
ri
ng
to
es
ta
bi
is
h
Te
ve
Ts
in
wa
te
r
an
d
fi
sh
wo
ui
d
be
wo
rt
hw
hi
ie
.
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 Hexa
chio
robu
tene
(CAS
Reg
No:
6858
4338
)
(Tab
ie:
5)
Exp
osu
re
pro
fii
e:
The
com
pou
nd
was
det
ect
ed
in
a t
rib
uta
ry
to
Lak
e E
rie
at
a
con
cen
tra
tio
n o
f 2
1 u
g/L
.
The
use
pat
ter
n i
s n
ot
cTea
r.
The
com
pou
nd
is
pro
bab
iy
not
bio
deg
rad
ahi
e.
Inf
orm
ati
on
to
ass
ess
exp
osu
re
is
presentiy insufficient.
Toxicity profiie:
OraT L050: No data found.
Carcinogenicity: No data found.
Chronic Adverse Effects: No data found.
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: No data found.
Permissibie Exposure Limit: No data found.
Inmediateiy Dangerous to Life or Heaith: No data found.
Existing Environmentai ReguTations: None known.
 
Rec
omm
end
ati
on:
The
dat
a a
vai
iab
ie
on
tox
ici
ty
and
exp
osu
re
are
ins
uff
ici
ent
for
eve
n t
he
mos
t p
rei
imi
nar
y a
sse
ssm
ent
of
haz
ard
or
ris
k.
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Hexachlorocyclohexane (all isomers (CAS Reg No: 319846) (Table: 3)
except lindane) (HCH) '
Exposure profile: Lake Huron fishcontain up to 50 ug/g of the gamma and
beta isomers. The alpha isomer was not found. Herring gull eggs from
Lake Superior contained 0.03 i 0.02 mg/kg of the beta isomer. HCH isomers
resemble lindane with regard to biodegradability and bioaccumulation.
Toxicity profile:
Oral L050: 100 mg/kg in the rat. Oral L050 in the rat for the various
isomers excluding a-HCH (lindane) ranged from 177 to 6,000 mg/kg (1).
Carcinogenicity: a-HCH and technical HCH are considered to be carcinogenic in
mice but there is only limited evidence that b-HCH is carcinogenic (12).
Chronic Adverse Effects: Two year exposures of rats to several HCH isomers
led to liver and to a lesser extent, kidney damage; effects were observed
at 50-100 mg/kg. Major chronic effects are nodular hyperplasia and
neoplasms in the liver. The no-effect level in rats is 25 mg/kg (56).
CNS Effects: Chronic poisoning 4n man has led to CNS signs including:
vertigo; mental confusion; blindness and convulsions (56).
Reproductive Effects: Probably minor effects at levels slightly higher than
the effect level for lindane. See toxicity profile for lindane.
Teratogenicity: Transplacental transfer occurs but is limited. Fetal
development was affected by b—HCH (level unknown) (56).
Mutagenicity: HCH is a very weakmutagen (56).
Permissible Exposure Limit: see lindane (a-HCH) (42).
Inmediately Dangerous to Life or Health: see lindane (a-HCH) (42)—
Existing Environmental Regulations: None known.
 
Recommendation: Monitoring for hexachlorocyclohexane isomers should be
considered although these are generally detected with lindane.
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 Hexachloroethane
(CAS
Reg
No:
67721)
(Table:
3)
Exposure
profile:
This
compound
was
detected
in
one
water
column
sample
but
was
not quantified.
It
is
produced
or
used
in
quantity
(92,880
lbs
per
year
by
NYS).
It
is
probably
not
biodegradable.
It
is
lipophilic
and
likely
to
accumulate
in
living
tissue.
There
is
clearly
not
sufficient
information to estimate exposure.
Toxicity profile:
Oral L050: 600 mg/kg-in rats (1).
Carcinogenicity:
A
recent
NCI
bioassay
showed
that
hexachloroethane
was
associated
with
the
formation
of
hepatocellular
tumors
in
mice
(39).
Chronic
Adverse
Effects:
Damage
to
liver,
kidney
and
the
central
nervous
system
has
been
reported
at
high
doses.
0.2 g/kg
caused
no
effects
in
the
horse (44).
CNS
Effects:
At
acute
dose
levels
of
hexachloroethane,
rats
experienced
ataxia,
tremors
and
convulsions
(39).
1—1.4
g/kg
in dogs
caused
CNS
depression,
ataxia
and
staggering
(44).
Reproductive
Effects:
When
pregnant
rats
were
dosed
with
500
mg/kg
hexachloroethane
on
days
6-16
of
gestation,
resorptions
increased
and
live
births per dam decreased (39).
Teratogenicity:
No
significant
skeletal
or
soft
tissue
anomalies
were
observed
in fetuses
from
pregnant
rats
dosed
with
500 mg/kg
hexachloroethane
on
days
6-16
of
gestation
(39).
Mutagenicity:
No mutagenic
effect
of hexachloroethane
was
observed
in
tests
conducted
with
Saccharomyces
cerevisiae
and
Salmonella
typhimurium
(39).
  
Permissible
Exposure
Limit:
1
ppm
(2).
Inmediately
Dangerous
to
Life
or
Health:
300
ppm
(2).
Existing
Environmental
Regulations:
None
known.
Recommendation:
The
chronic
toxicity
of
this
compound
coupled
with
the
lack
of
exposure
data
suggest
monitoring
be
carefully
considered.
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 Kepone
(Chiordecane)
(CAS
Reg
No:
143500)
(Tabie:
1)
Exposure
profiie:
Not
found
in
Great
Lakes.
Toxicitx profiie:
Ora]
L050:
65
mg/kg
in
rabbits
and
200
mg/kg
in
dogs
(1).
Carcinogenicity:
Kepone
has
been
shown
to
cause
iiver
tumors
in
mice
fed
26
ppm in the diet (9).
Chronic
Adverse
Effects:
In
humans,
weight
loss,
pieuritic
and
joint
pains
and
oiigospermia
have
been
reported
after
chronic
exposure
to
kepone
(3).
CNS
Effects:
Generaiized
tremors
occurred
when
kepone
was
administered
in
the
diet
of
mice
(20-40
ppm)
and
rats
(8-26
ppm)
(3).
Reproductive
Effects:
At
dietary
levels
as
iow
as
10
ppm,
both
the
number
and
size
of
mouse
iitters
were
significantiy
reduced
(3).
Teratogenicity:
No
data
found._,
Mutagenicity: No data found.
Permissible
Exposure
Limit:
No
data
found.
Immediateiy
Dangerous
to
Life
or
Heaith:
No
data
found.
Existing
Environmentai
Reguiations:
None
known.
Recommendation:
Kepone
has
not
been
found
in
the
Great
Lakes
and
is
not
registered
for
use
in
the
area.
Monitoring
is
not
recommended
at
this
time.
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 Lead
(inorganic)
(Table:
1)
Exposure
profile:
Lead
was
singled
out
by
the
PLUARG
group
as
the
trace
metal
of
concern
in
the
Great
Lakes.
Contributions
to
the
Great
Lakes,
via
atmospheric
transport
from
automotive
sources
and
coal
burning
and
from
industrial
wastewaters
have
been
large,
and
the
occurrence
of
the
element
in
alkylated
form
has
caused
concern.
The
lowering
of
lead
levels
in
automotive
fuel
and
other
controls
have
resulted
in
a
decrease
in
atmospheric
lead
concentrations,
but
a
decline
in
lead
levels
in
the
Great
Lakes
ecosystem
thus
far
has
not
been
documented.
Concentrations
of
lead
in
Great
Lakes
waters
are
presently
acceptable,
but
concentrations
in
tributaries
(MilWaukee
Harbor,
Wisconsin;
Grand
River,
Michigan)
have
been
or
are
excessive.
Concentrations
in
fish
are
generally
below
0.5
ppm,
with
isolated
findings
of
up
to 1.5
ppm.
Toxicity profile:
Oral
L050:
No
data
found
but
oral
LDLO
values
indicate
lead
compounds
have
a
wide
range
of
toxicities
from
1,330-8,000
mg/kg
in
rodents
(66).
Carcinogenicity:
In
a
2
year
feeding
study,
exposure
of
rats
or
mice
to
0.1%
basic
lead
acetate
in
the
diet
produced
adenomatous
and
carcinomatous
tumors
in
the
kidneys.
There
is
no
evidence
that
exposure
to
lead
salts
causes
cancer
in
man
(40).
Chronic
Adverse
Effects:
Wide-ranging
effects
have
been
reported
in
man
and
animals:
disorders
of
the
haematopoetic
system;
vascular
system;
liver;
thyroid;
renal
atrophy
(0.4
mg/L
for
10
weeks
in
rats);
and
adrenal
dysfunction (40).
CNS
Effects:
Peripheral
neuropathies
have
been
reported
in
animals
and
man
exposed
to
lead
and
resulted
in
ataxia,
hyperaesthesia,
anaesthesia
and
analgesia.
Encephalopathy
is
observed
in
children
(more
than
adults)
chronically
exposed
to
high
lead
levels
and
may
lead
to
irreversible
neurological
and
psycological
damage
(40).
Reproductive
Effects:
Lead
decreases
the
fertility
of
men;
the
frequency
of
asthenospermia,
hypospermia
and
teratospermia
is
increased.
Historical
literature
indicates
stillbirths
have
been
associated
with
high
levels
of
occupational
lead
exposure
(40).
Teratogenicity:
Placental
transfer
occurs
but
is
limited.
Fetotoxicity
and
fetal
malformations
of
the
urorectocaudal
system
have
been
reported
in
studies
of
lead
nitrate
administered
to
rats
(54).
Mutagenicity:
Negative
in
bacteria,
plants
and
Drosophila.
Lead
acetate
weakly
induces
chromosomal
aberrations
in
cultured
manmalian
cells.
Inorganic
lead
is
weakly
effective
in
producing
chromosome
gaps
in
in
vivo
mamnalian
studies
(65).
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 Permissible Exposure Limit: 0.05 mg/m3 (OSHA) (42) and a drinking water
guideline in Canada of 0.05 mg/L (40).
Immediately Dangerous to Life or Health: Variable (OSHA) (42).
Existing Environmental Regulations:
Canada: Drinking Water Guideline.
IJC Objectives: Yes.
Recommendation: Continued monitoring and special studies on transport and
fate of lead are recommended.
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Leptophos (CAS Reg No: 21609905) (TabIe: 4)
Exposure profiie: This pesticide is no Tonger produced or used in the basin.
Appendix E Tists its occurrence in rainwater (1,100 ug/L, one positive
resuTt). The compound is very sTowTy metaboTized in soiT. There is no
information on mineraIization.‘ It is stroneg TipophiTic and TikeTy to
accumuTate in Iiving tissue. '
Toxicity profiTe:
Ora] L050: Is 24—124 mg/kg in rats (23).
Carcinogenicity: No evidence of carcinogenicity was seen in mice fed up to
100 ppm Teptophos in the diet for 18 months (23).
Chronic Adverse Effects: In dogs fed up to 60 ppm Teptophos in the diet for
two years, no adverse effects were noted on mortaTity, growth, food
consumption and behavior, or on histoTogicaT appearance of seTected
tissues (23). Effects on bIood choTinesterase were reversibTe (96).
CNS Effects: Leptophos administered at acute TeveTs causes hypoactivity and
tremors (23). It is a potent choiinesterase inhibitor and therefore
neurotoxic to man and animaTs (96).
Reproductive Effects: In rats, a significantTy reduced pup survivaT was
observed in rats fed Teptophos at a 60 ppm dietary TeveT (23).
Teratogenicity: Ora] administration of 3 mg/kg Teptophos to pregnant rabbits
during organogenesis eTicited no terata in fetuses (23).
Mutagenicity: Leptophos exerted no effect on reproduction parameters in a
dominant Tetha] study performed in maTe rats administered a singTe oraI
dose of up to 30 mg/kg (23).
PermissibIe Exposure Limit: No data found.
ImmediateTy Dangerous to Life or HeaTth: No data found.
Existing EnvironmentaT ReguTations: None known.
Recommendation: Monitoring is not required for this compound because it is no
Tonger used in the Great Lakes Basin.
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 Li
mo
ne
ne
(C
AS
Re
g
No
:
13
88
63
)
(T
ab
ie
:
4)
Ex
po
su
re
pr
of
ii
e:
Li
mo
ne
ne
wa
s
fo
un
d
in
co
nc
en
tr
at
io
ns
of
13
0
to
50
0
pg
/L
in
di
sc
ha
rg
es
fr
om
th
e
fo
re
st
pr
od
uc
ts
in
du
st
ry
on
La
ke
Su
pe
ri
or
.
It
is
a
na
tu
ra
ii
y
oc
cu
rr
in
g
co
mp
ou
nd
an
d
pr
ob
ab
iy
no
t
st
ab
ie
in
th
e
en
vi
ro
nm
en
t.
Toxicity profiie:
Or
ai
L0
50
:
5,
00
0
mg
/k
g
in
ra
ts
(1
).
Ca
rc
in
og
en
ic
it
y:
No
da
ta
fo
un
d.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
Ma
y
ac
t
as
a
sk
in
ir
ri
ta
nt
an
d
ai
ie
rg
en
.
CN
S
Ef
fe
ct
s:
No
da
ta
fo
un
d.
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
No
da
ta
fo
un
d.
Te
ra
tO
ge
ni
ci
ty
:
Pr
eg
na
nt
ra
ts
we
re
gi
ve
n
2,
86
9
mg
/k
g
du
ri
ng
fe
ta
i
or
ga
no
-
ge
ne
si
s.
Wh
ii
e
no
te
ra
to
ge
ni
c
ef
fe
ct
s
we
re
ob
se
rv
ed
ma
te
rn
ai
to
xi
ci
ty
an
d
fe
ta
]
gr
ow
th
re
ta
rd
at
io
n
we
re
re
po
rt
ed
(5
5)
.
Mu
ta
ge
ni
ci
ty
:
No
da
ta
fo
un
d.
Pe
rm
is
si
bi
e
Ex
po
su
re
Li
mi
t:
No
da
ta
fo
un
d.
Im
ne
di
at
ei
y
Da
ng
er
ou
s
to
Li
fe
or
He
ai
th
:
No
da
ta
fo
un
d.
E
xi
s
t
i
n
g
E
n
vi
r
o
n
m
e
n
t
a
i
R
e
g
ui
a
t
i
o
n
s
:
N
o
n
e
kn
ow
n.
R
e
c
o
m
m
e
n
d
a
t
i
o
n
:
O
n
i
y
a
f
e
w
t
o
x
i
c
o
l
o
g
i
c
a
i
d
a
t
a
w
e
r
e
f
o
u
n
d
f
o
r
i
i
m
o
n
e
n
e
,
h
o
w
e
v
e
r
t
h
e
s
e
d
a
t
a
i
n
d
i
c
a
t
e
it
is
n
o
t
v
e
r
y
t
o
x
i
c
a
c
u
t
e
i
y
an
d
m
a
y
n
o
t
be
v
e
r
y
t
o
xi
c
c
h
r
o
n
i
c
a
i
i
y
.
L
i
m
o
n
e
n
e
p
r
o
b
a
b
l
y
d
e
g
r
a
d
e
s
r
a
p
i
d
i
y
a
n
d
h
e
n
c
e
e
xp
o
s
ur
e
is
1i
ke
1y
to
be
io
w.
E
f
f
i
ue
n
t
m
o
n
i
t
o
r
i
n
g
m
a
y
be
wa
r
r
a
n
t
e
d
.
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 Li
nd
an
e
(
a
—h
e
xa
c
h
i
o
r
o
c
yc
i
o
h
e
xa
n
e
)
(C
AS
Re
g
No
:
58
89
9)
(T
ab
ie
s:
1
&
2)
E
x
p
o
s
u
r
e
p
r
o
f
i
i
e
:
L
i
n
d
a
n
e
ha
s
be
en
f
o
u
n
d
in
G
r
e
a
t
L
a
k
e
s
w
a
t
e
r
in
co
nc
en
tr
at
io
ns
of
0.
00
01
6
pg
/L
an
d
0.
04
ug
/
g
in
fi
sh
(L
ak
e
Su
pe
ri
or
).
S
i
m
i
i
a
r
c
o
n
c
e
n
t
r
a
t
i
o
n
s
oc
cu
r
in
wi
id
ii
fe
.
Ai
r
ov
er
La
ke
S
up
e
r
i
o
r
co
nt
ai
ns
5
pp
t
of
Li
nd
an
e.
Pr
od
uc
ti
on
an
d
us
e
ar
e
si
gn
if
ic
an
t.
Th
e
pr
od
uc
t
is
si
ow
iy
mi
ne
ra
ii
ze
d,
if
at
ai
i.
It
is
t
r
a
n
s
f
o
r
m
e
d
b
i
o
i
o
g
i
c
a
i
i
y
to
ot
he
r
ch
io
ri
na
te
d
co
mp
ou
nd
s
an
d
it
is
co
nc
en
tr
at
ed
in
1i
vi
ng
ti
ss
ue
s.
T
o
x
i
c
i
t
y
p
r
o
f
i
i
e
:
Or
a]
LD
50
:
In
r
o
d
e
n
t
s
,
i
v
a
r
i
e
s
f
r
o
m
60
to
3
6
0
m
g
/
k
g
(1
).
E
s
t
i
m
a
t
e
d
L
0
5
0
f
o
r
m
a
n
is
1
2
5
m
g
/
k
g
(
5
6
)
.
C
a
r
c
i
n
o
g
e
n
i
c
i
t
y
:
L
i
n
d
a
n
e
f
e
d
to
m
i
c
e
at
4
0
0
m
g
/
k
g
wa
s
r
e
p
o
r
t
e
d
to
c
a
u
s
e
l
i
v
e
r
t
u
m
o
r
s
(8
)
an
d
is
c
o
n
s
i
d
e
r
e
d
an
an
im
ai
c
a
r
c
i
n
o
g
e
n
(1
2)
.
C
h
r
o
n
i
c
A
d
v
e
r
s
e
E
f
f
e
c
t
s
:
L
i
v
e
r
e
n
i
a
r
g
e
m
e
n
t
o
c
c
u
r
r
e
d
in
do
gs
f
e
d
up
to
2
0
0
p
p
m
1
i
n
d
a
n
e
f
o
r
32
we
e
k
s
,
bu
t
t
h
i
s
c
o
u
i
d
no
t
be
c
o
r
r
e
i
a
t
e
d
w
i
t
h
a
n
y
hi
st
op
at
ho
io
gi
ca
i
ch
an
ge
s
(6
).
CN
S
Ef
fe
ct
s:
Hu
ma
ns
ex
po
se
d
to
1i
nd
an
e
on
a
ch
ro
ni
c
ba
si
s
ex
hi
bi
te
d
m
yo
c
i
o
n
i
c
j
e
r
k
s
,
g
e
n
e
r
a
i
i
z
e
d
c
e
r
e
b
r
a
i
s
e
i
z
u
r
e
s
a
n
d
h
y
p
e
r
e
x
c
i
t
a
b
i
i
i
t
y
(8
).
R
e
p
r
o
d
uc
t
i
ve
Ef
fe
ct
s:
An
in
cr
ea
se
d
in
ci
de
nc
e
of
st
ii
i
bi
rt
hs
ha
s
be
en
r
e
p
o
r
t
e
d
in
d
o
g
s
f
e
d
7
.
5
-
1
5
m
g
/
k
g
1
i
n
d
a
n
e
.
10
m
g
/
k
g
f
o
r
4
m
o
n
t
h
s
r
e
d
u
c
e
d
c
o
n
c
e
p
t
i
o
n
r
a
t
e
s
in
r
a
t
s
an
d
8
m
g
/
k
g
d
e
i
a
y
e
d
se
xu
ai
m
a
t
u
r
i
t
y
in
m
i
c
e
.
C
o
n
f
i
i
c
t
i
n
g
d
a
t
a
e
x
i
s
t
f
o
r
ra
ts
;
d
i
e
t
a
r
y
1
e
v
e
i
s
up
to
10
0
m
g
/
k
g
f
o
r
3
g
e
n
e
r
a
t
i
o
n
s
h
a
d
n
o
e
f
f
e
c
t
i
n
o
n
e
s
t
u
d
y
b
u
t
o
r
a
i
d
o
s
i
n
g
o
f
0
.
5
m
g
/
k
g
f
o
r
4
m
o
n
t
h
s
d
i
d
c
a
u
s
e
r
e
p
r
o
d
u
c
t
i
v
e
d
i
s
t
u
r
b
a
n
c
e
s
i
n
a
n
o
t
h
e
r
s
t
u
d
y
(
5
6
)
.
T
e
r
a
t
o
g
e
n
i
c
i
t
y
:
N
o
t
e
r
a
t
a
w
e
r
e
n
o
t
e
d
in
r
a
b
b
i
t
(6
),
r
a
t
or
m
o
u
s
e
(5
6)
f
e
t
u
s
e
s
w
h
o
s
e
m
o
t
h
e
r
s
w
e
r
e
f
e
d
u
p
t
o
1
5
m
g
/
k
g
,
2
5
m
g
/
k
g
o
r
6
0
m
g
/
k
g
1
1
n
d
a
n
e
,
r
e
s
p
e
c
t
i
v
e
i
y
,
d
u
r
i
n
g
g
e
s
t
a
t
i
o
n
.
M
u
t
a
g
e
n
i
c
i
t
y
:
C
h
r
o
m
o
s
o
m
a
i
a
b
e
r
r
a
t
i
o
n
s
w
e
r
e
n
o
t
e
d
i
n
h
a
m
s
t
e
r
f
i
b
r
o
b
i
a
s
t
s
e
x
p
o
s
e
d
t
o
1
i
n
d
a
n
e
i
n
v
i
t
r
o
(
1
)
.
L
i
n
d
a
n
e
is
w
e
a
k
i
y
m
u
t
a
g
e
n
i
c
i
n
t
h
e
A
m
e
s
t
e
s
t
.
T
h
e
r
e
s
u
i
t
s
o
f
n
u
m
e
r
o
u
s
o
t
h
e
r
t
e
s
t
s
w
e
r
e
n
e
g
a
t
i
v
e
(
5
6
)
.
P
e
r
m
i
s
s
i
b
i
e
E
x
p
o
s
u
r
e
L
i
m
i
t
:
0
.
5
m
g
/
m
3
(
O
S
H
A
)
(2
).
C
a
n
a
d
i
a
n
D
r
i
n
k
i
n
g
W
a
t
e
r
G
ui
d
e
i
i
n
e
is
0.
00
4
mg
/L
.
I
m
n
e
d
i
a
t
e
i
y
D
a
n
g
e
r
o
u
s
t
o
L
i
f
e
o
r
H
e
a
i
t
h
:
1
,
0
0
0
m
g
/
m
3
(
O
S
H
A
)
(
2
)
.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
i
Re
gu
ia
ti
on
s:
Ca
na
da
:
D
r
i
n
k
i
n
g
W
a
t
e
r
Gu
id
ei
in
e.
IJC Objectives: Yes.
R
e
c
o
n
m
e
n
d
a
t
i
o
n
:
M
o
n
i
t
o
r
i
n
g
as
r
e
q
u
i
r
e
d
n
o
w
s
h
o
u
l
d
b
e
c
o
n
t
i
n
u
e
d
a
n
d
s
h
o
u
i
d
in
ci
ud
e
fi
sh
an
d
wi
id
ii
fe
.
 Maiathion (Tabie: 4)
Exposure profiie: This synthetic insecticide is produced and used in quantity
in the Great Lakes Basin. It is rapidiy degraded bioiogicaiiy and does
not significantiy accumuiate in bioiogicai tissues. Appendix E indicates
the infrequent occurrence (i.e., in 1ess than 1% of the sampies) in
Ontario agricuiturai watersheds tributary to Lake Erie.
Toxicity profiie:
Ora] L050: In rodents, ranges from 570 to 880 mg/kg (1).
Carcinogenicity: Maiathion was not a carcinogenic agent under the conditions
of a recent NCI-sponsored carcinogenesis bioassay (1).
Chronic Adverse Effects: A reduction in food intake and growth was observed
in rats fed up to 20,000 ppm maiathion for 2 years (3).
CNS Effects: Maiathion is a reversibie choiinesterase inhibitor and produces
CNS signs after acute exposure.
Reproductive Effects: A significant reduction was observed in the survivai of
the offspring of rats fed 4,000 ppm of maiathion in the diet (3) and
pregnant rats fed 240 mg/kg produced no live 1itters (55).
Teratogenicity: Maiathion has been reported to be a teratogen (6); however
there is confiicting evidence. No teratogenic activity was indicated when
pregnant rats were fed 300 mg/kg on days 6-15 of gestation (55).
Mutagenicity: Maiathion has been shown to be an in yitrg mutagenic agent (1).
Permissibie Exposure Limit: 15 mg/m3 (2).
Imnediateiy Dangerous to Life or Hea1th: 5,000 mg/m3 (2).
Existing Environmenta] Reguiations: None known.
Recommendation: Maiathion poses a minimai heaith risk; it has 10w chronic
toxicity and degrades rapidiy. Monitoring is not required.
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 Methylmercury ' (Tables: 1 & 2)
Exposure profile; Mercury has been introduced into the Great Lakes ecosystem
by the widespread use in earlier years of mercury—containing wood product
preservatives and by the chlor—alkali industry. Control of these sources
has led to a decrease in concentrations of mercury both as total mercury
and its alkylated forms. Increased Coal burning may result in new
significant inputs both locally and over large areas (through long—
distance atmospheric transport). The concentrations of mercury in Great
Lakes water are presently not excessive, concentrations in fish are either
acceptable or near—acceptable.
Toxicity profile:
Oral LD50: Ranges from 16 mg/kg to 115 mg/kg depending on rodent species
and methylmercury compound tested.
Carcinogenicity: Not thought to be carcinogenic (60).
Chronic Adverse Effects: No clear distinction between acute and chronic
effects can be made. Reversible kidney and liver damage and ultimately
irreversible CNS damage, seizures and death can result from exposures of 1
mg/kg/day (40)-
CNS Effects: Neurological symptoms (ataxia, visual impairment, mental
deterioration, rigidity, hyperkenesia, salivation, sweating) have been
observed in man after chronic exposure to 4 mg/kg body weight/day. Large
acute exposures can lead to sensory nerve damage and later CNS damage
weeks after exposure (40).
Reproductive Effects: Readily crosses the placenta to the fetus causing
mental retardation, cerebral palsy and convulsions. The fetus is more
susceptible to damage than the child; the child is more susceptible to
damage than the adult (45).
Teratogenicity: No data found.
Mutagenicity: Induces mitochondrial petites but not nuclear mutation in yeast (65).
Permissible Exposure Limit: Dginking Water Guideline in Canada is 1 UQ/L
(40), air level is 10 ug/m and level in fresh fish is 0.5 ug/g (45).
Imnediately Dangerous to Life or Health: 5 to 50 mg/kg body weight can lead
to mild sensory disorders (45).
Existing Environmental Regulations:
gsgz Drinking Water Standards.
95
Canada: Drinking Water Guideiine and fish action 1eveis.
IJC Objectives: Yes.
Recomnendation: Probiems of sample preservation and anaiysis of the
different forms of mercury at very 10w concentrations have previousiy
hindered work designed to examine the sources, forms of transport and the
fate of mercury in the environment. As mercury is subject to bio—
methyiation and subsequent bioaccumuiation, an understanding of the
movement of this eiement is important for its controi. Emphasis shouid be
on research and speciai studies in this fieid in addition to continued
monitoring of water and fish.
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 Met
hox
ych
ior
(CA
S R
eg
No:
724
35)
(Ta
bie
:
2)
Exp
osu
re
pro
fiT
e:
Thi
s
pes
tic
ide
was
det
ect
ed
in
tri
but
ari
es
fro
m
'
agr
icu
itu
rai
wat
ers
hed
s a
t c
onc
ent
rat
ion
of
0.0
2 u
g/L
or
Tow
er,
it
was
fou
nd
in
rai
nwa
ter
in
the
Lak
e E
rie
wat
ers
hed
(13.
1 u
g/T
ite
r)
and
in
was
tew
ate
r
eff
iue
nts
(up
to
0.1
65
ug/
L).
Con
cen
tra
tio
ns
in
fis
h r
ang
ed
fro
m n
ot
det
ect
abT
e t
o 0
.05
pg/
fwt
.
'Th
e c
omp
oun
d
acc
umu
iat
es
in
Tiv
ing
tis
sue
.
Bio
deg
rad
ati
on
pro
cee
ds
sTo
wiy
but
muc
h f
ast
er
tha
n f
or
DDT
.
Toxicity profiie:
Ora
] L
050
:
l,8
50-
5,0
00
mg/
kg
in
var
iou
s r
ode
nt
spe
cie
s
(1)
.
Car
cin
oge
nic
ity
:
Not
car
cin
Oge
nic
for
mic
e
exp
ose
d
der
maT
Ty
or
int
rap
eri
—
ton
eai
iy
(67
)
or
for
rat
s
exp
ose
d
ora
TTy
to
Tev
eis
as
hig
h
as
1,6
00
ppm
(44
)
(68
).
How
eve
r,
non
—ma
iig
nan
t a
den
oma
s h
ave
bee
n r
epo
rte
d i
n r
ats
(67
).
Chr
oni
c A
dve
rse
Eff
ect
s:
Aft
er
5-8
wee
ks
of
4 g
/kg
dai
Ty
dog
s h
ad
fas
ci-
cui
ati
ons
, t
rem
ors
,
hyp
ere
sth
esi
a,
ton
ic
sei
zur
es
and
tet
ani
c c
onv
uis
ion
s;
the
dog
s
die
d w
ith
in
3
wee
ks
aft
er
the
ons
et
of
sym
pto
ms
(44
).
The
chr
oni
c,
no-
eff
ect
,
Tev
ei
is
10
mg/
kg/
day
in
rat
s.
Hyp
erp
ias
ia
of
dig
est
ive
sys
tem
and
uro
gen
ita
i
tra
ct
hav
e b
een
rep
ort
ed
in
dog
s a
nd
pig
s
and
kid
ney
dam
age
in
pig
s
(67
).
300
mg/
kg/
day
had
no
eff
ect
on
dog
s a
fte
r
one
yea
r
of
exp
osu
re
(85
).
In
hum
ans
,
hep
ati
c
ceT
T
deg
ene
rat
ion
and
ren
ai
tubuiar necrosis have been reported (67).
CNS
Eff
ect
s:
Met
hox
ych
ior
is
a c
onv
uis
ant
in
dog
s a
nd
cau
ses
CNS
dep
res
sio
n
more frequentiy than excitation (67).
Reproductive Effects: No data found.
Te
ra
to
ge
ni
ci
ty
:
In
pr
eg
na
nt
ra
ts
fe
d
20
0
and
40
0
mg
/k
g,
fe
ta
i
to
xi
ci
ty
occurred and some fetuses had wavy ribs (55).
Mut
age
nic
ity
:
Non
-mu
tag
eni
c i
n S
aTm
one
TTa
(65
).
Per
mis
sib
ie
Exp
osu
re
Lim
it:
15
mg/
m3
(OS
HA)
(42
)
and
10
mg/
m3
ACG
IH
(43
).
Imm
edi
ate
iy
Dan
ger
ous
to
Lif
e
or
Hea
lth
:
7,5
00
mg/
m3
(OS
HA)
(42
).
The
Tow
est
pub
iis
hed
tox
ic
dos
e i
n m
an
(de
rma
T)
is
2,4
14
mg/
kg;
the
iow
est
pub
iis
hed
Tet
haT
ora
l
dos
e i
n m
an
is
6,4
30
mg/
kg
(67
).
Existing Environmentai Reguiations:
Canada: Drinking Water Guideiine.
Recomnendation: Monitoring shouid continue.
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 Methyi methacryiate (CAS Reg No: 80626) (Tabie: 4)
Ex osure rofiie: Methyi methacryiate is a monomer or raw materiai in
piastics (acryiics) manufacture. It is used in 1arge amounts but probabiy
not wasted reguiariy in significant quantities. It has been detected, but
not quantified, in Lake Michigan waters. It is voiatiie, quite
water-soiubie, does not bioaccumuiate and is subject to microbiai
degradation. Significant exposure is un1ike1y except during accidentai
reiease.
Toxicity profiie:
0ra1 LD5O: 6,300 mg/kg (guinea pigs) (1) and 5 mL/kg (dogs) (67).
Carcinogenicity: Subcutaneous impiants of methyi methacryiate in mice and
rats for up to 39 months increased the incidence of iocai fibrosarcoma
compared to giass impiant controis (67). IARC conciuded that no
evaiuation was possible based on the avaiiabie data (102).
Chronic Adverse Effects: Rats and dogs fed 16, 60 and 2,000 ppm and 10,100
and 1,000 pun respectiveiy for 2 years exhibited no evidence of toxicity
(67). Exposure of rats to 116 ppm for 8 hr per day for 3-6 months
decreased subcutaneous fat deposits, body, 1ung and spieen weights and
intestinai transit performance and a1tered biood chemistry.
CNS Effects: A sma11 amount of methyi methacryiate vapor found in casting
piants induced functionai abnormaiities in the nervous system of piant
workers (67).
Reproductive Effects: No data found.
Teratogenicity: 0.13-0.44 mL/kg injected into pregnant rats on days 5, 10 and
15 of gestation affected absorptions, fetai survivai and size.
Hemangiomas were observed in some fetuses from the highest dose group (67).
Mutagenicity: No data found.
Permissibie Exposure Limit: 410 mg/m3 (OSHA) (42).
Immediateiy Dangerous to Life or Heaith: Probabie L0 in man is 5—15 g/kg
(between 1 pint and 1 quart for a 70 kg person) (53).
Existing Environmentai Reguiations: None known.
Recommendation: Methyi methacryiate generaiiy has a 10w order of toxicity;
monitoring is not recommended except on industriai waste streams.
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Mir
ex
(Ta
ble
s:
1 &
2)
Exp
osu
re
pro
fil
e:
Wat
er
col
umn
con
cen
tra
tio
ns
are
rep
ort
ed
in
App
end
ix
E
as
0.0
000
4
to
0.0
006
8 u
g/L
(on
e
stu
dy)
,
con
cen
tra
tio
ns
in
fis
h
as
0.0
4
to
0.2
2 u
g/g
(La
ke
Ont
ari
o)
and
con
cen
tra
tio
ns
in
wil
dli
fe
to
a m
axi
mum
of
0.4
ug/
g.
Lar
ge
amo
unt
s
are
sti
ll
at
han
d,
alt
hou
gh
use
has
bee
n
dis
con
tin
ued
in
the
bas
in.
Lak
e
lev
els
pro
bab
ly
ref
lec
t
dis
pos
al
of
mir
ex
dur
ing
man
ufa
ctu
re.
The
com
pou
nd
is
hig
hly
bio
acc
umu
lat
ive
and
env
iro
nme
nta
lly
sta
ble
exc
ept
for
its
slo
w
con
ver
sio
n
to
8—m
ono
hyd
rom
ire
x
(photomirex). .
Toxicity profile:
Ora
l
L05
0:
Is
60
0—
70
0
mg
/k
g
in
ra
ts
(1)
.
Ca
rc
in
Og
en
ic
it
y:
In
di
et
ar
y
fe
ed
in
g
st
ud
ie
s,
mi
re
x
pr
od
uc
ed
be
ni
gn
an
d
mal
ign
ant
liv
er
tum
ors
in
mic
e
and
rat
s
of
bot
h
sex
es.
It
is
con
sid
ere
d
to
be
car
cin
oge
nic
to
ani
mal
s
by
IAR
C
(12
).
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
Ra
ts
fe
d
up
to
25
ppm
mi
re
x
in
th
e
di
et
fo
r
166
day
s
dev
elo
ped
his
tol
ogi
cal
cha
nge
s
in
the
liv
er.
The
off
Spr
ing
of
dam
s
fed
mirex developed cataracts (37).
CNS
Ef
fe
ct
s:
Ra
ts
fed
mi
re
x
at
ac
ut
e
le
ve
ls
(25
0
ppm
)
su
ff
er
ed
fr
om
we
ak
ne
ss
and hyperexcitability (37).
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
Re
du
ce
d
li
tt
er
si
ze
wa
s
ob
se
rv
ed
in
2
st
ra
in
s
of
mi
ce
fed
mir
ex
in
a d
iet
ary
con
cen
tra
tio
n
of
5 m
g/k
g/d
ay
bef
ore
and
aft
er
mating (12).
Ter
ato
gen
ici
ty:
Whe
n p
reg
nan
t r
ats
wer
e a
dmi
nis
ter
ed
mir
ex
at
a d
ose
leve
l o
f
12.
5 m
g/k
g o
n d
ays
6-1
5 o
f g
est
ati
on,
fet
use
s s
uff
ere
d r
edu
ced
sur
viv
al,
red
uce
d w
eig
ht
and
an
inc
rea
sed
inc
ide
nce
of
vis
cer
al
ano
mal
ies
(12)
.
Mut
age
nic
ity
:
Mir
ex
pro
ved
to
be
non
-mu
tag
eni
c i
n a
dom
ina
nt
let
hal
tes
t i
n
rats (12).
Permissible Exposure Limit: No data found.
Imnediately Dangerous to Life or Health: No data found.
Existing Environmental Regulations:
g§ﬂz Action level in fish.
Qan
aga
:
Dri
nki
ng
Wat
er
Gui
del
ine
and
act
ion
leve
l i
n f
ish
.
Rec
omn
end
ati
on:
Con
tin
ued
mon
ito
rin
g i
n f
ish
and
wil
dli
fe
is
rec
omm
end
ed
to
doc
ume
nt
the
dec
lin
e
in
lev
els
in
the
env
iro
nme
nt.
Exi
sti
ng
sto
cks
sho
uld
be disposed of properly.
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Monochiorophenoi (CAS Reg No: 25167800) (Tabie: 5)
Exposure profiie: The isomer of the indicated CAS number was found but not
quantified in a discharge to the Lower Fox River. No usage and discharge
data are avaiiabie, but the compound is 1ike1y to be present in many
disc
harg
es a
nd i
andf
iiis
of i
ndus
trie
s e
ngag
ed i
n th
e pr
oduc
tion
of
chlorinated aromatic compounds. The monochiorophenois are moderateiy
iipophiiic and are mineraiized by bacteria at moderate rates, except when
chiorine is in the meta-position.
Toxicity profiie:
Ora] L050: 570 mg/kg in rats (1).
Carc
inog
enic
ity:
Z-Ch
ioro
phen
oi
prom
otes
beni
gn t
umor
form
atio
n in
mice
afte
r
an initiating dose of dimethyibenzanthracene. It is not tumorigenic on
its own (64).
Chronic Adverse Effects: No information was found and no documented cases of
hmnan poisoning have occurred. 2-Chiorophenoi can uncoupie oxidative
phosphoryiation reactions (64). Chiorophenoi is a skin irritant.
CNS
Eff
ect
s:
Mot
or
wea
kne
ss,
tre
mor
s,
chr
oni
c c
onv
uis
ion
s a
nd
com
a h
ave
bee
n
reported in rats (60).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: No data found.
Permissible Exposure Limit: No data found.
Inme
diat
eiy
Dang
erou
s t
o Li
fe o
r He
aith
:
Prob
abie
1eth
a1
dose
in m
an
is
50-5
00 m
g/kg
or (
betw
een
1 te
aspo
onfu
i a
nd 1
oz f
or a
70 k
g pe
rson
) (
67).
Existing Environmentai Regulations: None known.
 
Reco
mnen
dati
on:
No a
sses
smen
t ca
n be
made
unti
i mo
re
expo
sure
data
are
avai
iabi
e.
Chro
nic
toxi
city
data
is b
arei
y ad
equa
te.
Moni
tori
ng
is
reco
mpen
ded
oniy
if s
uffi
cien
t qu
anti
ties
are
dete
rmin
ed t
o be
in u
se.
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Na
ph
th
aT
en
e
(CA
S
Re
g
No:
91
20
3)
(Ta
bTe
:
4)
Exp
osu
re
pro
fiT
e:
Nap
hth
aTe
ne
is
use
d
in
miT
Tio
ns
of
kiT
ogr
ams
ann
uaT
Ty
in
th
e
Gr
ea
t
La
ke
s
Ba
si
n.
Di
sc
ha
rg
es
fr
om
On
ta
ri
o
ar
e
gi
ve
n
as
30
0
kg
ann
uaT
Ty.
The
com
pou
nd
was
det
ect
ed
in
tra
ce
qua
nti
tie
s
in
sev
era
T
st
at
io
ns
on
La
ke
Mi
ch
ig
an
and
in
co
nc
en
tr
at
io
ns
of
0.
01
to
0.5
pg
/g
in
La
ke
Hu
ro
n
an
d
La
ke
Su
pe
ri
or
fi
sh
.
It
oc
cu
rr
ed
in
un
qu
an
ti
fi
ed
am
ou
nt
s
in
a d
isc
har
ge
to
the
St.
CTa
ir
Riv
er
and
in
fis
h
fro
m
the
Det
roi
t
Riv
er
and
Ha
mi
lt
on
Ha
rb
or
.
Na
ph
th
aT
en
e
is
ac
cu
mu
Ta
te
d
in
to
Ti
vi
ng
ti
ss
ue
bu
t
is
aTs
o
co
mp
Te
te
Ty
bi
od
eg
ra
da
bi
e.
Th
e
sT
ow
ra
te
s
of
its
mi
ne
ra
Ti
za
ti
on
are
th
e
re
su
Tt
of
it
s
ve
ry
Ti
mi
te
d
so
Tu
bi
Ti
ty
in
wa
te
r.
Th
er
ef
or
e,
up
ta
ke
by
fi
sh
ca
n
oc
cu
r
wh
er
ev
er
th
e
co
mp
ou
nd
is
di
sc
ha
rg
ed
in
qu
an
ti
ty
.
Toxicity profiTe:
Ora) LD50: 1,780 mg/kg in rats (1).
Carcinogenicity: No data found.
Chr
oni
c
Adv
ers
e
Eff
ect
s:
Nap
hth
aTe
ne
vap
or
cau
ses
hem
oTy
tic
dis
ord
ers
,
eye
ir
ri
ta
ti
on
and
ha
s
ca
us
ed
ca
ta
ra
ct
s
in
an
im
aT
s
and
ma
n.
Pr
og
re
ss
iv
e
de
ge
ne
ra
ti
ve
ch
an
ge
s
in
vo
Tv
e
th
e
ki
dn
ey
.
No
in
fo
rm
at
io
n
on
th
e
ef
fe
ct
s
of
ch
ro
ni
c
or
aT
ex
po
su
re
wa
s
fo
un
d
(4
4)
.
CNS
Ef
fe
ct
s:
Ca
us
es
co
nv
uT
si
on
s
and
co
ma
in
hu
ma
ns
and
ex
po
se
d
in
fa
nt
s
ha
ve
de
ve
To
pe
d
ke
rn
ic
te
ru
s
(1
).
Na
ph
th
aT
en
e
ca
n
ca
us
e
an
ef
fe
ct
vi
a
th
e
inhaTation, oraT or dermaT route.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mut
age
nic
ity
:
Neg
ati
ve
in
SaT
mon
eTT
a
(65
).
Pe
rm
is
si
bT
e
Ex
po
su
re
Li
mi
t:
50
mg
/m
3
(OS
HA)
(42
).
Im
me
di
at
eT
y
Da
ng
er
ou
s
to
Li
fe
or
He
aT
th
:
50
0
pp
m
(OS
HA)
(42
).
Lo
we
st
do
se
cau
sin
g
dea
th
in
ch
de
re
n
is
100
mg/
kg
(1)
.
Exi
sti
ng
Env
iro
nme
nta
T
Reg
uTa
tio
ns:
Non
e
kno
wn.
 
Rec
omn
end
ati
on:
The
sma
TT
amo
unt
of
tox
ico
Tog
y
dat
a
ava
iTa
bTe
ind
ica
te
na
ph
th
aT
en
e
is
of
mi
ni
ma
T
co
nc
er
n
to
he
aT
th
in
th
e
Gr
ea
t
La
ke
s
Ba
si
n.
Intermittent monitoring may be warranted.
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Nic
kel
(Ta
ble
s:
1 &
3)
Exp
osu
re
pro
fil
e:
Nic
kel
ent
ers
the
Gre
at
Lak
es
Bas
in
eco
sys
tem
fro
m
ind
ust
ria
l d
isc
har
ges
and
to
a l
ess
er
ext
ent
fro
m t
he
atm
osp
her
e,
pro
bab
ly
as a
resu
lt
of c
oal
burn
ing.
Conc
entr
atio
ns i
n th
e wa
ter
colu
mn
are
belo
w
100
ug/L
, wi
th t
ribu
tari
es r
ich
in m
etal
proc
essi
ng w
aste
s (
Gran
d Ri
ver,
Mich
igan
) a
t ti
mes
show
ing
slig
htly
high
er v
alue
s.
Fish
data
are
scar
ce:
up to 0.4 ppm have been reported for Lake Superior fish.
Toxicity profile:
Ora
l L
050
:
Met
all
ic
nic
kel
is
ext
rem
ely
tox
ic.
Ora
l
L05
0 i
n t
he
gui
nea
pig
is
5 m
g/k
g.
Nic
kel
com
pou
nds
hav
e L
050
val
ues
in
rod
ent
s r
ang
ing
from 350 mg/kg to 1,620 mg/kg (54).
Car
cin
Oge
nic
ity
:
Exp
eri
men
tal
tum
ori
gen
esi
s h
as
bee
n o
bse
rve
d i
n s
eve
ral
ani
mal
spe
cie
s a
dmi
nis
ter
ed
a v
ari
ety
of
nic
kel
com
pou
nds
via
the
ip,
im,
sc,
inh
ala
tio
n a
nd
tra
nsp
lac
ent
al
rou
tes
.
Squ
amo
us
cell
car
cin
oma
s o
f t
he
lun
gs
and
nasa
l s
inu
ses
hav
e b
een
obs
erv
ed
in
wor
ker
s i
n t
he
nic
kel
refining industry (54).
Chr
oni
c A
dve
rse
Eff
ect
s:
Ino
rga
nic
nic
kel
sal
ts
are
tol
era
ted
well
by
rod
ent
s
whe
n a
dmi
nis
ter
ed
ora
lly
.
250
-1,
000
ppm
had
no
eff
ect
in
rat
s (
8 w
eek
s)
and
mon
key
s (
24
wee
ks)
and
5 p
pm
in
wat
er
had
no
eff
ect
on
mic
e
(li
fe-
tim
e).
A 9
0 d
ay
exp
osu
re
of
rats
to
3 m
g/k
g/d
ay
to
NiS
O4.
6H2
0
did
res
ult
in
bio
che
mic
al
and
mic
ros
cop
ic
les
ion
s i
n k
idn
ey,
hea
rt
and
tes
tes
(54)
.
In
man
der
mat
iti
s,
app
are
nt
ast
hma
and
dys
pne
a h
ave
bee
n
reported (44).
CNS Effects: No data found.
Reproductive Effects: One report details minor effects on testes (biochemical
and
micr
osco
pic)
of r
ats
fed
3 mg
/kg
NiSO
4.6H
20 f
or 9
0 da
ys.
Simi
lar
results have been found at 25 mg/kg. A decline in litter size over 3
gene
rati
ons
was
repo
rted
in r
ats
fed
wate
r co
ntai
ning
5 pp
m ni
ckel
(54)
.
Tera
toge
nici
ty:
Nick
el
is p
roba
bly
only
a we
ak t
erat
ogen
; fe
w fe
tal
anom
alie
s
have been reported although fetotoxicity has been observed (66).
Mutagenicity: Tests with E. coli and the mouse host-mediated assay on a
var
iet
y o
f n
ick
el
sal
ts
ind
ica
tes
nic
kel
is
not
mut
age
nic
(54)
.
NiC
12
did
indu
ce p
oint
muta
tion
s in
vitr
o in
the
TK m
ouse
lymp
homa
cell
assa
y
(65).
(42); Ni (soluble
Permissible Exposure Limit: Ni (metal) 1 mgém3 (OSHA)
(ACGIH) (43).
compounds) 1 mg/m3 (OSHA) (42); 0.1 mg/m
Immediately Dangerous to Life or Health: No data found.
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Exi
sti
ng
Env
iro
nme
nta
i
Reg
uia
tio
ns:
Non
e
kno
wn.
Rec
omn
end
ati
gn:
Emp
has
is
sho
uld
be
pia
ced
on
the
con
tro
i
of
ind
ust
ria
i
sou
rce
s a
nd
a m
oni
tor
ing
pro
gra
m t
o d
ete
rmi
ne
atm
osp
her
ic
dep
osi
tio
n o
f
nickei intiated.
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Oxychiordane (CAS Reg No: 21858413) (Tabies: 1 & 3)
Exposure profiie: The compound was detected in Lake Superior and Lake Huron
fish in concentrations from 0.01 to 0.1 ug/g and in birds at Lake
Michigan at 0.01 ug/kg. For properties refer to the profiie for
Chiordane.
Toxicitx profile:
Ora] L050: No data found.
Carcinogenicity: No data found.
Chronic Adverse Effects: No data found.
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: No data found.
Permissibie Exposure Limit: No data found.
Imnediateiy Dangerous to Life or Heaith: No data found.
Existing Environmentai Reguiations: None known.
Reco
mmen
dati
on:
The
comp
ound
is o
f co
ncer
n be
caus
e of
its
pres
uned
pers
iste
nce.
No a
sses
smen
t is
poss
ibie
at t
his
time
beca
use
of t
he l
ack
of exposure and toxicity data.
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 Pen
tac
hlo
rop
hen
ol
(PCP
)
(CAS
Reg
No:
878
65)
(Tab
les:
1 &
3)
Expo
sure
prof
ile:
This
comp
ound
is w
idel
y us
ed
in w
ood
pres
erva
tive
s,
alt
hou
gh
use
in
hig
hly
con
cen
tra
ted
for
m a
ppe
ars
to
hav
e b
een
som
ewh
at
restricted. Michigan reports discharges of 600,000 lbs per year. It is
wid
ely
dis
tri
but
ed
in
Gre
at
Lak
es
wat
ers
(0.
005
to
1.7
ug/
L a
re
rep
ort
ed
in
App
end
ix
E).
Add
iti
ona
l p
rod
uct
ion
and
mon
ito
rin
g d
ata
are
giv
en
in
the 1980 Report of the International Joint Commission's Aquatic Ecosystems
Committee. The compound is quite persistent and subject to
bioaccumulation. PCP is also frequently contaminated with higher
chlorinated dioxins. ”
Toxicity profile:
Ora
l L
050:
In
rod
ent
s,
ran
ges
fro
m 5
0 t
o 1
68
mg/
kg
(1).
Carc
inog
enic
ity:
Pent
achl
orop
heno
l wa
s fo
und
to b
e no
n-ca
rcin
ogen
ic w
hen
fed
to
rat
s a
t d
iet
ary
lev
els
of
up
to
30
mg/
kg/
day
for
22
mon
ths
(38
).
Chr
oni
c A
dve
rse
Eff
ect
s:
Rat
s f
ed
pen
tac
hlo
rop
hen
ol
at
die
tar
y l
evel
s u
p t
o
500
ppm
for
8 m
ont
hs
suf
fer
ed
inc
rea
sed
liv
er
wei
ght
and
red
uce
d b
ody
weig
ht g
ain
(38)
.
PCP
can
be c
onta
mina
ted
with
dibe
nzo-
p-di
oxin
s.
CNS
Eff
ect
s:
Ane
sth
esi
a,
res
pir
ato
ry
dif
fic
ult
ies
and
com
a h
ave
bee
n r
epo
rte
d
for humans exposed to acute levels of pentachlorophenol (3).
Rep
rod
uct
ive
Eff
ect
s:
Whe
n p
reg
nan
t r
ats
wer
e g
ive
n u
p t
o 5
0 m
g/k
g o
f
pen
tac
hlo
rop
hen
ol
on
day
s
6-1
3
of
ges
tat
ion
,
the
off
Spr
ing
suf
fer
ed
a
do
se
-r
el
at
ed
de
cr
ea
se
in
bo
dy
we
ig
ht
and
cr
ow
n-
ru
mp
le
ng
th
re
la
ti
ve
to
con
tro
ls
(38)
.
Con
tam
ina
nts
in
PCP
may
hav
e c
ont
rib
ute
d t
o t
he
obs
erv
ed
effects.
Tera
toge
nici
ty:
When
preg
nant
rats
were
give
n up
to 5
0 mg
/kg
of p
enta
chlo
ro—
ph
en
ol
on
da
ys
6-
13
of
ge
st
at
io
n,
fe
tu
se
s
su
ff
er
ed
a
si
gn
if
ic
an
t
in
cr
ea
se
in
the
inc
ide
nce
of
ske
let
al
def
ect
s (
ribs
, s
ter
neb
rae
, v
ert
ebr
ae)
(38)
.
Mut
age
nic
ity
:
Pen
tac
hlo
rop
hen
ol
was
not
mut
age
nic
in
the
Ame
s
tes
t,
the
hos
t-m
edi
ate
d a
ssa
y a
nd
the
sex
-li
nke
d l
eth
al
tes
t o
n D
ros
oph
ila
(38
).
Permissible Exposure Limit: 0.5 mg/m3 (OSHA) (2).
Imm
edi
ate
ly
Dan
ger
ous
to
Lif
e o
r H
eal
th:
150
mg/
m3
(OS
HA)
(2)
.
Existing Environmental Regulations: None known.
Rec
omm
end
ati
on:
A s
mal
l
sca
le
mon
ito
rin
g
pla
n
for
pen
tac
hlo
rop
hen
ol
sho
uld
be
cons
ider
ed t
o pr
ovid
e tr
end
data
on P
CP l
evel
s in
wate
r an
d wi
ldli
fe
(including fish).
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Pho
tom
ire
x
(8-
mon
ohy
dro
mir
ex)
(Ta
bie
s:
1 &
3)
Exp
osu
re
pro
fii
e:
Pho
tom
ire
x i
s a
pho
to-
oxi
dat
ion
pro
duc
t
of
mir
ex
and
has
be
en
de
te
ct
ed
in
he
rr
in
g
gui
i
eg
gs
at
a
co
nc
en
tr
at
io
n
of
0.
14
i
0.
12
ppm
.
It
is
tho
ugh
t
to
be
per
sis
ten
t.
Con
cen
tra
tio
ns
in
fis
h
are
pre
sen
tiy
dec
rea
sin
g
as
are
the
con
cen
tra
tio
ns
of
the
par
ent
com
pou
nd,
mir
ex.
Toxicity profiie:
Ora] LD5O: 200 mg/kg in rats (1).
Car
cin
oge
nic
ity
:
Not
kno
wn
but
hep
ato
mas
hav
e
bee
n
rep
ort
ed
in
mic
e f
ed
mir
ex.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
Ma
le
ra
ts
ex
po
se
d
fo
r
13
we
ek
s
to
di
et
ar
y
ph
ot
om
ir
ex
dev
elo
ped
hep
ato
meg
aiy
on
a 5
ppm
die
t.
Liv
er
and
thy
roi
d
cha
nge
s
wer
e
ob
se
rv
ed
at
0.
2
pp
m
and
de
at
h
oc
cu
re
d
at
125
pp
m
(58
).
Ph
ot
om
ir
ex
is
app
rox
ima
tei
y
5 t
ime
s
mor
e
hep
ato
tox
ic
tha
n
the
par
ent
com
pou
nd
mir
ex
and
1es
s
to
xic
to
fe
ma
ie
ra
ts
th
an
ma
ie
ra
ts
(59
).
CNS Effects: No data found.
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
A
re
du
ct
io
n
in
me
an
fe
ta
i
we
ig
ht
at
te
rm
was
ob
se
rv
ed
in
ra
bb
it
s
fe
d
10
mg
/k
g
on
day
s
6
th
ro
ug
h
18
of
ge
st
at
io
n
(57
).
Te
ra
tO
ge
ni
ci
ty
:
No
te
ra
ta
we
re
ob
se
rv
ed
in
ra
bb
it
fe
tu
se
s
af
te
r
pr
eg
na
nt
da
ms
we
re
fe
d
up
to
10
mg
/k
g
on
da
ys
6
th
ro
ug
h
18
of
ge
st
at
io
n.
Tr
an
sp
ia
ce
nt
ai
transfer occurred (57).
Mu
ta
ge
ni
ci
ty
:
Ne
ga
ti
ve
in
th
e
Sa
im
on
ei
ia
/m
an
na
ii
an
—m
ic
ro
so
me
as
sa
y
(5
7)
.
Pe
rm
is
si
bi
e
Ex
po
su
re
Li
mi
t:
No
t
es
ta
bi
is
he
d.
Im
me
di
at
ei
y
Da
ng
er
ou
s
to
Li
fe
or
He
ai
th
:
No
t
es
ta
bi
is
he
d.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
l
Re
gu
ia
ti
on
s:
No
ne
kn
ow
n.
Re
co
mn
en
da
ti
on
:
Ph
ot
om
ir
ex
ha
s
co
ns
id
er
ab
ie
ch
ro
ni
c
to
xi
ci
ty
an
d
mo
ni
to
ri
ng
fo
r
le
vel
s
in
fi
sh
an
d
wi
id
ii
fe
is
wo
rt
hw
hi
ie
.
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Polyaromatic Hydrocarbons (PAH's):
Ben
zo(
a)p
yre
ne
(CAS
Reg
No:
503
28)
(Tab
le:
3)
Chr
yse
ne
(CA
S
Reg
No:
218
019
)
0ib
enz
(a,
h)a
nth
rac
ene
(CA
S R
eg
No:
537
03)
EXQ
OSu
re
pro
fil
e:
The
se
thr
ee
pol
ycy
cli
c
hyd
roc
arb
ons
are
tre
ate
d t
oge
the
r
her
e b
eca
use
of
the
ir
sim
ila
rit
y i
n o
rig
in,
dis
tri
but
ion
and
pro
per
tie
s.
Ben
zo(
a)p
yre
ne
is
wid
ely
dis
tri
but
ed
in
the
env
iro
nme
nt
in
low
con
cen
tra
tio
ns.
Lik
e w
ith
the
oth
er
two
com
pou
nds
,
it
is
mos
tly
der
ive
d
fro
m c
omb
ust
ion
pro
ces
ses
and
occ
urs
in
coa
l
tar
.
Cok
e o
ven
s h
ave
bee
n
a
maj
or
sou
rce
.
Oth
er
maj
or
sou
rce
s a
re
inc
ine
rat
ors
and
run
off
fro
m
str
eet
s
whe
re
bot
h
the
aSp
hal
t
sur
fac
e
and
die
sel
emi
ssi
ons
are
con
tri
but
ors
.
The
com
pou
nd
is
min
era
liz
ed
slo
wly
by
acc
lim
ate
d m
icr
obi
al
com
nun
iti
es
in
soi
ls
and
in
aqu
ati
c
(ae
rob
ic)
env
iro
nme
nts
.
It
occ
urs
in
par
tic
ula
te
for
m i
n w
ate
r.
It
has
bee
n f
oun
d
in
alg
ae
and
acc
umu
lat
es
in
fis
h
tis
sue
.
The
rea
son
may
be
tha
t
it
is
acc
umu
lat
ed
fas
ter
tha
n
it
is
deg
rad
ed.
App
end
ix
E s
how
s w
ate
r c
olu
mn
con
cen
tra
tio
ns
of
0.2
to
0.3
pg/
L
and
con
cen
tra
tio
ns
in
fis
h f
ill
ets
fro
m t
he
Det
roi
t R
ive
r a
nd
Hamilton Harbor of 14 to 128 ug/kg.
Chr
yse
ne
has
bee
n
ide
nti
fie
d
in
fis
h f
rom
the
Det
roi
t R
ive
r
and
Ham
ilt
on
Har
bor
and
is
pro
bab
ly
of
wid
esp
rea
d o
ccu
rre
nce
in
sim
ila
rly
pol
lut
ed
env
iro
nme
nts
.
Alt
hou
gh
slo
wly
deg
rad
ed
by
bac
ter
ia,
upt
ake
and
acc
umu
lat
ion
int
o l
ivi
ng
tis
sue
s m
ay
be
a m
ore
eff
ici
ent
pro
ces
s.
0ib
enz
(a,
h)a
nth
rac
ene
was
det
ect
ed
but
not
qua
nti
fie
d i
n f
ish
fro
m t
he
Det
roi
t R
ive
r
and
fro
m H
ami
lto
n H
arb
or.
No
fur
the
r
inf
orm
ati
on
is
ava
ila
ble
.
Pro
per
tie
s
are
sim
ila
r t
o B
enz
o(a
)py
ren
e a
nd
Chr
yse
ne.
Toxicity profile:
Or
al
LD
50
:
No
da
ta
fo
un
d
fo
r
an
y
PA
H‘
s.
Ho
we
ve
r,
th
e
TD
EO
(o
ra
l)
fo
r
be
nz
o(
a)
py
re
ne
fo
r
ro
de
nt
s
is
be
tw
ee
n
1,
00
0-
7,
00
0
mg
/
g
fe
d
co
nt
in
ou
sl
y
over several weeks (1).
Ca
rc
in
og
en
ic
it
y:
Be
nz
o(
a)
py
re
ne
ca
us
es
tu
no
rs
of
th
e
st
om
ac
h,
eo
so
ph
og
us
and
mam
nar
y
gla
nd
in
rod
ent
s
(3)
.
Epi
dem
iol
ogi
cal
evi
den
ce
poi
nts
to
hum
an
carcinogenicity (40).
Ch
ry
se
ne
is
co
ns
id
er
ed
an
ani
mal
ca
rc
in
og
en
.
To
ica
l
or
in
te
rm
us
cu
la
r
tre
atm
ent
res
ult
s
in
pap
ilo
mas
and
sar
can
as
(63
g.
0i
be
nz
(a
,h
)a
nt
hr
ac
en
e
pr
od
uc
ed
tu
no
rs
by
di
ff
er
en
t
ro
ut
es
of
adm
ini
str
ati
on
in
mic
e,
rat
s,
gui
nea
pig
s,
fro
gs,
pig
eon
s
and
chi
cke
ns.
It
dem
ons
tra
tes
bot
h
loc
al
and
sys
tem
ic
car
cin
oge
nic
eff
ect
s.
No
obs
erv
ati
ons
ind
ica
tin
g c
arc
ino
gen
ici
ty
in
man
wer
e f
oun
d
(77
).
Chr
oni
c A
dve
rse
Eff
ect
s:
Ben
zo(
a)p
yre
ne
pol
yar
oma
tic
hyd
roc
arb
ons
are
gen
era
lly
exc
ret
ed
ver
y
rap
idl
y
reg
ard
les
s
of
the
rou
te
of
exp
osu
re.
The
chr
oni
c e
ffe
cts
rep
ort
ed
usu
all
y a
re
the
app
ear
anc
e o
f c
arc
ino
mas
(40
).
D7
For chrysene the chronic effects reported are the appearance of tumors and
carcinomas (63).
No data found for dibenz(a,h)anthracene.
CNS Effects: None known for PAH's.
Reproductive Effects: Resorbed and dead fetuses were observed in pregnant
rats fed 1 mg/g diet of benzo(a)pyrene. Sterility in female mice has also
been reported (55). No data were found for chrysene or dibenz(a,h)-
anthracene.
Teratogenicity: A suspect teratogen in rats (15). No data were found for
chrysene or dibenz(a,h)anthracene.
Mutagenicity: Positive in most test systems (and used as a positive control)
including in vivo mammalian studies (65).
Chrysene is positive in Salmonella and induces sister-chromatid exchanges
in vivo in Chinese hamsters 1655.
Dibenz(a,h)anthracene is positive in Salmonella and in mamnalian cells in
culture. Induces sister chromatid exchanges in Chinese hamsters (65).
Permissible Exposure Limit: Not found for PAH's.
Immediately Dangerous to Life or Health: Not found for PAH's.
Existing Environmental Regulations: None known.
 
Recommendation: Exposure data for these hydrocarbons, both singly and as a
group are not sufficiently developed for a definitive assessment of
exposure and risk. Removal of particulate matter at water works may
effectively reduce human intake from drinking water; body burdens from
inhalation and food stuffs are likely to be much higher than those from
drinking water. Based on their carcinogenicity they should be considered
for monitoring.
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 Po
ly
br
om
in
at
ed
Bi
ph
en
yl
s
(PB
Bs)
(Ta
ble
:
3)
Ex
po
su
re
pr
of
il
e:
Th
e
nu
me
ro
us
PB
Bs
are
tr
ea
te
d
he
re
as
one
gro
up.
Wh
il
e
one
inc
ide
nt
of
the
ir
ina
dve
rte
nt
int
rod
uct
ion
int
o
liv
est
ock
has
bee
n
inv
est
iga
ted
and
wid
ely
pub
lic
ize
d,
the
ir
tru
e
dis
tri
but
ion
is
not
co
mp
le
te
ly
kno
wn.
Wa
te
r
co
lu
mn
co
nc
en
tr
at
io
ns
ha
ve
bee
n
re
po
rt
ed
as
0.
4
to
9.
8
ug
/L
,
co
nc
en
tr
at
io
ns
in
fi
sh
at
2.8
ppm
(t
ri
bu
ta
ry
to
La
ke
Hu
ro
n)
,
duc
k
br
ea
st
ti
ss
ue
was
fo
un
d
co
nt
am
in
at
ed
wi
th
up
to
2.7
ppm
.
Us
ag
e
in
Ne
w
Yo
rk
St
at
e
is
gi
ven
as
5,
01
0
lb
an
nu
al
ly
.
PB
Bs
are
ba
nn
ed
in
Ca
na
da
.
Th
e
P8
85
of
lo
we
r
ch
lo
ri
ne
co
nt
en
t
ar
e
sl
ow
ly
bi
od
eg
ra
da
bl
e
as
are the polychlorinated biphenyls.
 
Toxicity profile:
Or
al
LD
5O
:
21
.5
g/
kg
in
ra
ts
(1
).
Ca
rc
in
og
en
ic
it
y:
An
in
cr
ea
se
d
in
ci
de
nc
e
of
he
pa
to
ce
ll
ul
ar
ca
rc
in
om
a
has
bee
n
re
po
rt
ed
in
bo
th
Sh
er
ma
n
fe
ma
le
ra
ts
an
d
in
mi
ce
fe
d
P8
8
(1
0)
.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
To
xi
c
ef
fe
ct
s
in
ra
ts
and
mi
ce
fe
d
PBB
in
cl
ud
e
de
cr
ea
se
d
bo
dy
we
ig
ht
,
liv
er
hy
pe
rt
rO
ph
y
and
fa
tt
y
in
fi
lt
ra
ti
on
(11
).
CNS
Ef
fe
ct
s:
Ra
ts
and
mi
ce
ex
hi
bi
te
d
ne
ur
om
us
cu
la
r
dy
sf
un
ct
io
n
in
a
va
ri
et
y
of
te
st
s
af
te
r
ad
mi
ni
st
ra
ti
on
of
P8
8
(1
1)
.
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
PBB
ca
us
ed
an
in
cr
ea
se
d
in
ci
de
nc
e
of
re
so
rp
ti
on
and
de
ad
fe
tu
se
s
wh
en
ad
mi
ni
st
er
ed
by
av
ag
e
(8
00
mg
/k
g)
to
pr
eg
na
nt
fe
ma
le
ra
ts
on
da
ys
6—
14
of
ge
st
at
io
n
(1
1?
'
Te
ra
to
ge
ni
ci
ty
:
Do
se
s
of
40
0
or
80
0
mg
/k
g,
ad
mi
ni
st
er
ed
by
ga
va
ge
to
pr
eg
na
nt
ra
ts
on
da
ys
6-
14
of
pr
eg
na
nc
y,
ca
us
ed
cl
ef
t
pa
la
te
s
an
d
di
ap
hr
ag
ma
ti
c
he
rn
ia
s
in
fe
tu
se
s
(1
1)
.
‘
Mu
ta
ge
ni
ci
ty
:
No
mu
ta
ge
ni
c
pr
op
er
ti
es
ha
ve
be
en
re
po
rt
ed
.
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
No
da
ta
fo
un
d.
Im
me
di
at
el
y
Da
ng
er
ou
s
to
Li
fe
or
He
al
th
:
No
da
ta
fo
un
d.
Exi
sti
ng
Env
iro
nme
nta
l
Reg
ula
tio
ns:
Non
e
kno
wn.
 
Re
co
mn
en
da
ti
on
:
PB
Bs
ha
ve
su
ff
ic
ie
nt
ch
ro
ni
c
to
xi
ci
ty
th
at
mo
ni
to
ri
ng
of
us
e
an
d
am
bi
en
t
co
nc
en
tr
at
io
ns
is
re
co
mm
en
de
d.
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Po
Ty
ch
To
ri
na
te
d
Bi
ph
en
yT
s
(P
CB
s)
(T
ab
Te
:
2)
Ex
po
su
re
pr
of
iT
e:
Th
es
e
co
mp
ou
nd
s
pe
rs
is
t
in
th
e
Gr
ea
t
La
ke
s
Ba
si
n
ec
os
ys
te
m
an
d
ar
e
f0
un
d
in
fi
sh
in
co
nc
en
tr
at
io
ns
ex
ce
ed
in
g
5
pg
/g
,
pa
rt
ic
uT
ar
Ty
in
th
e
up
pe
r
Gr
ea
t
La
ke
s.
Th
ey
ar
e
de
te
ct
ab
Te
aT
so
in
ai
r
an
d
wa
te
r
co
Tu
mn
sa
mp
Te
s.
PC
Bs
wi
TT
co
nt
in
ue
to
be
ad
de
d
to
th
e
Gr
ea
t
La
ke
s
fr
om
pa
st
us
es
,
as
eq
ui
pn
en
t
co
nt
ai
ni
ng
th
em
is
de
co
mm
is
si
on
ed
or
PC
B-
co
nt
ai
ni
ng
co
mp
on
en
ts
ar
e
di
sc
ar
de
d.
PC
Bs
ar
e
ve
ry
st
ab
Te
co
mp
ou
nd
s.
Th
ey
ar
e
mi
ne
ra
Ti
ze
d
by
ba
ct
er
ia
on
Ty
if
ch
To
ri
ne
su
bs
ti
tu
ti
on
is
To
w.
Toxicity profiTe:
Or
aT
L0
50
:
In
ra
ts
ra
ng
es
fr
om
1.
25
-1
0
g/
kg
,
de
pe
nd
in
g
on
th
e
de
gr
ee
of
chTorination (3).
Ca
rc
in
Og
en
ic
it
y:
Ra
ts
fe
d
PC
B
at
10
0
mg
/k
g
fo
r
21
mo
nt
hs
de
ve
To
pe
d
a
si
gn
if
ic
an
t
in
ci
de
nc
e
of
he
pa
to
ce
TT
uT
ar
ca
rc
in
om
a
(1
).
Ep
id
em
io
To
gi
ca
T
ev
id
en
ce
in
di
ca
te
s
a
po
ss
ib
Te
Ti
nk
be
tw
ee
n
PC
B
ex
po
su
re
of
in
du
st
ri
aT
wo
rk
er
s
an
d
ma
Ti
gn
an
ci
es
(9
7)
.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
Ra
ts
fe
d
PC
B
at
10
0
mg
/k
g
fo
r
1
ye
ar
sh
ow
ed
no
vi
si
bT
e
si
gn
s
of
iT
Tn
es
s,
bu
t
ex
pe
ri
en
ce
d
en
Ta
rg
ed
he
pa
to
cy
te
s
an
d
fo
ca
T
ar
ea
s
of
he
pa
to
ce
TT
uT
ar
de
ge
ne
ra
ti
on
(8
).
Ch
To
ra
cn
e
ha
s
be
en
no
te
d
in
in
du
st
ri
aT
wo
rk
er
s
ex
po
se
d
de
rm
aT
Ty
to
PC
Bs
(9
7)
.
CN
S
Ef
fe
ct
s:
CN
S
de
pr
es
si
on
de
ve
To
pe
d
in
ra
ts
in
tu
ba
te
d
wi
th
4.
25
g/
kg
of
PC
B
(8
).
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
Wh
en
ra
ts
we
re
fe
d
10
0
mg
/k
g
PC
B
fo
r
up
to
18
6
da
ys
pr
io
r
to
ma
ti
ng
,
th
e
of
fs
pr
in
g
su
ff
er
ed
in
cr
ea
se
d
mo
rt
aT
it
y
an
d
re
du
ce
d
mating performance (1]).
Te
ra
to
ge
ni
ci
ty
:
Wh
en
pr
eg
na
nt
fe
ma
Te
mo
nk
ey
s
we
re
fe
d
2.
5
an
d
5.
0
mg
/k
g
PC
B
fo
r
6
mo
nt
hs
or
To
ng
er
,
su
rv
iv
in
g
of
fs
pr
in
g
we
re
sm
aT
T,
wi
th
de
cr
ea
se
d
he
ad
ci
rc
um
fe
re
nc
e
an
d
de
cr
ea
se
d
Te
ng
th
in
To
ng
bo
ne
s
(1
1)
.
Mu
ta
ge
ni
ci
ty
:
Cu
rr
en
t
in
fo
rm
at
io
n
in
di
ca
te
s
th
at
PC
Bs
ha
ve
Ti
mi
te
d
mu
ta
ge
ni
c
potentiai (3).
Pe
rm
is
si
bT
e
Ex
po
su
re
Li
mi
t:
No
da
ta
fo
un
d.
In
me
di
at
ei
y
Da
ng
er
ou
s
to
Li
fe
or
He
aT
th
:
No
da
ta
fo
un
d.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
i
Re
gu
Ta
ti
on
s:
No
ne
kn
ow
n.
Re
co
mm
en
da
ti
on
:
Co
nt
in
ue
d
mo
ni
to
ri
ng
of
PC
Bs
in
fi
sh
an
d
wd
eT
if
e
is
recommended.
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 Saf
rol
e
(CA
S
Reg
No:
945
97)
(Ta
ble
:
4)
Exp
osu
re
pro
fil
e:
Saf
rol
e m
ay
occ
ur
as
a m
ino
r c
omp
one
nt
in
was
te
eff
lue
nts
in
the
for
est
pro
duc
ts
ind
ust
ry.
It
was
ten
tat
ive
ly
ide
nti
fie
d
in
one
such
dis
cha
rge
to
Lak
e S
upe
rio
r.
No
qua
nti
fic
ati
on
was
give
n.
The
compound is probably biodegradable.
Toxicity profile:
Ora
l
L05
0:
1,9
50
mg/
kg
(ra
ts)
and
2,3
50
mg/
kg
(mi
ce)
(1)
.
Car
cin
oge
nic
ity
:
Saf
rol
e
is
a p
roc
arc
ino
gen
tha
t r
equ
ire
s
bio
che
mic
al
act
iva
tio
n.
Cho
lan
gio
car
cin
oma
s,
hep
ato
mas
,
ade
nom
as
and
ade
noc
arc
ino
mas
hav
e b
een
pro
duc
ed
in
mic
e a
nd
rat
s f
ed
hig
h l
eve
ls
of
saf
rol
e (
1,0
00
to
5,000 ppm) in the diet (67).
Chr
oni
c
Adv
ers
e
Eff
ect
s:
The
maj
or
chr
oni
c
eff
ect
s
are
neo
pla
sms
in
the
liv
er
and lung (67).
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mut
age
nic
ity
:
Neg
ati
ve
in
Sal
mon
ell
a a
nd
pos
iti
ve
in
yea
st
(65
).
Permissible Exposure Limit: Not known.
Imn
edi
ate
ly
Dan
ger
ous
to
Lif
e o
r H
eal
th:
Pro
bab
le
oral
LDL
O f
or
hum
ans
is
0.5
-5.
0 g
/kg
(be
twe
en
1 o
z a
nd
1 p
int
for
a 7
0 k
g p
ers
on)
(74
).
Existing Environmental Regulations: None known.
Rec
onm
end
ati
on:
Alt
hou
gh
neo
pla
sms
hav
e b
een
obs
erv
ed
in
ani
mal
s f
ed
hig
h
dos
es
it
is
unl
ike
ly
tha
t s
afr
ole
is
a s
ign
ifi
can
t t
hre
at
to
hum
an
hea
lth
in the Great Lakes Basin. Monitoring is not recommended.
111
 Sa
li
cy
li
c
ac
id
(C
AS
Re
g
No
:
69
72
7)
(T
ab
le
:
4)
Ex
po
su
re
pr
of
il
e:
Th
is
co
mp
ou
nd
ap
pe
ar
s
to
be
us
ed
in
mo
de
ra
te
am
ou
nt
s
in
th
e
ch
em
ic
al
in
du
st
ry
.
It
is
al
so
an
in
te
rm
ed
ia
te
in
th
e
mi
cr
ob
ia
l
de
co
m—
po
si
ti
on
of
na
ph
th
al
en
e
an
d
so
me
of
it
s
de
ri
va
ti
ve
s.
It
is
in
hi
bi
to
ry
to
ba
ct
er
ia
in
hi
gh
co
nc
en
tr
at
io
ns
bu
t
ra
pi
dl
y
mi
ne
ra
li
ze
d
in
lo
w
co
nc
en
tr
at
io
ns
.
It
is
wa
te
r
so
lu
bl
e
an
d
do
es
no
t
ac
cu
mu
la
te
in
li
vi
ng
ti
ss
ue
s.
It
wa
s
de
te
ct
ed
in
Mu
sk
eg
on
,
Mi
ch
ig
an
,
wa
st
ew
at
er
bu
t
wa
s
ab
se
nt
from the final effluent.
Toxicity profile:
Or
al
LD
50
:
48
0-
89
1
mg
/k
g
in
va
ri
ou
s
ro
de
nt
sp
ec
ie
s
(1
).
Ca
rc
in
og
en
ic
it
y:
No
da
ta
fo
un
d.
Ch
ro
ni
c
Ad
ve
rs
e
Ef
fe
ct
s:
Su
ba
cu
te
in
to
xi
ca
ti
on
in
ma
n
ca
us
es
he
ad
ac
he
,
di
zz
in
es
s,
ri
ng
in
g
in
ea
rs
,
di
ff
ic
ul
ty
in
he
ar
in
g,
di
mn
es
s
of
vi
si
on
,
me
nt
al
co
nf
us
io
n,
la
ss
it
ud
e,
dr
ow
si
ne
ss
,
sw
ea
ti
ng
,
th
ir
st
,
na
us
ea
,
hy
pe
rv
en
ti
la
ti
on
,
vo
mi
ti
ng
an
d
oc
ca
si
on
al
ly
di
ar
rh
ea
(6
7)
.
CN
S
Ef
fe
ct
s:
No
da
ta
fo
un
d.
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
No
da
ta
fo
un
d.
Te
ra
to
ge
ni
ci
ty
:
Sa
li
cy
cl
ic
ac
id
is
te
ra
to
ge
ni
c
wh
en
in
je
ct
ed
su
bc
ut
an
eo
us
ly
in
to
pr
eg
na
nt
ra
ts
:
it
ma
y
bi
nd
mi
ne
ra
ls
in
th
e
ma
te
rn
al
fe
ta
l
.
en
vi
ro
nm
en
t
ma
ki
ng
th
em
in
su
ff
ic
ie
nt
ly
av
ai
la
bl
e
fo
r
th
e
de
ve
lo
pi
ng
fe
tu
s
(6
7)
.
Ra
ts
fe
d
0.
4%
in
di
et
th
ro
ug
h
ge
st
at
io
n
da
ys
8-
14
sh
ow
ed
te
mp
or
ar
y
lo
ss
in
bo
dy
we
ig
ht
,
sa
li
va
ti
on
an
d
pi
lo
er
ec
ti
on
;
th
er
e
wa
s
hi
gh
mo
rt
al
it
y
an
d
gr
ow
th
re
ta
rd
at
io
n
in
fe
tu
se
s
(6
7)
.
Mutagenicity: No data found.
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
No
da
ta
fo
un
d.
Im
me
di
at
el
y
Da
ng
er
ou
s
to
Li
fe
or
He
al
th
:
Pr
ob
ab
le
or
al
le
th
al
do
se
in
ma
n
is
50
-5
00
mg
/k
g
(b
et
we
en
1
te
as
po
on
fu
l
an
d
1
oz
fo
r
a
70
kg
pe
rs
on
)
(7
4)
.
Ex
is
ti
ng
En
vi
ro
nm
en
ta
l
Re
gu
la
ti
on
s:
No
ne
kn
ow
n.
 
Re
co
mn
en
da
ti
on
:
Ba
se
d
on
th
e
to
xi
ci
ty
da
ta
av
ai
la
bl
e
an
d
ex
po
su
re
in
th
e
Gr
ea
t
La
ke
s
it
is
li
ke
ly
th
at
sa
li
cy
li
c
ac
id
is
of
mi
ni
ma
l
co
nc
er
n.
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Sei
eni
um
(Tab
ie:
2)
Exp
osu
re
pro
fil
e:
The
Gre
at
Lak
es
are
ioc
ate
d
in
a r
egi
on
whi
ch
is
not
nat
ura
iiy
ric
h i
n s
eie
niu
m.
Sei
eni
um
com
pou
nds
ent
er
the
Gre
at
Lak
es
fro
m
ind
ust
ria
i
dis
cha
rge
s,
the
dec
ay
of
pro
duc
ts
con
tai
nin
g s
eie
niu
m a
nd
fro
m
the
atm
osp
her
e a
s t
he
reS
Uit
of
coa
i
bur
nin
g.‘
Mic
hig
an
est
ima
tes
ann
uai
ind
ust
ria
i u
se
of
7,0
00
- 5
0,0
00
1bs
and
annu
ai
dis
cha
rge
s i
n t
he
ran
ge
of
1,8
00
- 1
3,0
00
1bs
.
New
Yor
k e
sti
mat
es
emi
ssi
ons
int
o t
he
atm
OSp
her
e i
n
its
por
tio
n o
f t
he
Lak
e D
nta
rio
Bas
in
of
1 t
on/
yr.
Rai
nwa
ter
in
the
Lak
e
Ont
ari
o B
asi
n w
as
fou
nd
to
con
tai
n
1 u
g
sei
eni
um
per
iit
er.
Con
cen
—
tra
tio
ns
in
the
wat
er
coi
unn
s d
o n
ot
exc
eed
3 u
g/L
(2
ug/
L f
oun
d
in
Lak
e
Mic
hig
an
epi
iim
nio
n,
up
to
4.8
ug/
L
in
the
hyp
oii
mni
on)
.
Tri
but
ary
wat
ers
con
tai
n 1
ess
tha
n 5
ug/
L.
Bio
acc
umu
iat
ion
fac
tor
s f
or
se1
eni
um
are
in
the
ran
ge
of
2,0
00
to
6,0
00.
Fis
h i
n t
he
Gre
at
Lak
es
con
tai
n 1
.5
mg/kg or 1ess on a fresh weight basis.
Toxicity profiie:
0ra
1 L
D5
:
Eie
men
tai
sei
eni
um,
6,7
00
mg/
kg
for
the
rat
;
sei
eni
tes
(Na
sai
t),
2.3-?0 mg/kg in rodents (66).
Car
cin
oge
nic
ity
:
Sei
eni
um
is
pro
bab
iy
not
car
cin
oge
nic
ait
hou
gh
rat
s
fed
5—1
0
ppn
se1
eni
um
in
the
ir
die
t f
or
18-
24
mon
ths
did
dev
eio
p
som
e
ade
nom
as
and
iow
-gr
ade
car
cin
oma
s
of
the
1iv
er
in
res
ear
ch
con
duc
ted
in
the
194
0's
(44
).
Chr
oni
c A
dve
rse
Eff
ect
s:
5-1
5
ppm
of
die
tar
y
sei
eni
um
cau
ses
hep
ati
c
nec
ros
is,
hem
orr
hag
e
and
cir
rho
sis
in
ani
mai
s.
Mar
ked
and
pro
gre
ssi
ve
ane
mia
has
bee
n r
epo
rte
d i
n o
the
r s
pec
ies
fed
sei
eni
um
(44
).
0.1
to
0.2
mg/
kg
sel
eni
um
in
hum
an
die
ts
has
bee
n c
orr
eia
ted
wit
h j
aun
dic
e,
chi
oas
ma,
ve
rt
ig
o,
ga
st
ro
in
te
st
in
ai
di
se
as
e
de
rm
at
it
is
,
nai
i
ch
an
ge
s,
ia
ss
it
ud
e
and
fatigue (40).
CNS
Eff
ect
s:
Ata
xia
,
vis
uai
imp
air
men
t a
nd
par
aiy
sis
hav
e b
een
rep
ort
ed
in
ani
mai
s c
hro
nic
aii
y e
xpo
sed
to
sei
eni
um
(40
).
Ano
rex
ia,
ner
vou
s
dis
tur
ban
ces
and
irr
ita
bii
ity
hav
e b
een
rep
ort
ed
in
man
(66
).
Rep
rod
uct
ive
Eff
ect
s:
Low
iev
eis
of
sei
eni
um
hav
e b
ene
fic
iai
eff
ect
s.
Ter
ato
gen
ici
ty:
Ter
ato
gen
ic
and
emb
ryo
tox
ic
eff
ect
s o
f s
eie
niu
m h
ave
bee
n
rep
ort
ed;
how
eve
r,
sei
eni
um
ais
o a
ppe
ars
to
hav
e a
pro
tec
tiv
e e
ffe
ct
on
ani
mai
s e
xpo
sed
to
oth
er
met
ais
tha
t a
re
ter
ato
gen
ic
(66)
.
Mut
age
nic
ity
:
Sei
eni
te
ind
uce
s c
hro
mos
ome
abe
rra
tio
ns,
DNA
fra
gme
nta
tio
n,
DNA
rep
air
syn
the
sis
and
mit
oti
c i
nhi
bit
ion
in
hum
an
dip
ioi
d f
ibr
obi
ast
s.
Sei
ena
te
ind
uce
s
a 1
0w
1ev
ei
of
DNA
rep
air
syn
the
sis
in
the
sam
e
tes
t
system (65).
Per
mis
sib
ie
Exp
osu
re
Lim
it:
In
air
, 0
.2
mg/
m3
(OS
HA)
(42
).
Dri
nki
ng
Wat
er
Guideiine in Canada is 0.01 mg/L (40).
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 Immediateiy Dangerous to Life or Heaith:
Existing Environmentai Regulations:
Canada: Drinking Water Guideiine
IJC Objectives: Yes.
Recommendation:
114
100 mg/m3 (OSHA) (42).
Seienium is presentiy being monitored.
 
  
Silver (Tables: 1 & 2)
Ex osure rofile: Silver has been included in the list of trace metals to be
monitored in drinking water in the U.S. In fact, however, reclaiming of
silver from effluents of the major users has made contamination extremely
rare. The highest values forthis element in waters of the Great Lakes
and their tributaries reported in Appendix E are 9 pg/L, tissues of fish
and wildlife apparently have not been analyzed but significant
contamination is unlikely.
Toxicity profile:
Oral L050: 50—123 mg/kg in various rodents and for various silver salts (54).
Carcinogenicity: No data found.
Chronic Adverse Effects: Few effects have been reported in man. Deposition
of silver in the subepithelial portions of the skin and mucous membranes
is called "argyria". Changes were observed in rats fed a silver saltin
water at the following concentrations: changes in spleen at 1 ug/L;
changes in spleen (1 mg/L); kidney and liver at 0.4-0.7 mg/L (44).
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: AgN03 injected into chicken eggs produced no defects; it
was, however, embryotoxic with an LD50 of 0.10 mg/egg (55).
Mutagenicity: Non-mutagenic in D. subtilis rec assay.
Permissible Exposure Limit: 0.1 mg/m3 (OSHA) (42).
Immediately Dangerous to Life or Health: No data found.
Existing Environmental Regulations:
ESQ: Drinking Water Standard.
ganaga: Drinking Water Guideline.
IJC Objectives: Proposed.
Recomnendation: This element is being monitored, probably excessively so and
is of no further concern for the purposes of this investigation.
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Silvex
(2,4,5-Trichlorophenoxy-
(CAS
Reg
No:
93721)
(Table:
2)
propionic acid)
Exposure
profile:
Appendix
E
shows
that
this
compound
was
looked
for
in
the
waters
of
Lake
Superior
but
not
detected.
No
other
infonnation
is
given.
Silvex
is
a
synthetic
herbicide
which
formerly
was
used
extensively
in
landscaping
and
on
rights-of-way,
but
its
use
has
become
more
strictly
controlled
and
has
decreased
accordingly.
Use
in
New
York
is
given
as
between
1,000
and
10,000
lbs
per
year.
Silvex
is
lipOphilic
and
has
a
potential
for
accumulation
into
living
tissues,
but
it
is
also
rapidly
mineralized by bacteria.
Toxicity profile:
Oral
LD50:
Is
650
mg/kg
in
rats
(1).
Carcinogenicity:
Mice
fed
silvex
at
121
ppm
for
18
months
experienced
no
increase
in
tunorigenesis
above
control
values
(3).
Chronic
Adverse
Effects:
Rats
fed
silvex
(possibly
contaminated
with
TCDD)
at
100
ppm
for
90
days
experienced
liver
and
kidney
danage
(3).
CNS Effects: No data found.
Reproductive
Effects:
When
pregnant
rats
were
administered
silvex
at
doses
up
to
100 mg/kg
on
days
6—15
of
gestation,
significant
effects
were
noted
on
fetal
survival
and
birth
weight
(36).
Teratogenicity:
When
pregnant
rats
were
given
silvex
orally
on
days
12—15
of
gestation
(398
mg/kg/day),
fetuses
suffered
a
significant
incidence
of
;
cleft palate (3).
Mutagenicity:)
Limited
testing
has
not
demonstrated
any
mutagenicity
for
silvex 3 .
Permissible
Exposure
Limit:
Canadian
Drinking
Water
Guideline
is
0.01
mg/L,
(40).
Immediately
Dangerous
to
Life
or
Health:
No
data
found.
Existing
Environmental
Regulations:
Canada:
Drinking
Water
Guideline.
Recommendation:
Monitoring
for
silvex
presently
occurs.
 
  
Styrene (CAS Reg No: 100425) (Table: 3)
Exposure profile; Styrene has been detected in the City of Cleveland water
supply but was not quantified. It was also detected in a discharge to the
St. Clair River. Styrene is handled in very large amounts by the chemical
industry. New York reports an annual usage of 1 million pounds, Michigan
172 million pounds and Ontario over 1 million kilograms. Michigan's
annual discharge may contain 3,300 to 24,000 pounds. Styrene is slightly
soluble in water and lipophilic; bioaccumulation data are not available.
Styrene is degraded by microorganisms with the fonnation of more water
soluble aromatic alcohols and acids - as intermediate products. Conplete
mineralization occurs in the presence of an acclimated microbial community.
Toxicity profile:
Oral L050: 316 mg/kg in mice (1)
Carcinogenicity: No evidence was found for the carcinogenicity of styrene
under the conditions of a recent NCI—sponsored bioassay with rats and mice (35).
Chronic Adverse Effects: In a gavage study, rats dosed 5 days/wk for 185 days
at doses up to 667 mg/kg day experienced increased liver and kidney
weights (3).
CNS Effects: Styrene is a CNS depressant when administered at acute exposure
levels (34).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Styrene is mutagenic in several i3 113:9 assay systems (1).
Permissible Exposure Limit: 100 ppm (OSHA) (2).
Immediately Dangerous to Life or Health: 5,000 ppm (OSHA) (2).
Existing Environmental Regulations: None kn0wn.
Recomnendation: Large amounts of styrene are consumed in the Great Lakes
Basin. The limited toxicology data suggest that monitoring should be
considered.
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 2,3,7,8-Tetrachlorodibenzodioxin
(TCDD)
(Table:
2)
Exposure
profile:
This
compound
has
entered
and
continues
to
enter
the Great
Lakes
Basin
Ecosystem
as
a
contaminant
in
pesticides
and
herbicides,
as
a
product of the incomplete combustion of other chlorinated
compounds and
from
waste
chemical
dumps.
Michigan
reports
the
handling of
20,000
lbs
of
chlorinated dioxins annually.
It is not detectable in the water column by
present
techniques
but
is
found
in Lake
Ontario fish
at
concentrations
of
several
parts per trillion and in fish-eating
birds in this
lake.
 
Toxicity profile:
Oral LD50:
The L050 has a wide range between species, e.g. 0.6 ug/kg in
guinea pigs and 114 pg/kg in mice (1).
Carcinogenicity:
Produces
nodular hyperplasia in the liver that may be
precancerous.
2,3,7,8-TCDD
is a
likely co—carcinogen.
Chronic Adverse Effects:
Thymic and lymphoid involution was seen in rats
given daily oral
doses
of 1 ug/kg TCDD
for 8 weeks
(26).
The following
were also observed in non-hunan primates and rats:
liver danage; loss of
body weight;
chloracne;
allopica;
internal
hemorrhage;
and pancytopenia.
Effect level is 0.01 mg/kg (90).
CNS
Effects:
Anorexia and depression were observed
in dogs treated with acute
(0.3 mg/kg) doses of TCDD (25). Polyneuropathy of the peripheral nervous
system has been observed in man (90).
Reproductive Effects:
A three-generation reproduction study on rats fed as
little as 0.01 pg TCDD per day demonstrated that TCDD induced smaller
litter size,
decreased survival
and reduced growth of offspring (27).
Teratogenicity:
Oral
administration of 40 ug/kg TCDD to pregnant mice
during gestation caused a 50% incidence of cleft palate in the offspring (24).
Mutagenicity:
TCDD
exhibits
negative
mutagenicity
in
several
assay systems,
but
has
been
reported
by
one worker
to
be mutagenic
(3).
Permissible Exposure Limit:
A maximum
of 20 ug of 2,3,7,8-TCDD
in fish and
no detectable dioxin in water,
have been proposed.
Immediately Dangerous
to Life or Health:
More than 50 ug in food.
Existing Environmental Regulations:
ygg: Proposed fish action levels.
Canada:
Pr0posed
fish
action
levels.
IJC Objectives: Proposed.
Recommendation:
2,3,7,8;TCDD has considerable acute and chronic toxicity.
Monitoring of fish for this and other chlorinated dioxins is recunnended.
Current
levels
in water
are
unlikely
to
be
a health
concern.
~
1
1
8
‘
\
 Tetrachioroethane (TCE) (CAS Reg No: 79345) (Tabie: 1)
Exposure profile: Tetrachioroethane is a soivent and chemicai used in
chemicat syntheses. It was found in water coiunn sampies in con—
centrations of 1 to 44 ug/L.
New York reports production and/or use of
100,000 1bs annuaiiy. No other data are avaiiabie. The compound is
voiatiie and pooriy, if at aii, mineraiized by bacteria.
Toxicity profiie:
Ora] L050: 200 mg/kg in rats (1).
Carcinogenicity: No data found.
Chronic Adverse Effects:
Long-term exposure has resuited in fatigue, ioss of
appetite, weight ioss, constipation abdominai pain, kidney, heart and
1iver damage, haematoiogica) changes and jaundice (44).
CNS Effects: TCE is a CNS depressant; synptoms in man inciude dizziness,
headache, irritabiiity, nervousness, insomnia, nausea and tremors (44).
Reproductive Effects: Reproductive anomaiies have been observed in animais
exposed to high 1eve1s (44).
Teratogenicity: No feta] toxicity or teratogenicity was found when ratswere
exposed to approximateiy 600 ppn (vapor) (55).
Mutagenicity: Positive in Saimoneiia (65).
Permissibie Ex osure Limit: For 1,1,2,2-tetrachioroethane, OSHA gives a vaiue
of 35 mg/m (42).
Inmediateiy Dangerous to Life or Heaith: For 1,1,2,2-tetrach1oroethane, OSHA
gives a vaiue of 150 ppn (42).
Existing Environmentai Reguiations: None known.
 
Recomnendation: Tetrachioroethane is quite toxic on an acute exposure basis;
however, it is uniikeiy to pose a chronic heaith hazard. Monitoring may
be required to obtain a better understanding of the distribution of this
compound. Tetrachioroethane shouid be detectabie in drinking water
suppiies using estabiished methods.
  
Tetrachloroethylene
(CA5
Reg
No:
127184)
(Table:
3)
Exposure
profile:
Tetrachloroethylene
is
one
of
the
most
cannon
solvents
used
in
dry
cleaning
and
in
many
other
operations.
Production
and
use
in
New
York
are
over
100
million
lbs
per
year,
in
Ontario
nearly
13
million
kg.
Annual
discharges
from
Ontario
to
the
Great
Lakes
are
estimated
as
25,000
kg,
with
additional
anounts
escaping
to
the
atmOSphere.
Michigan
reports
discharges
of
12,000
to
24,000
lbs
annually.
The
compound
is
volatile
and
poorly,
if
at
all
mineralized.
It
is
probably
ubiquitous
in
the
Great
Lakes
in
trace
concentrations.
Toxicity profile:
Oral
LD50:
8,100
mg/kg
in
mice
(1).
 
Carcinogenicity:
A
highly
dose-dependant
hepato-carcinogen
in
mice
(67).
Chronic
Adverse
Effects:
Rats
exposed
chronically
to
1,600
ppn
showed
enlargement
of
the
liver
and
kidneys.
Chronically
exposed
humans
developed
tolerances
to
the
effects
of
tetrachloroethylene.
Symptoms
of
exposure
include
headache,
mild
eye,
nose
or
throat
irritation,
flushing,
sleepiness
and
difficulty
in
speaking
(67).
CNS
Effects:
Long
term
industrial
exposures
caused
various
neuropathies
such
as
nunbness,
trenbling,
neuritis
and
defects
of
memory
(44).
Tetra-
chloroethylene
is
a
CNS
depressant
in
humans
and
can
lead
through
several
stages
of
clinical
anesthesia
to
death
from
reSpiratory
paralysis.
Toxic
neuropathies
have
also
been
observed
in
mice
(67).
Reproductive
Effects:
No
data
found.
Teratogenicity:
No
data
found.
Mutagenicity:
Negative
in
Salmonella
(65).
Permissible
Exposure
Limit:
100
ppm
(44).
Immediately
Dangerous
to
Life
or
Health:
300
ppn
(44),
500
ppn
(OSHA)
(42).
Existing
Environmental
Regulations:
None
known.
Recommendation:
Tetrachloroethylene
is
in
widespread
use
andhas
chronic
toxicity
of
concern.
Monitoring
to
determine
distribution
in
the
Great
Lakes
Basin
is
recannended.
It
is
readily
detectable
in
drinking
water
and
effluents
by
established
methods.
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 (CAS Reg No: 109999) (Table: 5)
Tetrahydrofuran
Exp
osu
re
pro
fil
e:
Wat
er
col
mnn
ana
lys
is
cit
ed
in
App
end
ix
E h
as
sho
wn
con
cen
tra
tio
ns
of
1 to
318
ug/
L.
New
Yor
k r
epo
rts
use
of
500
lbs
ann
ual
ly.
Thi
s
com
pou
nd
is
a c
omm
on
rea
gen
t
and
sol
ven
t
and
pro
bab
ly
han
dle
d i
n m
uch
lar
ger
amo
unt
s;
It
is
wat
er
mis
cib
le.
Inf
orm
ati
on
on
bi
od
eg
ra
da
bi
li
ty
co
ul
d
not
be
lo
ca
te
d.
In
fo
rm
at
io
n
is
pr
es
en
tl
y
insufficient to assess exposure potential.
Toxicity profile:
Ora
l
L05
0:
2,3
00-
3,2
00
mg/
kg
in
sev
era
l
rod
ent
spe
cie
s
(30
).
Car
cin
oge
nic
ity
:
Inf
orm
ati
on
is
not
ade
qua
te
to
mak
e
an
ass
ess
men
t
(30
).
Chr
oni
c
Adv
ers
e
Eff
ect
s:
Mic
e
fed
100
mg/
kg/
day
sho
wed
mod
era
te
wei
ght
los
s,
par
aly
sis
of
hind
lim
bs,
leu
kec
yto
sis
and
cha
nge
s i
n c
lot
tin
g t
ime
s.
Si
mi
la
r
ch
an
ge
s
we
re
ob
se
rv
ed
in
mi
ce
,
rat
s
and
ra
bb
it
s
gi
ven
20
mg
/k
g
per
day for 5-6 months (30).
CNS
Eff
ect
s:
In
hum
ans
,
diz
zin
ess
,
hea
dac
hes
and
nau
sea
occ
ur
wit
h
ove
r
ex
po
su
re
but
are
re
ad
il
y
re
ve
rs
ib
le
in
fr
es
h
air
(44
).
Ch
ol
in
es
te
ra
se
dep
res
sio
n
and
neu
rol
ogi
cal
sig
ns
hav
e
bee
n o
bse
rve
d
in
ani
mal
s
(30
).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Negative in Salmonella (65).
Pe
rm
is
si
bl
e
Ex
po
su
re
Li
mi
t:
59
0
mg
/m
3
(OS
HA)
(42
).
Im
ne
di
at
el
y
Da
ng
er
ou
s
to
Li
fe
or
Hg
al
th
:
20
,0
00
pp
m
(OS
HA)
(42
)
ho
we
ve
r,
one
pu
bl
ic
at
io
n
co
ns
id
er
s
70
0
mg
/m
as
da
ng
er
ou
s
(30
).
Existing Environmental Regulations: None known.
 
Re
co
mn
en
da
ti
on
:
Th
er
e
are
in
ad
eq
ua
te
to
xi
ci
ty
and
ex
po
su
re
da
ta
to
de
te
rm
in
e
re
qu
ir
em
en
ts
fo
r
mo
ni
to
ri
ng
or
to
as
se
ss
ha
za
rd
and
ri
sk
to
he
al
th
.
 Toluene (CAS Reg No: 108883) (Table: 4)
Ex osure rofile: Toluene was detected in trace concentrations (1 to 5 ug/L)
in Great Lakes water and in concentrations of up to 58 pg/L in the
Niagara River. Toluene is used in amounts of hundreds of millions of
kilograms per year and is a component of motor fuels. Ontario estimates
discharges to the Great Lakes of 203,000 kg annually. Additional anounts
are evaporated into the atmosphere. Toluene is slightly soluble in
water. It is mineralized by an acclimated microbial community, but at the
low concentrations which are found in aqueous media, decomposition is
slow. Its wide distribution in trace concentrations in water and air is
not surprising and may represent a steady state between discharges and
atnospheric inputs on the one hand and degradation on the other.
Toxicity profile:
Oral LD50: 5,000 mg/kg in rats (1).
Carcinogenicity: Nodata found.
Chronic Adverse Effects: No data found.
CNS Effects: Toluene vapor causes narcosis. Also observed in humans exposed
to 600 ppm for 8 hours were mild fatigue, weakness, confusion,
lacrimation, paraesthesia, euphoria, headache, dizziness, dilated pupils
and nausea. At 800 ppm for 8 hours the above symptoms were more
pronounced and after-effects, which persisted for several days, included
nervousness, muscular fatigue and insonnia (44).
Reproductive Effects: No significant reports of reproductive impairment were
found.
Teratogegicity: Toluene exposure of pregnant rats (1,500 mg/m3 or 1,000
mg/m ) produced no terata but some fetal growth retardation and maternal
mortality at the higher dose. Similar results were obtained from exposing
pregnant mice, at similar doses. Pregnant mice fed 1.0 mg/kg produced
fetuses with increased incidences of cleft palate (55).
Mutagenicity: Negative in Salmonella (65).
Permissible Exposure Limit: 200 ppm (OSHA) (42). ACGIH gives 375 mg/m3 for
skin exposure (43).
Immediately Dangerous to Life or Health: 2,000 ppm (OSHA) (42).
Existing Environmental Regulations: None known.
Recommendation: Toluene is unlikely to pose a health hazard (in water or
air) based on available toxicology data. Some intermittent monitoring of
industrial discharges may be worthwhile.
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Toxaphene (Camphechior) (CAS Reg No: 8001352) (Tabies: 1 & 2)
Exposure profiie: The group of compounds known as the pesticide Toxaphene has
been
foun
d in
Lake
Supe
rior
and
Lake
Huro
n wa
ter
in c
once
ntra
tion
s of
0.1
to 1.0 ug/L. It was aTso detected in fish off Sheboygan, Michigan, in
concentrations up to 4 ug/g. Data on usage are scanty (New York: 519
Tbs
annu
aiiy
).
Toxa
phen
e is
high
ly I
ipop
hiTi
c an
d pr
oba
ny
not
bio-
degradabIe. Additionai information on its occurrence may emerge from the
drin
king
wate
r su
rvei
IIan
ce p
rogr
ams
curr
entI
y in
effe
ct i
n th
e U.
S.
Toxicity profiie:
OraT L050: Ranges from 40 to 250 mg/kg in rodents (1).
Carc
inog
enic
ity:
In a
n MC
I-sp
onso
red
carc
inog
enes
is b
ioas
say,
toxa
phen
e wa
s
fou
nd
to
be
car
cin
oge
nic
in
mic
e.
It
cau
sed
an
inc
rea
sed
inc
ide
nce
of
hepa
toce
TIui
ar c
arci
noma
s (
29).
IARC
cons
ider
s to
xaph
ene
carc
inog
enic
for
bot
h m
ice
and
rat
s a
nd
con
cIu
des
the
re
is
aIso
a ri
sk
of
car
cin
oge
nic
ity
for man (12).
Chro
nic
Adve
rse
Effe
cts:
Mode
rate
dege
nera
tion
of t
he I
iver
was
expe
rien
ced
by
dog
s f
ed
200
ppm
of
tox
aph
ene
for
2 y
ear
s (
3).
In
ano
the
r s
tud
y I
ive
r
and
kidn
ey d
amag
e we
re o
bser
ved
in d
ogs
fed
4 mg
/kg
for
44 o
r 10
6 da
ys (
98).
CNS
Eff
ect
s:
Poi
son
ing
can
Iea
d t
o s
eiz
ure
s,
con
vuT
sio
ns,
res
pir
ato
ry
arr
est
and cerebraI edema (56).
Rep
rod
uct
ive
Eff
ect
s:
In
a t
hre
e—g
ene
rat
ion
rep
rod
uct
ion
stu
dy
wit
h r
ats,
no
eff
ect
was
cau
sed
by
die
tar
y I
eve
Is
of
tox
aph
ene
up
to
100
ppm
(3).
Teratogenicity: When toxaphene was administered to pregnant rats by gavage
(35
mg/
kg/
day
) d
uri
ng
ges
tat
ion
, f
etu
ses
suf
fer
ed
a r
edu
cti
on
in
wei
ght
and reduced skeIetaI ossification compared to controis (28).
Mut
age
nic
ity
:
Tox
aph
ene
has
bee
n r
epo
rte
d t
o b
e m
uta
gen
ic
tow
ard
s S
aTm
one
IIa
typhimuriun in an in vitro assay (3).
Perm
issi
bIe
Expo
sure
Limi
t:
0.5
mg/m
3 (O
SHA)
(2).
Cana
dian
Drin
king
Wate
r
GuideIine 0.005 mg/L (40).
Imme
diat
eiy
Dang
erou
s to
Life
or H
eaIt
h:
200
mg/m
3 (2
).
In h
unan
s 1
0 mg
/kg
ora
TIy
can
Iea
d t
o c
onv
uls
ion
s.
The
min
imu
m a
cut
e I
etha
T d
ose
(or
aII
y)
is
2-7 g/person. DermaI appiication of 46 g/person is dangerous (98).
Existing Environmentai Reguiations:
DSA: Drinking Water Standard.
Canada: Drinking Water Guideiine.
IJC Objectives: Yes.
Recomnendation: Toxaphene has significant acute and chronic toxicity and is
currentiy being monitored.
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Tri
chl
oro
eth
yle
ne
(CAS
Reg
No:
790
16)
(Ta
ble
: 3
)
Exp
osu
re
pro
fil
e:
Thi
s i
s a
not
her
ver
y c
omn
on
chl
ori
nat
ed
sol
ven
t w
hic
h h
as
man
y a
ppl
ica
tio
ns,
e.g
.
in
met
al
cle
ani
ng
and
by
the
nat
ure
of
its
man
y
end
uses
is w
idel
y di
stri
bute
d i
n th
e en
viro
nmen
t.
Usag
e is
in t
he
mil
lio
ns
of
kil
ogr
ams
; O
nta
rio
est
ima
tes
dis
cha
rge
s o
f 1
3,6
00
kg
ann
ual
ly
and
Mich
igan
esti
mate
s d
isch
arge
s of
2,30
0 to
21,6
00 l
bs.
Grea
t La
kes
con
cen
tra
tio
ns
ran
ge
up
to
10
pg/
L.
Tri
chl
oro
eth
yle
ne
is
vol
ati
le
and
poorly if at all mineralized by microorganisms.
Toxicity profile:
Oral LD50: 4,920 mg/kg in rats (1).
Car
cin
oge
nic
ity
:
Lif
eti
me
exp
osu
re
to
dri
nki
ng
wat
er
con
tai
nin
g 1
0 p
pb
tri
chl
oro
eth
yle
ne
has
bee
n
est
ima
ted
to
pro
duc
e
one
exc
ess
cas
e
of
can
cer
for
ever
y 50
,000
pers
ons
expo
sed.
Oral
expo
sure
of m
ice
for
78 w
eeks
pro
duc
ed
si
nif
ica
nt
dos
e-r
ela
ted
hep
ato
cel
lul
ar
car
cin
oma
s
and
ade
nom
as
in cats (67?.
Chr
oni
c A
dve
rse
Eff
ect
s:
Chr
oni
c i
nto
xic
ati
on
in
dOgs
fol
low
ing
3-8
wee
ks
of
inh
ala
tio
n o
f 5
00-
750
ppm
for
4-8
hrs
/da
y,
5—6
day
s/w
k,
app
ear
as
leth
argy
, an
orex
ia,
naus
ea,
vomi
ting
, we
ight
loss
and
live
r dy
sfun
ctio
n.
Cat
s a
nd
gui
nea
pig
s d
eve
lop
ed
liv
er
cir
rho
sis
and
bil
iar
y h
ype
rpl
asi
a
which later progressed in some animals to proliferative biliary
ade
nun
ato
sis
.
Liv
er
dis
eas
e a
nd
res
pir
ato
ry
dis
ord
ers
hav
e b
een
rep
ort
ed
in man (67).
CNS
Eff
ect
s:
CNS
eff
ect
s
hav
e
bee
n
rep
ort
ed
in
man
(pa
ral
ysi
s),
dog
s
(hy
per
san
nia
)
and
rat
s
(dy
seq
uil
ibr
iun
,
ata
xia
and
hyp
erk
ine
sis
)
(67
).
Reproductive Effects: No data found.
Ter
ato
gen
ici
ty:
Pre
gna
nt
rat
s
and
mic
e
exp
ose
d
to
app
rox
ima
tel
y
600
ppm
of
thi
s
vap
or
pro
duc
ed
hea
lth
y
lit
ter
s
and
no
fet
use
s
wit
h
ter
ata
.
Mut
age
nic
ity
:
Neg
ati
ve
in
Sal
mon
ell
a a
nd
pos
iti
ve
in
yea
st
(65)
.
Per
mis
sib
le
Exp
osu
re
Lim
it:
100
pun
(OS
HA)
(42
)
and
535
mg/
m3
(AC
GIH
)
(43
).
Imn
edi
ate
ly
Dan
ger
ous
to
Lif
e o
r H
eal
th:
1,0
00
ppm
(OSH
A)
(42)
.
Pro
bab
le
ora
l L
DLO
in
man
is
50-
500
mg/
kg
(be
twe
en
1 t
eas
poo
nfu
l
and
1 o
z f
or
a
70
kg
per
son
)
(74
).
Low
est
dos
e c
aus
ing
tox
ic
or
CNS
eff
ect
s i
n h
uma
ns
is
857 mg/kg (67).
Existing Environmental Regulations: None known.
 
Rec
omn
end
ati
on:
Inc
lud
ed
in
mon
ito
rin
g
of
dri
nki
ng
wat
ers
and
eff
lue
nts
by
est
abl
ish
ed
met
hod
s.
The
wid
esp
rea
d u
se
of
tri
chl
oro
eth
yle
ne
sug
ges
ts
the
nee
d f
or
mon
ito
rin
g d
ata
to
est
abl
ish
the
ris
k f
or
hun
an
hea
lth
.
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and (CAS Reg No: 88062) (TabTe: 3) (
Trichiorophenois 2,4,5-
2,4,6— (TCP) (CAS Reg No: 95954)
Exposure profiie: The trichiorophenois are bandied in miTTions of kiiograms
and are present in simiiar amounts in some chemicai Tandfiiis in the
basins from where they may Teach into TocaT runoff. The soTubiTity of
2,4,6—trichiorophenoi is 280 mg/L. Up to 100 pg/L were found in
effiuents to the Lower Fox River. The 2,4,5—isomer was detected in Lake
Michigan waters but\not quantified (Appendix E). The 2,4,5-isomer is
biodegraded pooriy if at aTT, whereas the 2,4,6—trichior0phen01 is
degraded at a moderate rate, but the nature of the end products has not
been determined. Both compounds are strongTy TipophiTic and may
accumuTate in Tiving tissues.
Toxicity profiie:
OraT L050: For 2,4,5-TCP, 820-1,000 mg/kg in various rodent species and for
2,4,6-TCP, 820 mg/kg in rats (1).
Carcinogenicity: 2,4,5,-TCP, promotes the appearance of tunors in mice
foTTowing an initiating dose of dimethyibenzanthracene (64) but avaiTabTe
data do not permit an evaTuation of the carcinogenicity of 2,4,5-TCP or
2,4,6-TCP (12).
Chronic Adverse Effects: ChToracne has been reported in man, however
cont
amin
atio
n of
2,4,
5-TC
P wi
th t
etra
chTo
rodi
oxin
was
susp
ecte
d.
Rats
fed
2,4,5-TCP showed no effect up to 100 mg/kg; at 300 and 1,000 mg/kg minor
Tiver and kidney danage was reported. 2,4,6-TCP is probabTy not very
toxic compared to the higher chiorinated phenois. It may cause mde Tiver (
and kidney damage or dermatitis when exposure is excessive (64).
CNS Effects: Injections of Targe amounts of either trichiorophenoi isaner
lead to trenors and coma in animais (64).
Reproductive Effects: No data found.
Teratogenicity: 2,4,5-TCP not teratogenic or embryotoxic to rats. However,
if contaminated with 2,3,7,8-tetrach1orodibenzo-p-dioxin teratOgenic
effects may be observed (64). No data on 2,4,6-TCP were found.
Mutagenicity: Both trichiorophenois were negative in Saimoneiia (65).
Permissible Exposure Limit: No data found.
Immediateiy Dangerous to Life or HeaTth: No data found.
Existing EnvironmentaT Reguiations: None known.
 
Recomnendation: AvaiTabTe information is cTearTy insufficient to aTTow an
assessment of exposure of humans to these compounds. Hence monitoring
shoqu be considered.
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 2,4
,5-
Tri
ch1
oro
phe
nox
yac
eti
c
aci
d
(CA
S R
eg
No:
937
65)
(Ta
bie
s:
1 &
3)
(2:4,5‘1.)
Exp
osu
re
pro
fii
e:
The
her
bic
ide
2,4
,5-
T i
s p
rod
uce
d
and
use
d i
n s
ign
ifi
can
t
amo
unt
s
in
the
bas
in
(Mi
chi
gan
:
140
,00
0
1bs
ann
uai
iy)
.
Dis
cha
rge
s
fro
m
Mic
hig
an
are
giv
en
as
bet
wee
n 1
01
and
500
1bs
ann
uai
iy.
It
has
bee
n
dis
cov
ere
d
in
sed
ime
nts
in
Lak
e
Eri
e
(up
to
14
pg/
g
dwt
)
and
the
Det
roi
t
Ri
ve
r
an
d
La
ke
Hu
ro
n
(no
t
qu
an
ti
fi
ed
).
It
ais
o
has
be
en
de
te
ct
ed
in
air
.
2,4
,5-
T i
s d
egr
ade
d s
iow
iy
by
acc
iim
ate
d m
icr
obi
ai
pop
uia
tio
ns
but
in
fo
nn
at
io
n
on
co
mp
ie
te
mi
ne
ra
ii
za
ti
on
is
1a
ck
in
g.
Co
nt
am
in
at
io
n
(de
pen
din
g o
n t
he
pro
duc
tio
n
pro
ces
s)
wit
h
tet
rac
h)o
ro-
dib
enz
odi
oxi
ns
mus
t
be considered.
Toxicity profiie:
Ora
i
LD5
0:
Ran
ges
fro
m
300
—38
9
mg/
kg
in
rod
ent
s
(1)
.
Ca
rc
in
og
en
ic
it
y:
2,
4,
5-
T
is
co
ns
id
er
ed
to
be
a
su
sp
ec
t
ani
ma)
ca
rc
in
og
en
(19
),
yet
thi
s
act
ivi
ty
may
be
att
rib
uta
bie
in
who
ie
or
in
par
t
to
co
nt
am
in
at
io
n
wi
th
di
ox
in
s
and
fu
ra
ns
.
Chr
oni
c A
dve
rse
Eff
ect
s:
Whe
n
rat
s
wer
e
giv
en
100
mg/
day
of
2,4
,5-
T f
or
90
day
s,
the
y
exp
eri
enc
ed
red
uct
ion
in
wei
ght
gai
n
and
in
foo
d
int
ake
(32
).
Co
nt
am
in
at
io
n
of
2,
4,
5—
T
ma
y
be
a f
ac
to
r.
CNS Effects: No data found.
Re
pr
od
uc
ti
ve
Ef
fe
ct
s:
Pr
og
en
y
fr
om
ra
ts
fe
d
2,
4,
5-
T
(1
,0
00
ppm
)
su
ff
er
ed
red
uce
d b
ody
wei
ght
and
red
uce
d w
eig
ht
of
1iv
er
and
bra
in
can
par
ed
to
controis (33).
Ter
ato
gen
ici
ty:
Whe
n
2,4
,5-
T w
as
adm
ini
ste
red
to
pre
gna
nt
mic
e a
t d
ose
s
gre
ate
r t
han
20
mg/
kg
(on
day
s 6
-15
of
ges
tat
ion
),
fet
use
s s
uff
ere
d
a
sig
nif
ica
nt
inc
ide
nce
of
cie
ft
pai
ate
and
red
uce
d
wei
ght
gai
n
com
par
ed
to
co
nt
ro
is
(19
).
Te
ra
to
ge
ni
c
ef
fe
ct
s
ha
ve
ai
so
be
en
no
te
d
in
ra
ts
an
d
ham
ste
rs
(99
).
Con
tam
ina
tio
n o
f 2
,4,
5-T
may
con
tri
but
e t
o i
ts
obs
erv
ed
teratogenicity.
Mut
age
nic
ity
:
Whe
n M
ong
oii
an
ger
bii
s w
ere
giv
en
5 c
ons
ecu
tiv
e d
ai1
y i
.p.
inj
ect
ion
s
of
2,4
,5-
T
(25
0 m
g/k
g
or
mor
e),
sig
nif
ica
nt
inc
rea
ses
wer
e
obs
erv
ed
in
chr
oma
tid
gap
s,
chr
oma
tid
bre
aks
and
fra
gne
nts
in
chr
omo
som
es
of bone marrow ceiis (19).
Permissibie Exposure Limit: 10 mg/m3 (OSHA) (2).
Im
pe
di
at
ei
y
Da
ng
er
ou
s
to
Li
fe
or
He
ai
th
:
5,
00
0
mg
/m
3
(OS
HA)
(2)
.
Existing Environmental Reguiations: None known.
Re
co
mm
en
da
ti
on
:
2,
4,
5—
T
ou
gh
t
to
be
mo
ni
to
re
d
in
th
e
Gr
ea
t
La
ke
s
Ba
si
n
as
are
2,4,—D and 2,4,5—TP (Siivex).
 
 Trichlorotrifluoroethane (Freon) (CAS Reg No: 354585) (Tables: 1 & 4)
Ex903ure profile: This volatile chlorofluorocarbon has been detected in the
water couumn at concentrations of 2 to 30 ug/L in one study. The
compound is only very sparingly soluble in water and stable. No other
data are available. « '
Toxicity profile:
Oral L050: 43 mg/kg in rats (1).
Carcinogenicity: One fibrosarcoma was observed in six rats exposed to 12,000
ppm Freon 113 for 2 hrs/day, 5 days/wk for 730 days (67).
Chronic Adverse Effects: Exposure of rats to 2,520 ppm for 7 hours daily, 5
days/wk for 30 days produced no ill effects, while at 5,000 pun there were
effects on the liver. 10 women and 3 men occupationally exposed to
1,1,2-trichloro- 1,2,2- trifluoroethane showed no indication of
solvent-caused adverse effects (67).
CNS Effects: Trichlorotrifluoroethane causes CNS depression, signs of
narcosis and ataxia in animals. Hunans exposure for 2.75 hours to 2,500
pun resulted in slight psychomotoa performance deterioration; (67)
exposure to high vapor concentrations (eg. 20%) may cause confusion,
trenors and rarely cana (74).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: No data found.
Permissible Exposure Limit: For 1,1,2-trichloro-l,2,2-trifluoroethane, OSHA
gives a value of 7,600 mg/m3 (42).
Inmediately Dangerous to Life or Health: For 1,1,2-trichloro-
1,2,2-trifluoroethane, OSHA gives a value of 4,500 ppn (42).
Existing Environmental Regulations: None known.
Recomnendation: Although acutely toxic, it is unlikely that long—term
exposure to trichlorotrifluoroethane is a concern for human health. Sane
monitoring data would assist future assessments.
 Triphenyl phosphate (TPP) (CAS Reg No: 115866) (Table: 5)
Exposure profile: This compound was found in fish in Muskegon Harbor in
conc
entr
atio
ns o
f 0.
06 t
o 0.
12 p
pn.
New
York
repo
rts
an a
nnua
l u
sage
of
700 lbs. The compound is highly lipophilic and likely to accumulate into
living tissues. There are no data on biodegradability.
Toxicity profile:
Oral L050: No data found.
Carcinogenicity: No data found.
Chronic Adverse Effects: No data found.
CNS
Effe
cts:
TPP
is a
neur
otox
in.
A si
ngle
i.p.
inje
ctio
n of
0.1-
0.4
g/kg
caus
ed p
aral
ysis
in c
ats
16-1
8 da
ys a
fter
trea
tnen
t.
Occu
pati
onal
exposure has led to a reduction in erythrocyte cholinesterase activity
over lengthy periods (0.2-3.5 mg/m3) (44).
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: No data found.
Permissible Exposure Limit: 3 mg/m3 (OSHA) (42).
Inm
edi
ate
ly
Dan
ger
ous
to
Lif
e o
r H
eal
th:
Not
kno
wn.
Existing Environnental Regulations: None known.
Rec
ann
end
ati
on:
The
ava
ila
ble
inf
orm
ati
on
is
cle
arl
y i
nsu
ffi
cie
nt
to
ass
ess
the distribution of this compound or its toxicity.
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 Vanadium (Tables: 1 & 5)
Exposure profile: Vanadiun has been associated with the burning of heavy oil
and may reach the Great Lakes via the atmosphere. Smaller amounts occur
in iron ores and generally in rocks and soils, Industrial applications
(alloys) will not readily provide soluble forms of vanadiun. Vanadium is
a micronutrient for photosynthetic organisms. Few monitoring data are
available. Concentrations in Lake Michigan are 26 ug/L or lower;
maximun concentrations found in fish from Lakes Huron, Superior, and
Michigan are 0.08 to 0.26 ppm.
Toxicity profile:
Oral L050: Vanadiun 3+ salts have values of 23-130 mg/kg in rodents
depending on the salt and the dietary sufficiency (66). Oxides of
vanadiun have oral L050 values of between 10 and 382 mg/kg in rodents.
Carcinogenicity: Vanadiun (as vanadyl sulphate, V0604, in drinking water)
at 5 ppn was not found to be carcinOQenic in mice.
Chronic Adverse Effects: Approximately 25 ppm vanadiun in special diets was
capable of producing toxic effects in rats exposed for 70-200 days. There
can be up to a 10—fold difference in toxicity to Vanadiun depending on the
nutritional adequacy of the diet. Lifetime exposure to vanadium
(V205) at 10 and 100 ppm in the diet did not affect dogs or rats other
than to promote longevity in rats. Exposure to vanadiun dust (V205)
has not led to any signs of pneunoconiosis in animals (54) and reSpiratory
signs observed in man are reversible (44). '
CNS Effects: No data found.
Reproductive Effects: No data found.
Teratogenicity: No data found.
Mutagenicity: Positive in the B. subtilis rec assay.
Per
mis
sib
le
Exp
osu
re
Lim
it:
0.5
mg/
m3
for
V20
5 d
ust
(OSH
A)
and
0.1/mg/m3 for V205 fumes (OSHA).
Immediately Dangerous to Life or Health: 70 mg/m3 (OSHA) (42).
Existing Environmental Regulations: None known.
Reco
mnen
dati
on:
Moni
tori
ng f
or
vana
dium
can
assi
st i
n th
e ch
arac
teri
zati
on
'of
atm
osp
her
ic
par
tic
ula
tes
to
ind
ica
te
the
ir
sou
rce
and
wou
ld
ass
ist
the
risk
ass
ess
men
t p
roc
ess
by
pro
vid
ing
dat
a o
n e
xpo
sur
e.
Hig
h c
onc
ent
rat
ion
short-term exposure is of concern.
     
Vinyl bromide (CAS Reg No: 593602) (Tables: 1 & 3)
  
    
    
    
Exposure profile: This compound was found in a discharge to the St. Clair
River but not quantified. No other data are available. Vinyl bromide is
lipophilic but its potential for bioaccumulation is uncertain.
Toxicity profile:
Oral LD50: Is 500 mg/kg in rats (30).
   
      
   
     
    
      
  
  
 
     
  
  
Carcinogenicity: Preliminary results from an inhalation study in rats
indicate that vinyl bromide induces tunor developnent in the liver and
other sites after exposure for up to 52 weeks at levels of 250 ppm and
1,250 ppn (31). IARC concluded that no evaluation was possible based on
the available data (102).
Chronic Adverse Effects: No adverse effects were observed in rats, rabbits
and monkeys exposed to up to 500 ppn vinyl bromide for 6 hr/day, 5 days/wk
for 6 months (30).
CNS Effects: Rats exposed to an atmosphere containing 10,000 ppm of vinyl
bromide became hypoactive and drowsy within one hour (30).
Reproductive Effects: No data found.
Teratogenicity: No data found.
 
Mutagenicity: Vinyl bromide has been shown to be mutagenic to Salmonella
typhimurium in the Ames test (30).
Permissible Exposure Limit: No data found.
Imnediately Dangerous to Life or Health: No data found.
Existing Environmental Regulations: None known.
    
    
      
  
 
Recomnendation: Data are insufficient to assess distribution and potential
for human exposure. Conpound should be detectable by established methods
of drinking water and effluent monitoring. Monitoring is recomnended
until a risk assessment can be made. Vinyl bromide may have similar
toxicological properties to vinyl chloride.
 
   
  
 
  
Vinyl Chloride (VC) (CAS Reg No: 75014) (Tables: 1 & 3)
Exposure profile: Vinyl chloride was detected in 11 discharges to the St.
Clair River but was not quantified. New York reports annual usage of over
50 million lbs with 1 million lbs on hand. Vinyl chloride is a gas, but
soluble in water at a level of 1 mg/L. It is moderately lipophilic and
the potential for bioaccumulation may be slight. Its volatility may
provide a mechanism for removal from aquatic systems. Concern is
primarily with groundwater contaminated by leachate from chemical
landfills containing chlorinated ethylenes.
 
   
Toxicity profile:
Oral L050: 500 mg/kg in rats (1).
Carcinogenicity: A confirmed human and animal carcinogen (67). Male rats
exposed 20 hr/wk for 12 months to conmercial grade vinyl chloride
developed skin and lung tunors and liver tumors. Angiosarcoma is a very
comnon tunor and has been identified in hunans exposed occupationally to
PVC (75) (102).
Chronic Adverse Effects: Rats treated with 500 ppm, 7 hr/day, 5 days/wk for 6
months showed increased liver weight and micropathology; increased liver
weight was also observed at 200 or 100 ppm. These changes were not seen
in dogs or guinea pigs (67). Rats exposed to 30,000 ppm for 4 hr/day, 5
days/wk for up to 12 months showed degenerative changes in the liver
(interstitial hepatitis), brain and kidney (tubular nephrosis and
interstitial nephritis). 302 workers exposed to vinyl chloride monomer
developed various lesions including sclerotic changes of the skin,
circulatory disturbances, osteolysis, thrombocytopenia, marked fibrosis of
portal tract and impaired liver function. Splenanegaly has also been
observed. 0f 48 workers exposed to 140—1,200 mg/m3 vinyl chloride
monomer some had signs of irritation of respiratory tract and hepatitis
while 23 showed increased hemoglobin levels in blood (75).
CNS Effects: VC may be a narcotic at high concentrations (67) and showed
degenerative changes in brain tissue in rats exposed to 30,000 ppm for up
to 12 months (75). Humans exposed to 1,000 ppm or more exhibit slight
anesthesia, drowsiness, slight visual disturbances, faltering gait,
numbness and tingling of extremities (73); a concentration of 2%% of vinyl
chloride in air for a period of 3 minutes causes dizziness and
disorientation (60); coma and convulsions have been observed (74).
Reproductive Effects: Increased fetal mortality has been reported.
Teratogenicity: A study of the effects of exposure to polyvinyl chloride in
male workers showed a significant increase in fetal loss after PVC
exposure. Studies in rodents and rabbits exposed to 50 to 2,500 ppm
(vapor) during organogenesis showed no fetal effects. However, in another
study in which pregnant rats were exposed to 1,500 ppm, there was an
increase in fetal mortality. No malfonnations have been reported (55).
131
 Mutagenicity: Positive in Saimoneiia, yeast, Droso hiia. A150 induces
chromosome aberrations in exposed human populations (65). However,
dominant iethai studies of male mice exposed to 3,000, 10,000 and 30,000
ppm for 5 days showed no mutagenic effects (67).
Permissibie Exposure Limit: None found.
Imnediateiy Dangerous to Life or Heaith: In humans, iowest dose giving toxic
effect is 500 ppm/4 yr intermittent exposure (1).
Existing Environmentai Reguiations: None known.
Recomnendation: Quantification of viny) chloride in effluents and water is
recomnended. This compound is detectabie with estabiished methods for
monitoring drinking water and effiuents for voiatiie haiogenated organics.
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Xylenes (CAS Reg No: 1330207) (Table: 4)
 
Exposure profile: The xylenes are used as industrial chemicals and as
solvents. They are a component of leaded gasolines. Ontario alone
handles over 100 million kg annually and discharges 37,000 kg to the Great
Lakes. New York usage is given as over 34 million lbs annually.
Additional anounts are dissipated into the atmOSphere from the use of
xylene as paint solvents and in gasoline. One study cited in Appendix E
shows 19 pg/L of xylenes in Lake Michigan. The xylenes are less soluble
in water than benzene or toluene and are biodegradable at moderate rates
by acclimated microbial comnunities. The low concentrations found are
likely to be the result of continuous inputs and slow biological
degradations.
     
       
 
       
    
    
Toxicity profile:
Oral L050: 4,300 mg/kg in rats (1).
        
Carcinogenicity: No data found.
   
Chro
nic
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40-5
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e d
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n r
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. R
ever
sibl
e li
ver
and
kidn
ey d
amag
e ha
ve b
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rted
afte
r
sub
acu
te
exp
osu
re
how
eve
r,
han
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poe
tic
cha
nge
s a
re
the
mos
t s
ign
ifi
can
t
44 .
  
      
     
CNS
Eff
ect
s:
Nar
cos
is
has
bee
n r
epo
rte
d a
t h
igh
con
cen
tra
tio
ns.
Oth
er
stud
ies
repo
rt d
izzi
ness
, ex
cite
nent
, d
rows
ines
s,
unco
ordi
nati
on a
nd
staggering (44).
   
    
Reproductive Effects: No data found.
  
  
Tera
toge
nici
ty:
Chic
k em
bryo
s
expo
sed t
o a
xyle
ne a
tmos
pher
e sh
owed
a hi
gh
mal
fon
nat
ion
rate
; h
alf
the
def
ect
s w
ere
rum
ple
ssn
ess
.
Exp
osu
re
of
pre
gna
nt
rat
s t
o 1
,00
0 m
g/m
3 p
rod
uce
d n
o t
era
ta
oth
er
tha
n m
ino
r
skeletal ananalies (55).
    
          
Mutagenicity: No data found.
Permissible Exposure Limit: 435 mg/m3 (OSHA) (42).
    
 
 
  
  
Immediately Dangerous to Life or Health: 10,000 ppm (OSHA) (42).
Existing Environmental Regulations: None known.
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TERMS OF REFERENCE
for the
JOINT SCIENCE ADVISORY BOARD/WATER QUALITY BORD
IJC COMMITTEE ON THE ASSESSMENT OF HUMAN HEALTH EFFECTS
OF GREAT LAKES WATER QUALITY
The Committee will take the following under its purview:
1.
assess the risk to health posed by contaminants in the Great Lakes
ecosystem;
2.
review action
levels and guidelines for selected substances;
A
3.
provide to the International
Joint Commission through its Boards,
M~”"‘
interpretation and consultation
on health matters;
and
4.
maintain awareness of current advances
and knowledge as they relate
to human health aspects of the Great Lakes ecosystem.
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